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ABSTRACT 
Chondroitin sulfate are ubiquitously expressed linear, sulfated polysaccharides that 
play critical roles in neuronal development and regeneration growth factor signaling, 
morphogenesis, and virus invasion. The diverse sulfation patterns presented by chondroitin 
sulfate has been suggested to regulate its activity, but the structural complexity and 
heterogeneity have hampered the understanding of structure-activity relationship. Therefore, 
we envisioned that chemically synthesized chondroitin sulfate oligosaccharide may provide 
a unique opportunity to specifically study the functions of sulfation patterns. 
Here, we report the synthesis of a CS-D and CS-E tetrasaccharide in a step-efficient 
manner. By generating a disaccharide precursor from hydrolysis of polysaccharides, we were 
able to streamline the synthesis and reduce the number of steps by one-third comparing to 
the traditional synthesis without losing versatility of the synthetic route and functionality of 
the final product. With the structurally defined molecules, we were able to determine the 
NMR solution structure of CS-D and CS-E. In this work, we accomplished the first structural 
study of CS-D tetrasaccharide and the most thorough study of CS-E to date. Furthermore, 
we also discovered the existence of a second conformer in CS-D, which is the first time for 
such behavior to be observed experimentally in chondroitin sulfate. The electrostatic 
potential surface constructed based on the NMR structure presented unique structural 
features that may allow proteins to interact specifically.  
The CS-D and CS-E tetrasaccharide, along with a CS-D disaccharide, was 
investigated for their neuritogenic activity. We discovered that the CS-D tetrasaccharide 
specifically stimulates dendritic growth whereas the CS-E tetrasaccharide preferentially 
promoted axonal growth, revealing the potential critical role chondroitin sulfate with specific 
sulfation patterns may play in the nervous system. The lack of activity of the CS-D 
disaccharide suggested that the minimum motif required for activity of CS-D is a 
tetrasaccharide.  
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C h a p t e r  1  
INTRODUCTION TO GLYCOSAMINOGLYCANS 
The glycosaminoglycan family 
Glycosaminoglycans (GAGs) are a diverse class of polysaccharides that are 
covalently attached to core proteins, forming proteoglycans (PGs). After GAGs are 
synthesized in the Golgi apparatus, GAGs are inserted into the plasma membrane, secreted 
into the extracellular matrix (ECM), or stored in intracellular granules. Although GAGs 
were once thought of as simply structural components of connective tissue, they are now 
known to mediating a myriad of cellular processes including but not limited to neuronal 
development1-3, neuroregeneration4-5, cancer metastasis6-9 and viral invasion10-12. 
Structurally speaking, GAGs are linear polysaccharides composed of repeating 
disaccharide units. The combination of variable length, disaccharide constituent and 
sulfation pattern of GAGs creates extraordinary structural diversity that enables them to 
interact with a wide range of biological molecules and participate in diverse biological 
activities.   
Families of GAGs 
Based on the disaccharide constituents, five families of GAGs (figure 1.1) have 
been established, namely chondroitin sulfate (CS), dermatan sulfate (DS), heparin and 
heparan sulfate (HS), keratan sulfate (KS) and hyaluronic acid (HA). CS is the most 
abundant family in brain and in cartilage13 and participates in numerous biological 
processes including neuronal development and regeneration5, growth factor signaling14, 
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morphogenesis15, and virus infection16. It is composed of repeating glucuronic acid (GlcA)-
N-acetylgalactosamine (GalNAc) disaccharide units joined by β(1→3) and β(1→4) 
linkages, respectively. There are four major sulfation patterns of CS: CS-A, -C, -D, and -E 
(figure 1.2) which contain sulfate groups at the 2-O position of GlcA or the 4-O or 6-O 
positions of GalNAc. Although 3-O sulfation of GlcA is known as well17-18, it is less 
common. The expression of different CS sulfation pattern is regulated spatiotemporally by 
the corresponding sulfotransferases (STs), however, little is known about the exact 
mechanism of regulation.  
 
Figure 1.1. Structures of the five GAG families.  
 
Figure 1.2. Structures of the four major sulfation pattern of CS.  
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The next GAG family, DS, is the predominant GAG present in skin. DS has been 
reported to play roles in coagulation19, cardiovascular disease20, and bacterial invation21. It 
is composed of repeating iduronic acid (IdoA)-GalNAc disaccharide units joined by 
β(1→3) and β(1→4) linkages, which is identical to CS except for only one different 
stereocenter orientation at C5 of uronic acid. DS can be sulfated at the 2-O of GlcA, 4-O, 
or 6-O of GalNAc like CS. However, the 2-O sulfation of GlcA and 4-O sulfation of 
GalNAc are more common in DS22.  
Together heparin and HS constitute the most well studied family of GAGs that are 
particularly important in anticoagulation23, cell growth and development24, angiogenesis25-
26, and viral invasion27-28. Arixtra (figure 1.3), a methylated heparin pentasaccharide, is an 
anticoagulant medication that has a market of ~$500 million. Heparin and HS are both 
composed of alternating α(1→4) N-acetylglucosamine (GlcNAc) and β(1→4) GlcA units 
or alternating α(1→4) GlcNAc and α(1→4) IdoA units. They also share the same available 
positions for modifications, namely the sulfation at the 3-O and 6-O position of GlcNAc, 
sulfation of the 2-O position of GlcA or IdoA and N-sulfation or N-acetylation. Although 
heparin and HS are structurally related, they are still different in some key aspects29. 
Heparin is only produced by connective tissue type mast cells and has a smaller size (7 – 
20 kDa), while HS is expressed ubiquitously and larger in size (10 – 70 kDa). Although 
both IdoA and GlcA are present in both heparin and HS, the IdoA content is markedly 
higher in heparin (>70%) than in HS (30% - 50%). The extent of sulfation is also different 
in that the number of sulfates/disaccharide ratio is 0.8 – 1.8 in HS and 1.8 – 2.6 in heparin. 
Heparin thereby possesses the highest negative charge density of any known biological 
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macromolecule30. Additionally, N-sulfation is much more common in heparin (>80%) than 
in HS (40% - 60%).  
 
Figure 1.3. Structure of Arixtra.  
CS, DS, heparin and HS are linked to the core proteins with the tetrasaccharide 
linker GlcA-Gal-Gal-Xylose (Xyl). As shown in figure 1.4, after the linker unit was 
covalently linked to a serine residue of the core protein, addition of the first hexosamine 
commits the GAG chain to either CS and DS (GalNAc) or HS and heparin (GlcNAc). 
Subsequent chain elongation, epimerization, deacetylation (HS and heparin), and 
sulfation of the GAG chains then generates the corresponding GAGs.  
 
Figure 1.4. Biosynthesis of CS, DA, HS, and heparin.  
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KS, the last family of sulfated GAGs, is composed of repeating disaccharide units 
of galactose (Gal)-GlcNAc joined by β(1→4) and β(1→3) linkages, respectively. KSs can 
be classified in three categories, KS-I, -II, and -III, based on the GAG-core protein 
linkage31: KS-I is composed of N-linked chains that are abundant in cornea. KS-II is 
composed of chains O-linked through GalNAc and identified in cartilage. KS-III is 
extended from O-linked mannose and has been isolated from brain tissue.  KS is related  to 
maintaining the proper hydration levels of the cornea, which is relevant to keep the 
transparency of the tissue32. Aside from the principal function in cornea, KS also 
participates in developmental biology, cellular signaling, and migration, like CS, DS, and 
HS32. Both GlcNAc and Gal in KS can be sulfated at C6, but GlcNAc sulfation is most 
abundant33. Since KS only have two sulfation sites, the structural diversity of KS is 
significantly less than that of CS and HS.  
HA is the only family of GAGs that is not sulfated. Interestingly, it is also the only 
GAG family that does not covalently bind to core proteins to form PGs. Instead, HA binds 
to PGs though link proteins. A single HA chain can be linked with multiple PGs and form 
a brush-like structure (figure 1.5). Normally, HA are composed of 2,000–25,000 
disaccharide units of β(1→3) GlcA β(1→4) GlcNAc, which corresponds to 
polysaccharides with relative molecular masses of 106 -107 and polymer lengths of 2–
25 μm. HA is abundant not only in soft connective tissues, but also in epithelial and neural 
tissues. Due to the size and anionic nature of HA, it has a unique capacity in retaining water 
and is important to retaining moisture in the skin and lubricating movable parts of the body, 
such as joints and muscles.  
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Figure 1.5. The brush-like structure of HA-PG complex.  
Tools to study the role of sulfation 
Among the modifications of GAG chains, namely epimerization, deacetylation, and 
sulfation, sulfation is the most important, as sulfation alone can give rise to hundreds of 
possible tetrasaccharide structures. Also, the sulfate groups provide a charged surface 
which allow GAGs to electrostatically interact with proteins. Indeed, GAGs are known to 
bind to several hundreds of proteins, and the sulfation pattern of GAGs allow selective 
interactions with different molecules34. For example, in the well-studied HS-fibroblast 
growth factor (FGF) interaction, the binding of particular FGFs requires specific sulfation 
patterns. While FGF-2 requires 2-O-sulfation but not 6-O-sulfation for HS binding, FGF-
10 has the reverse preference, and FGF-1 requires both 2-O-sulfation and 6-O-sulfation35. 
Signaling molecules in the central nervous system (CNS) such as semaphoring 3A36, 
midkine37-38, pleiotrophin39, and neurotrophins40 have also been reported to preferentially 
bind to CS with specific sulfation patterns .  
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While diverse sulfation patterns allow GAGs to be formed and interact specifically 
with different proteins, complexity of the sulfation pattern also hampers the understanding 
of the structure-activity relationship (SAR) of GAGs. Although a number of tools are 
available, not all them allow the study of strictly defined sulfation motif.  
Genetic and biochemical approaches such as known-down of STs or digestion of 
polysaccharide by lyases have established important biological implications for GAGs. 
However, STs do not function independently and the removal of one ST may lead to global 
changes of the sulfation profile, making it difficult to specify the activity of a particular 
sulfation pattern. On the other hand, while GAG lyases can be used to study the function 
of each GAG family, the impact of specific sulfation patterns cannot be determined. GAG 
polysaccharides and oligosaccharides can also be isolated from natural sources. However, 
although polysaccharides enriched in a sulfation patterns are available, they are still far 
from homogeneous. The oligosaccharides obtained by partial digestion of polysaccharides 
also suffer from heterogeneity due to the nature of lyases and the source polysaccharides. 
Furthermore, the inherent sulfation motifs in available polysaccharides and selectivity of 
the available digestion enzymes limits the variety of sulfation patterns available for study.  
Our group envisioned that chemical synthesis can provide a powerful solution to 
these challenges as the length, sulfation pattern, and stereochemistry are all fully under 
control38,41-43. Aside from the ability to obtain defined oligosaccharides, the freedom of 
chemical synthesis also facilitates the generation of GAG-conjugated tools that are 
otherwise unavailable. For example, microarrays conjugated with GAG oligosaccharides 
allows rapid identification of GAG-protein interaction38,44. Glycopolymers with GAG 
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oligosaccharides attached to a polymeric backbone enable the study of specific sulfation 
patterns in a multivalent and polysaccharide-like context42-43,45-46. GAG oligosaccharides 
conjugated to immunogenic carrier proteins allow the generation of the most sulfation 
pattern-specific antibodies4,38,44,47.   
In the present study, we achieved streamlined chemical synthesis of CS-D and CS-
E tetrasaccharides. Next, we successfully calculated the solution structure of the 
tetrasaccharides based on nuclear magnetic resonance (NMR) data. This is the first NMR 
structural study of a CS-D tetrasaccharide and the most thorough study of a CS-E 
tetrasaccharide to date. Neuritogenic activity in hippocampal neurons of the 
tetrasaccharides was also investigated. We discovered that the CS-D tetrasaccharide 
specifically stimulates dendritic outgrowth and the CS-E tetrasaccharide specifically 
stimulates axonal outgrowth.  
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CHEMICAL SYNTHESIS OF THE CS-D AND CS-E TETRASACCHARIDES 
 
Introduction 
While the sulfation patterns of CS are essential to regulate specific biological 
functions, the chemical complexity and inherent heterogeneity of CS polysaccharides have 
hampered the detailed study of SAR. Although CS polysaccharides enriched in a specific 
sulfation motif are commercially available, the polysaccharides are far from homogeneous, 
as shown in table 2.1. While CS-A, CS-C, and CS-E have around 50% of the desired sulfation 
motifs, the CS-D polysaccharide contains only 20% of the D motif, highlighting the need for 
methods to obtain homogeneous CS-D.  
 CS-A  CS-C CS-D CS-E CS-0a 
CS-A (Sigma)b 62% 30% NDc 0.3% 7% 
CS-C (Sigma)b 27% 49% 20% 2% 3% 
CS-D (Seikagaku)1 36% 43% 20% 1% NDc 
CS-E (Seikagaku)1 19% 8% NDc 56% 8% 
Table 2.1. Disaccharide composition analysis of commercially available polysaccharides. 
Suppliers are given in parenthesis. aUnsulfated chondroitin. bUnpublished data provided by 
Dr. Sheldon Cheung. cNot detectable.  
Available methods to prepare chondroitin sulfate oligosaccharide include enzymatic 
digestion, chemoenzymatic synthesis, and organic synthesis. The digestion approach2-5 
offers a straightforward way to obtain multiple CS oligosaccharides with a few steps. The 
sulfation pattern of the product oligosaccharide can also be tuned by the choice of enzyme 
and reactant polysaccharide to some extent. However, separation of the product 
oligosaccharides is challenging in that high purity samples are not always available. 
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Furthermore, the available oligosaccharide structures are still limited by the available 
selectivity of enzymes and the source structure. The unsaturated reducing end generated by 
chondroitinase digestion may also negatively impact the SAR determination.  
While chemoenzymatic synthesis of heparin oligosaccharide has been more 
extensively studied6-7, the chemoenzymatic synthesis of homogeneous CS oligosaccharide 
was not reported until recently8. Although the chemoenzymatic approach offers shorter 
synthetic routes and higher overall yields, available structures are still limited by available 
enzyme specificity9.  
Organic synthesis of CS oligosaccharides is still the most powerful method, as 
virtually any desired CS structure can be prepared, even those with non-natural motifs10. 
However, the synthetic routes are usually long and challenging. The first reported synthesis 
of CS-D tetrasaccharide took 38 steps in total11, highlighting the need for improved methods 
to access CS oligosaccharides. The synthesis of the CS-A, CS-C, and CS-E tetrasaccharide 
previously reported by our group10,12, while modular and efficient, still required 27 steps to 
obtain the CS-E tetrasaccharide. Traditionally, the synthesis of CS begins with 
monosaccharide precursors  
In this study, we took advantage of the selective acid hydrolysis of CS polysaccharide 
first reported by Levene13 and Meyer and Davidson14 and improved by the Jacquinet group15 
to rapidly access disaccharide starting material, as opposed to the traditional CS synthesis 
that begins with monosaccharide precursors. Part of the protecting group strategy developed 
by the Jacquinet group15-16 was also adapted. The disaccharide starting material significantly 
streamlined the synthesis by reducing the number of steps required to obtain our target 
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molecule, the CS-D and CS-E tetrasaccharides, by about one-third. We also installed an allyl 
group at the reducing end of the tetrasaccharides to serve as a versatile chemical handle, 
which has yet to be done for CS-D. Although a CS-D tetrasaccharide with a dithiolane moiety 
has been reported17, no description of source, preparation, or characterization is available in 
the publication.  
To study the 3-D structure and neuritogenic activities of the CS-D and CS-E sulfation 
motifs, we chose to chemically synthesize the CS-D tetrasaccharide (1) and CS-E 
tetrasaccharide (2). The CS-D disaccharide (3) was also synthesized to determine the 
minimum length of the CS-D motif required for activity. The CS-E disaccharide has been 
synthesized in a previous study and reported to have no significant neuritogenic activity12, 
and hence is not included in the present study.  
 
Figure 2.1. Target CS oligosaccharides. All = allyl.  
Synthetic Design of the CS-D tetrasaccharide and disaccharide  
To synthesize the desired CS-D disaccharide and tetrasaccharide, we decided to 
utilize the polysaccharide digestion method13-14,16 to obtain the key disaccharide intermediate 
7. The key disaccharide intermediate will be further derivatized to the corresponding 
disaccharide donor 5 and acceptor 6 for the coupling reaction. The CS-D disaccharide 4 can 
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also easily be derivatized from the disaccharide donor 5. We chose to install an allyl group 
at the reducing end of the oligosaccharides as a convenient chemical handle for conjugation 
to proteins, small molecules, or surfaces, as previously developed by our group12,18. To 
ensure proper stereochemistry, regioselectivity, and orthogonality, the protecting groups 
were carefully chosen to facilitate the synthesis.  
 
Scheme 2.1. Retrosynthesis of the CS-D tetrasaccharide and disaccharide. All = allyl, Me = 
methyl, Lev = levulinyl, Bz = benzoyl, MCA = chloroacetyl, TCA = trichloroacetyl, Ph = 
phenyl, Ac = acetyl. 
For the most important step in the synthesis, the coupling reaction, the Schmidt 
trichloroacetimidate method19-20 was adopted for its mild reaction conditions, good 
stereocontrolling ability, and convenient donor preparation. To ensure β-glycoside 
formation, the neighboring participating group trichloroacetamide has been reported to be a 
powerful stereocontrolling auxiliary. Also, trichloroacetamides can be easily reduced to 
acetamides by tributyltin hydride in one step and was therefore chosen to be installed at the 
C2 position of GalNAc. 2-naphthylmethyl group was used to temporarily protect the C1 
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position of GalNAc for the selective and convenient deprotection with 2,3-Dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ).    
Benzoyl groups was used to protect the free hydroxyl groups of CS for its robustness 
because they were removed at the latest stage of the synthesis. The C4 position of GlcA is 
the glycosidic linkage site so a levulinyl group that can be selectively removed by hydrazine 
hydrate was used. The levulinyl group can also be removed by the same condition used to 
remove the benzoyl groups, saving one step at the final stage. For the sulfation sites of CS-
D, the C2 position of GlcA, and C6 position of GalNAc, chloroacetyl groups that can be 
selectively cleaved by thiourea were installed. Finally, a methyl group was chosen to mask 
the carboxylic acid that can deprotected along with other ester groups in the final stage.  
Synthesis of the CS-D disaccharide donor 
Starting from the rigorous acid hydrolysis, chondroitin polysaccharide was digested 
by sulfuric acid to produce the GlcA-GalNAc disaccharide with all the sulfates and acetyl 
groups removed. Esterification of the carboxylic acid with dilute methanolic HCl then 
rendered the methyl ester 8. N-Trichloroacetylation was achieved by pertrichloroacetylation 
with an excess of trichlroacetyl chloride followed by methanolysis of the O-trichloroacetyl 
esters. Purification of compound 9 was difficult, presumably because of the high polar and 
the degraded products from hydrolysis. However, further experiments showed that this 
product doesn’t need to be completely purified at this stage.  
The first differentiation of the hydroxyl groups was achieved by the selective 
formation of the 4,6-benzilidene acetal in the presence of three other hydroxyl groups. The 
following peracetylation then gave the temporary protection to the rest of the hydroxyl 
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groups. Selective deprotection of the anomeric acetate with hydrazine acetate followed by 
treatment with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and trichloroacetonitrile gave the 
α-acetimidate 7 exclusively under kinetic control.  
 
Scheme 2.2. Synthesis of the key disaccharide intermediate 7. Me = methyl, TCA = 
trichloroacetyl, Ph = phenyl, Ac = acetyl. 
Glycosylation of 7 with 2-naphthalenemethanol by catalytic Lewis acid boron 
trifluoride etherate gave the β-glycoside exclusively with good yield. 2,3,4-O-acetate 
deprotection was carried out under Zemplén transesterification condition with sodium 
methoxide. We tried several base loadings and reaction times after we found that the 
trichloroactamide could also be deprotected by sodium methoxide. The best result was 
obtained at 20 min duration and 0.33 equivalence of base per acetate (table 2.2). Preferential 
2,3-isopropylidene formation of the triol 19 could be achieved by 2-methoxypropene and 
camphorsulfonic acid (CSA). Treatment of 13 with levulinic acid, dicyclohexylcarbodiimide 
(DCC), and 4-dimethylaminopyridine (DMAP) afforded 14 with excellent yield. The 
isopropylidene acetal was then removed by mild acid hydrolysis. Since removal of 
benzylidene acetal was observed, we quenched the reaction prematurely to avoid tetraol 
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formation and recovered starting material. Therefore, the apparent yield 55% can be 
increased to an overall yield of 81% with two extra hydrolysis of recovered 14.  
 
Scheme 2.3. Synthesis of the disaccharide donor 5.  Me = methyl, Lev = levulinyl, Bz = 
benzoyl, MCA = chloroacetyl, TCA = trichloroacetyl, Ph = phenyl, Ac = acetyl, Nap = 2-
naphylmethyl. 
Regioselective benzoylation of the 3-hydroxyl group was achieved by benzoyl 
cyanide without forming 2-O-benzoate. Chloroacetic anhydride was then used to mask the 
2-O-sulfation site.  After a rigorous hydrolysis, the benzylidene acetal was removed to give 
diol 17. Selective chloroacetylation of the primary alcohol was achieved by slow addition of 
chloroacetic anhydride at low temperature. The last hydroxyl group was then protected by 
benzoyl chloride, affording the fully protected disaccharide 19. Consecutive DDQ and 
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trichloroacetonitrile/DBU treatment then gave the disaccharide donor 5 activated at the C1 
position. The CS-D disaccharide 3 and disaccharide acceptor 6 were then synthesized from 
the donor 5.  
 
Entry NaOMe Reaction time Yield 
1 2 eq 3 h 15% 
2 2 eq 2 h 27% 
3 1.5 eq 1 h 40% 
4 1 eq 40 min 70% 
5 1 eq 20 min 76% 
Table 2.2. Optimization of O-acetate deprotection of 12. Me = methyl, Ac = acetyl, TCA = 
trichloroacetyl, Ph = phenyl, Nap = 2-naphthylmethyl. 
Synthesis of the CS-D disaccharide 
The disaccharide donor 5 was first treated with allyl alcohol and 
trimethylsilyl trifluoromethanesulfonate (TMSOTf) to give the allyl glycoside 21. 
Interestingly, the 6-O-chloroacetate was deprotected upon the use of excess allyl alcohol, but 
the 2-O-chloroacetate remained intact. Both allyl glycoside 21 and 22 can be transformed 
into the diol 23 by thiourea.  
 
Scheme 2.4. Synthesis of diol 21. Me = methyl, TCA = trichloroacetyl, MCA = chloroacetyl, 
Lev = levulinyl, Bz = benzoyl, All = allyl.  
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Initial attempts to reduce the trichloroacetyl groups were unsuccessful due to the 
formation of partially reduced byproduct 25. Both tributyltin hydride/ 
azobisisobutyronitrile (AIBN) and Zn/Cu conditions were explored (table 2.3). The best 
result was obtained with a high equivalence of tributyltin hydride and AIBN at elevated 
temperature in toluene.  
 
Entry Reactant Reagent Condition Product 
1 23 6 eq. HSnBu3, 0.15 eq 
AIBN 
80 °C in benzene, 3 h 25 
2 25 10 eq. HSnBu3, 0.15 eq 
AIBN 
80 °C in benzene, 6 h 25 
3 23 15 eq. Zn/Cu 
 
55 °C in AcOH, 24 h 25/24 (4:1)a 
4 25 15 eq. Zn/Cu 
 
55 °C in AcOH, 24 h 25/24 (4:1)a 
5 23 + 25 15 eq. Zn/Cu + 15 eq. 
Zn/Cu after 24h 
75 °C in AcOH, 60 h 25/24(1:4)ab 
6 23 12 eq HSnBu3, 1.2 eq 
AIBN 
110 °C in toluene 24 (74%) 
Table 2.3. Optimization of trichloroacetamide reduction. Me = methyl, Ac = acetyl, TCA = 
trichloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl. aProduct ratio is determined by 
LC-MS. b Unidentified side product was found. 
Complete sulfation was then achieved by a large excess of sulfur trioxide 
trimethylamine complex in 48 h. A two-step saponification process was then carried out 
with sequential addition of LiOH/H2O2 and NaOH to avoid potential β-elimination at the 
GlcA21, affording the desired CS-D disaccharide 3. 
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Scheme 2.5. Synthesis of the CS-D disaccharide 3. Me = methyl, Ac = acetyl, TCA = 
trichloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl 
Structure of the CS-D disaccharide 3 was confirmed by NMR (see appendix for 
chapter 2). The doublet for the anomeric proton of GalNAc and GlcA has a J value of 7.7 
and 8.0 Hz, respectively, demonstrating the β-glycosidic bond. The C-2 proton of GlcA and 
the C-6 protons of GalNAc are at 4.07 ppm and 4.16 – 4.21 ppm, respectively, indicating the 
sulfation sites22.  
Synthesis of the CS-D tetrasaccharide 
The allyl glycoside 21 was first transformed to the disaccharide acceptor 6 by 
treatment of hydrazine hydrate, which selectively removed the levulinyl group. With the 
donor and acceptor in hand, we first attempted the coupling reaction with TMSOTf at room 
temperature. However, the donor was transformed into the oxazoline and was unable to react 
with the acceptor. We then tried the reaction with different Lewis acids, catalyst loading, 
equivalence of acceptor, temperature, and reaction time (table 2.4), but the desired 
tetrasaccharide was still not observed. Trimethylsilyl ether 28 was observed with TMSOTf 
treatment in elevated temperature (entry 3). High Bu2BOTf loading with long reaction time 
transformed the oxazoline to the hydrolyzed and decomposed product as determined by LC-
MS (entry 10).  
 
Scheme 2.6. Synthesis of the disaccharide acceptor 6. Me = methyl, TCA = trichloroacetyl, 
MCA = chloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl. 
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Entry Donor 5 Catalyst Condition Product 
1 1.5 eq TMSOTf (0.2 eq) DCM, RT, 1 h 26 + 6 
2 1.2 eq TMSOTf (0.2 eq) DCM, RT, 3 h 26 + 6 
3 1.2 eq TMSOTf (0.2 eq) DCE, 40 °C, 3 h 26 + 6 + 7 
4 1.2 eq TBSOTf (0.2 eq) DCM, RT, 3 h 26 + 6 
5 1.2 eq TBSOTf (0.2 eq) DCE, 40 °C, 3 h 26 + 6 
6 1.2 eq BF3·Et2O (1.0 eq) DCE, 40 °C, 3 h 26 + 6 
7 1.2 eq Bu2BOTf (0.1 eq) DCM, -45 °C  
to -20 °C, 3h 
26 + 6 + 5 
8 1.2 eq Bu2BOTf (0.1 eq) DCM, RT, 3 h 26 + 6 
9 1.2 eq Bu2BOTf (0.3 eq) DCE, 40 °C, 3 h 26 + 6 
10 1.5 eq Bu2BOTf (0.3 eq + 
0.6 eq after 12 h) 
DCE, 40 °C, 16 h 6 + byproductsa 
11 1.2 eq TMSOTf (0.2 eq) DCM, RT, 2 h, in 
glove box 
25 (40%) + 6 
12 1.2 eq TMSOTf (0.2 eq) DCM, RT, 2 h, in 
Schlenk flask 
25 (58%) +6 
Table 2.4. Optimization of the coupling reaction. Me = methyl, MCA = chloroacetyl, TCA 
= trichloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl, TMS = trimethylsilyl. a-
Oxazoline derived byproducts as determined by the disappearance of oxazoline spot on TLC 
or peak in HPLC.  
Since the initial attempts were all carried out with the presence of 4Å molecular 
sieves (entry 1-10), we next tried the reaction without molecular sieves in a glove box to 
avoid moisture. To our delight, the desired tetrasaccharide was observed and isolated (entry 
11). Further attempts to carry the reaction with a Schlenk flask in a common hood were also 
successful (entry 12). While molecular sieves are commonly used in glycosidation reactions 
to prevent hydrolysis of the acetimidates resulted from trace amount of water, their slightly 
basic nature of may be the cause of oxazoline formation. Fortunately, by achieving strictly 
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dry conditions with Schlenk flasks in the absence of molecular sieves, we were able to 
prevent both hydrolysis and oxazoline formation. 
After obtaining the tetrasaccharide 26, thiourea treatment then selectively removed 
the chloroacetyl groups, exposing the sulfation sites. Radical-mediated reduction of the N-
trichloroacetyl group with tributyltin hydride and AIBN provided 29. Complete sulfation was 
achieved by a large excess of sulfur trioxide trimethylamine complex in 48 h in one step 
without partially sulfated product as determined by HPLC. Sequential addition of 
LiOH/H2O2 and NaOH resulted in complete ester hydrolysis and gave the target CS-D 
tetrasaccharide 1.  
 
Scheme 2.7. Synthesis of the CS-D tetrasaccharide 1. Me = methyl, MCA = chloroacetyl, 
TCA = trichloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl. 
Structure of the CS-D tetrasaccharide 1 was also confirmed by NMR (see appendix 
for chapter 2). The doublet for the anomeric protons of the GalNAc and GlcA units have J 
values of 8.4, 8.0, 7.3, and 7.6 Hz, all indicating the β-glycosidic bond of each linkage. The 
C-2 protons of GlcA are at 4.06 and 4.12 ppm, confirming the 2-O-sulfation. The C-6 protons 
28 
 
of GalNAc are at 4.16-4.19 ppm and 4.20 – 4.22 ppm, also fully consistent with the chemical 
shift of 6-O-sulfated C-6 protons22.  
Synthetic design of the CS-E tetrasaccharide 
The Schmidt glycosidation and the neighboring participating group 
trichloroacetamide was adopted for the synthesis of CS-E tetrasaccharide as well. Since we 
do not attempt to synthesize oligosaccharides longer than tetrasaccharides in this study, we 
envisioned that the key disaccharide intermediate can be directly used as the disaccharide 
donor, which saved a great amount of material. The sulfation sites, the C4 and C6 position 
of GalNAc were already protected with a benzylidene acetal that can be selectively removed. 
The rest of the hydroxyl groups can stay protected with acetyl groups and do not require 
further differentiation. If longer oligosaccharides are desired, the donor used in the coupling 
reaction can still be derived from an intermediate in the synthesis of disaccharide acceptor 
32 without the need to develop an independent route.  
 
Scheme 2.8. Retrosynthesis of the CS-E tetrasaccharide. All = allyl, Me = methyl, Lev = 
levulinyl, Bz = benzoyl, TCA = trichloroacetyl, Ph = phenyl, Ac = acetyl. 
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The acceptor was designed accordingly. The C4 position of GlcA was protected with 
a levulinyl group to facilitate the (1→4) linkage. C2 and C3 position of GlcA were protected 
with benzoyl groups. The C4 and C6 position of GalNAc was masked with a benzylidene 
acetal to allow a 1-step deprotection to expose all the sulfation sites of the CS-E 
tetrasaccharide. This protecting group strategy also allows the synthesis of the CS-A and CS-
C tetrasaccharide, as the primary alcohol can be either selectively sulfated or protected after 
hydroxyl groups at the C4 and C6 position are exposed.   
Synthesis of the CS-E tetrasaccharide 
Glycosylation with allyl alcohol by catalytic TMSOTf gave the β-glycoside 33 
exclusively with excellent yield. Deprotection of the acetate group and preferential 2,3-
isopropylidene formation gave alcohol 34 smoothly. Protection of the C4 position of 34 with 
levulinyl group was achieved with excellent yield. The 2,3-isopropylidene was then removed 
with mild acid hydrolysis. Similar to the synthesis of CS-D, benzylidene deprotection was 
observed during the reaction. Benzoylation of the free 2,3-hydroxyl groups and subsequent 
deprotection of the levulinyl group then afforded the disaccharide acceptor 32.  
Optimization of the coupling reaction (table 2.5) successfully allowed the 
tetrasaccharide 37 to be obtained with moderate yield. Next, hydrolysis under mild acidic 
condition removed the benzylidene groups, exposing the sulfation sites. Treatment of 
HSnBu3 and AIBN in toluene/N,N-dimethylacetamide then reduced the trichloroacetamide 
group. Exhaustive sulfation was achieved by a large excess of sulfur trioxide trimethylamine 
complex in 48 h to give the sulfated tetrasaccharide 39. The CS-A and CS-C tetrasaccharides 
can be easily derived from tetrasaccharide 39 with 3 and 2 steps, respectively, as shown in 
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scheme 2.11. Saponification was then carried out with LiOH/H2O2 treatment followed by 
NaOH/MeOH to yield the CS-E tetrasaccharide 2. It should be noted that the sulfated 
tetrasaccharide 39 is very acid sensitive. Near-complete decomposition was observed when 
the compound was left in an acidic condition (pH ≈ 3.5) for 12 h.  
 
Scheme 2.9. Synthesis of the CS-E disaccharide acceptor 32. All = allyl, Me = methyl, Lev 
= levulinyl, Bz = benzoyl, MCA = chloroacetyl, TCA = trichloroacetyl, Ph = phenyl, Ac = 
acetyl. 
 
Entry Donor 7 TMSOTf Yield 
1 1.3 eq 0.2 eq 20% 
2 1.6 eq 0.2 eq 28% 
3 2.0 eq 0.2 eq 29% 
4 2.0 eq 0.4 eq 35% 
5 2.0 eq 0.6 eq 50% 
Table 2.5. Optimization of the coupling reaction. Me = methyl, Ac = acetyl, TCA = 
trichloroacetyl, Ph = phenyl, TCA = trichloroacetyl, Bz = benzoyl.   
31 
 
Structure of the CS-E tetrasaccharide 2 was confirmed by NMR (see appendix for 
Chapter 2). The doublet for the anomeric protons of the GalNAc and GlcA units have J 
values of 8.5, 7.9, 7.3, and 7.8 Hz, all indicating the β-glycosidic bond of each linkage. The 
characteristic C4 protons of GalNAc units are at 4.83 and 4.77 ppm, confirming the 4-O-
sulfation22. The C6 protons of GalNAc are at 4.16-4.21 ppm and 4.24 – 4.29 ppm, also fully 
consistent with the chemical shift of 6-O-sulfated C-6 protons22.  
 
Scheme 2.10. Synthesis of the CS-E tetrasaccharide 1. Me = methyl, MCA = chloroacetyl, 
TCA = trichloroacetyl, Lev = levulinyl, Bz = benzoyl, All = allyl. 
 
Scheme 2.11. Derivatization of 39 towards the CS-A and CS-C tetrasaccharides.  
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Conclusion 
In summary, we developed synthetic routes for CS-D and CS-E tetrasaccharides 
equipped with an allyl group functional handle in a step-efficient manner. By taking 
advantage of the disaccharide precursor generated by hydrolysis, the number of steps 
required to obtain the tetrasaccharides are reduced to 26 steps and 19 steps, which are roughly 
one-third less than the 38 steps and 27 steps required in traditional synthesis that utilized 
monosaccharide precursors. While the synthesis of the CS-E tetrasaccharide is shortened, 
our protecting group strategy still allows rapid access to the CS-A and CS-C tetrasaccharide 
like our previous synthesis does10. The chemically synthesized homogenous compounds 
allowed us to investigate the 3-D structure and neuritogenic activity of CS with the D and E 
sulfation pattern.   
Experimental Methods 
General Methods 
Unless stated otherwise, reactions were performed in flame dried glassware under an 
argon atmosphere using dry solvents (distilled or passed over a column of activated alumina). 
Molecular sieves were flame dried prior to use. All other commercially obtained reagents 
were used as received, unless otherwise noted. Thin-layer chromatography (TLC) was 
performed using E. Merck silica gel 60 F254 precoated plates (0.25 mm).  Visualization of 
the developed chromatogram was performed by UV, cerium ammonium molybdate and 
ninhydrin stain, as necessary. ICN silica gel (particle size 0.032 – 0.063 mm) was used for 
flash chromatography. 1H, 13C NMR experiments were recorded on Varian Inova 500 (at 500 
MHz), or Bruker AVANCE AV400 (at 400 MHz) and are reported relative to residual 
solvent peaks. Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity (s = 
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singlet, d = doublet, t = triplet, m = multiplet), coupling constant in Hz, and integration. 13C 
NMR spectra were obtained on a Varian Inova 500 (at 125 MHz) or Bruker AVANCE 
AV400 (at 100 MHz) and are reported in terms of chemical shift relative to residual solvent 
peaks. Chemical shift of 13C spectra were measured in aqueous solvent were determined 
using the absolute reference method. When necessary, proton and carbon assignments were 
assigned by means of 1H-1H COSY, and 1H-13C HSQC. High-resolution mass spectrometry 
was performed at the Mass Spectrometry Facility at the California Institute of Technology 
on either a JEOL JMS-600H High Resolution Mass Spectrometer or a UPLC-LCT Premier 
XT TOF Mass Spectrometer. 
O-(Methyl β-D-glucopyranosyluronate)-(1→3)-2-amino-2-deoxy-D-galactopyranose 
hydrochloride (8). 
A solution of chondroitin sulfate (50 g) in water (500 ml) was acidified with 
Amberlite® IR120 Hydrogen form resin to pH 1.6. The resin was filtered off and washed 
with water (4 x 100 ml). The volume of the filtrate was adjusted to 970 ml. Concentrated 
H2SO4 (18 M, 27.8 ml) was added, and the mixture was stirred for 6 h at 100 
°C, After the 
solution was cooled down, Ba(OH)2 was added portionwise under vigorous stirring to pH 
3.5. The slurry was allowed to sit overnight. The solids were then filtered off through a celite 
pad, washed with water, and the yellow filtrate was concentrated to approximately 500 ml 
and slowly applied to a column of Amberlite IR-120 [H+] resin (500 ml, settled volume). The 
column was washed with water (1 L), AcOH/water (3:1, 1 L), then with aqueous HCl (1m, 
3 L). The fractions containing ninhydrin-positive material were collected, concentrated, 
evaporated with water (2 x 500 ml), and dried under vacuum. The residue was treated with 
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methanolic HCl (0.02 M, 500 ml) for 4 d at 0 °C. Co-evaporation of the solution with absolute 
EtOH several times gave the crude product as greyish powder (36.0 g).  
O-(Methyl β-D-glucopyranosyluronate)-(1→3)-2-deoxy-2-trichloroacetamido-D-
galactopyranose (9).  
Trichloroacetyl chloride (85 ml, 0.76 mol) was slowly added to a solution of crude 8 
(27 g, 0.65 mol) in pyridine (300 ml) at 0 °C and the solution was stirred at 0 °C for 1 h. 
Water (35 ml) was then slowly added to the solution by an addition funnel. The solution was 
then diluted with CH2Cl2 (600 ml) and washed quickly with cold water and brine. A solution 
of the residue in MeOH/CH2Cl2/pyridine (1:1:1, 200 ml) was stirred for 4 h at RT and was 
then concentrated. Flash silica chromatography (MeOH/CH2Cl2 1:4) gave the product (18.3 
g, 50% from the polysaccharide) as a brown foam. 1H NMR (300 MHz, D2O, internal H2O, 
δH=4.79): δ = 5.30 (d, J=3.8 Hz; GalNAc H-1α), 4.72 (d, J =6.3Hz; GalNAc H-1β), 4.40-
4.00 (m, 5H), 3.90-3.80 (m, 2H), 3.85 (s, 3H; COOCH3), 3.75- 3.35 (m, 6H). 
O-(Methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-1-Oacetyl-4,6-O-
benzylidene-2-deoxy-2-trichloroacetamido-D-galactopyranose (10).  
A mixture of 9 (14.9 g, 28.9 mmol), trifluoroacetic acid (5.6 ml) and benzaldehyde 
(110 ml) was stirred for 24 h at RT. Anhydrous NaOAc (9.2g, 112 mmol), pyridine (110 ml) 
and acetic anhydride (70 ml) was then added sequentially and the mixture was stirred for 16 
h. The mixture was poured into crushed ice and stirred for 2h. The mixture was then extracted 
with CH2Cl2 (3 x 200 ml) and the organic layer was washed with water, saturated aqueous 
NaHCO3, and water. The organic phase was dried over MgSO4 and concentrated. Flash silica 
chromatography (acetone/CH2Cl2 1:15 to 1:12) gave the product as a white powder (9.0g, 
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40%). 1H NMR (500 MHz, CDCl3): δ = 7.50-7.30 (m, 5H), 6.80 (d, J=7.8 Hz, 1H; GalNAc 
NH), 6.47 (d, J1,2=3.4 Hz,1H; GalNAc H-1), 5.53 (s, 1H; CHPh), 5.30-5.19 (m, 3H) 5.08 
(m, 1H), 4.94 (d, 1H), 4.64 (m, 1H), 4.47 (m, 2H), , 4.07 (m, 3H; 2GalNAc H-6, GlcA H-5), 
3.84 (s, 1H), 3.73 (s, 3H; COOCH3), 2.17 (s, 3H), 2.02 (s, 3H), 2.01 (s, 6H).  
O-(Methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-4,6-Obenzylidene-2-
deoxy-2-trichloroacetamido-1-O-trichloroacetimidoyl-α-D-galactopyranose (7). 
A mixture of 10 (11.5 g, 14.9 mmol) and hydrazine acetate (2.4 g, 25 mmol) in DMF 
(100 ml) was stirred for 30 min at RT. The mixture was then diluted with EtOAc (300 ml) 
and washed with water, brine, and water. The organic phase was dried over MgSO4 and 
concentrated. A mixture of the residue, CCl3CN (13 ml, 130 mmol) and DBU (350 µl, 2.3 
mmol) in CH2Cl2 (100 ml) was stirred for 1 h. Then more DBU was added and stirred until 
TLC showed completion. The solvent was removed. Flash silica chromatography 
(EtOAc/CH2Cl2 1:10) and recrystallization from diethyl ether gave the product (7.4g, 57%) 
as a white powder. 1H NMR (500 MHz, CDCl3): δ = 8.76 (s, 1H; NH), 7.55–7.30 (m, 5H; 
Ar-H), 6.78 (d, J=8.2 Hz, 1H; GalNAc NH), 6.64 (d, J=3.4 Hz, 1H; GalNAc H-1), 5.57 (s, 
1H; CHPh), 5.22 (m, 2H), 5.09 (t, J=8.0 Hz, 1H), 4.95 (d, J=7.7 Hz, 1H), 4.77 (m, 1H), 4.55 
(d, J=3.4 Hz, 1H), 4.39 (dd, J=11.0 Hz, 3.5 Hz, 1H), 4.33 (d, 12.7 Hz, 1H), 4.12–4.05 (m, 
2H), 3.92 (s, 1H), 3.72 (s, 3H; COOCH3), 2.02 (s, 3H; COCH3), 2.01 (s, 3H; COCH3), 2.00 
(s, 3H; COCH3). 
2-Naphthylmethyl O-(methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-
4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (12).  
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A mixture of the trichloroacetimidate 7 (20.1 g, 23.1 mmol), 2-naphthalene methanol 
(5.7 g, 36.1 mmol) and 4 Å molecular sieves (2.50 g) in CH2Cl2 (180 ml) was stirred under 
argon at RT for 1 h. The mixture was then cooled down to -60 °C before borontrifluoride 
etherate (300 µl, 2.43 mmol) in CH2Cl2 (2.3 ml) was added. The mixture was slowly warmed 
to -20 °C in 3 h and then quenched with triethylamine, filtered, and concentrated. Flash silica 
chromatography (EtOAc/CH2Cl2 1:10) and gave the product (16.7 g, 83%) as a white solid. 
1H NMR (500 MHz, CDCl3): δ = 7.80–7.30 (m, 12H; Ar-H), 7.05 (d, J=6.9 Hz, 1H; GalNAc 
NH), 5.62 (s, 1H; CHPh), 5.17 (m, 3H, 5.04(dd, J=8.8, 8.2 Hz, 1H), 4.95 (ABq, 2H; CH2Ar), 
4.90 (d, 1H, J=7.6 Hz), 4.67 (dd, J=11.2, 3.5 Hz, 1H), 4.46 (d, 1H; J=3.4 Hz), 4.41 (dd, 1H; 
J=12.5, 1.6 Hz), 4.03 (d, J=1.8 Hz, 1H), 4.00 (d, J=9.9 Hz, 1H) 3.90 (m, 1H;), 3.71(s, 3H; 
COOCH3), 3.55 (s, 1H), 2.01 (s, 3H; COCH3), 2.00 (s, 3H; COCH3), 1.99 (s, 3H; COCH3). 
2-Naphthylmethyl O-(methyl 2,3-O-isopropylidene-β-D-glucopyranosyluronate)-
(1→3)-4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (13).  
0.5 M Methanolic sodium methoxide (2.5 ml,1.25 mmol) was added to a solution of 
12 (1.1g, 1.25 mmol) in dry THF/methanol (1:4, 12.5 ml) and the solution was stirred for 30 
mins. The mixture was then neutralized with Amberlite IR-120 [H+] resin, filtered, and 
concentrated to give the crude triol 20. 2-Methoxypropene (150 µl, 1.58 mmol) were added 
every 20 min to a solution of the crude triol 20 and CSA (88 mg, 0.38 mmol) in DMF (10 
ml). Triethylamine (0.5 ml) was added and the mixture was concentrated. The residue was 
dissolved in EtOAc (30 ml) and washed with saturated aqueous NaHCO3, brine, and water, 
dried with MgSO4, and concentrated. Flash silica chromatography (EtOAc/Hexane 4:6 to 
6:4, containing 0.5% triethylamine) gave the product as a white solid (587 mg, 60%). 1H 
NMR (500 MHz, CDCl3): δ = 7.85-7.30 (m, 12H; Ar-H), 7.21 (d, J=6.6 Hz, 1H; GalNAc 
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NH), 5.60 (s, 1H; CHPh), 5.33 (d, J=8.2 Hz, 1H), 4.93 (ABq, 2H; CH2Ar), 4.79 (d, J=11.7 
Hz, 1H), 4.74 (dd, J=11.3, 3.6 Hz, 1H), 4.47 (d, J=3.4 Hz, 1H), 4.41 (dd, J=12.4, 1.6 Hz, 
1H), 4.13 (dd, J=12.4, 1.7 Hz, 1H), 4.07 (m, 1H), 3.90 (m, 1H), 3.83-3.80 (m, 4H), 3.57 (s, 
1H), 3.58-3.39 (m, 2H), 3.21 (d, J=2.3 Hz, 1H), 1.41 (s, 3H), 1.38 ppm (s, 3H)  
2-Naphthylmethyl O-(methyl 2,3-O-isopropylidene-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-4,6-O-benzylidene-2-deoxy-2-trichloroacetamido- 
β-D-galactopyranoside (14).  
DCC (1.74 g, 8.3 mmol) was added portionwise to a mixture of 13 (5.22 g, 6.7 mmol), 
levulinic acid (661 µl, 8.3 mmol) and DMAP (230 mg, 1.8 mmol) in dry CH2Cl2 (83 ml) and 
stirred for 5 h. The solids were filtered off and washed with CH2Cl2/hexane (1:1) several 
times. The filtrate was washed with saturated aqueous NaHCO3 and water, dried with MgSO-
4, and concentrated. Flash silica chromatography (EtOAc/CH2Cl2 1:10, containing 0.5% 
triethylamine) gave the product (5.80 g, 99%) as a white solid. 1H NMR (500 MHz, CDCl3): 
δ = 7.82–7.30 (m, 12H; Ar-H), 7.17 (d, J=6.6 Hz, 1H; NH), 5.62 (s, 1H; CHPh), 5.27 (m, 
2H), 4.95 (ABq, 2H; CH2Ar), 4.88 (d, J=7.3 Hz, 1H), 4.71 (dd, J=11.2 Hz, J=3.3 Hz, 1H), 
4.42 (d, J=3.5 Hz, 1H), 4.40 (dd, J=1.7, 12.5 Hz, 1H), 4.13 (dd, J=1.7, 12.5 Hz, 1H), 3.92 (d, 
J=8.3 Hz, 1H), 3.90 (m, 1H), 3.69 (s, 3H; COOCH3), 3.62–3.52 (m, 3H), 2.85–2.55 (m, 4H), 
2.18 (s, 3H; COCH3), 1.39 (s, 3H), 1.35 (s, 3H). 
2-Naphthylmethyl O-(methyl 4-O-levulinoyl-β-D-glucopyranosyluronate)-(1→3)-4,6-
O-benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (15).  
A solution of 14 (6.90 g, 7.8 mmol) in CH2Cl2/AcOH/water (5:4:1, 140 ml) was 
stirred for 20 h at RT. The solution was then concentrated and azeotroped with toluene three 
38 
 
times. Flash silica chromatography (MeOH/CH2Cl2 1:19, containing 0.5% triethylamine) 
gave the product (4.8 g, 73%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 7.85–7.32 
(m, 12H; Ar-H), 7.08 (d, J=6.9 Hz, 1H; NH), 5.60 (s, 1H; CHPh), 4.96 (ABq, 2H; CH2Ar), 
5.14 (d, J=8.2 Hz, 1H), 5.03 (dd, J=9.2 Hz, J=10.0 Hz, 1H), 4.58 (dd, J=3.5, 11.0 Hz, 1H), 
4.51 (d, J=7.8 Hz, 1H), 4.42 (d, J=3.5 Hz, 1H), 4.40 (dd, J=1.7, 12.4 Hz, 1H), 4.12 (dd, J=1.7, 
12.4 Hz, 1H), 3.96 (m, 1H), 3.92 (d, J=10 Hz, 1H), 3.72 (s, 3H; COOCH3), 3.66 (t, J=9.3 Hz, 
1H), 3.54 (m, 2H), 2.80–2.55 (m, 4H), 2.17 (s, 3H; COCH3). 
2-Naphthylmethyl O-(methyl 3-O-benzoyl-4-O-levulinoyl-β-D-glucopyranosyluronate)-
(1→3)-4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (16).  
A mixture of 15 (4.30g, 5.11 mmol) and benzoyl cyanide (1.68g, 12.78 mmol) in 
anhydrous pyridine (80 ml) was stirred for 6 h at RT. Methanol (10 ml) was then added and 
stirred for 5 min. The mixture was then concentrated. Flash silica chromatography 
(aceton/CH2Cl2 1:11, containing 0.5% triethylamine) gave the product (4.8g, 95%) as a white 
solid. 1H NMR (500 MHz, CDCl3): δ = 8.00–7.30 (m, 17H; Ar-H), 7.15 (d, J=6.9 Hz, 1H; 
NH), 5.61 (s, 1H; CHPh), 5.30 (m, 2H), 5.17 (d, J=8.0 Hz, 1H), 4.94 (ABq, 2H; CH2Ar), 
4.67 (d, J=7.7 Hz, 1H), 4.62 (dd, J=3.4, 11.1 Hz), 4.45 (d, J=3.6 Hz, 1H), 4.40 (dd, J=1.7, 
12.5 Hz, 1H), 4.14 (dd, J=1.7, 12.5 Hz, 1H), 4.06 (m, 1H), 3.97 (m, 1H), 3.80 (m, 1H), 3.74 
(s, 3H; COOCH3), 3.56 (s, 1H), 2.65–2.30 (m, 4H), 2.03 (s, 3H; COCH3). 
2-Naphthylmethyl O-(methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside 
(17).  
A mixture of 16 (4.31g, 4.55 mmol) and chloroacetic anhydride (3.1g, 18.2 mmol) in 
dry pyridine/ CH2Cl2 (1:4, 75 ml) was stirred for 2 h at RT. Methanol (5 ml) was then added 
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and stirred for 5 min. The mixture was diluted with CH2Cl2 (100 ml) and washed with water, 
saturated aqueous NaHCO3 and water, dried with MgSO4 and concentrated. A mixture of the 
crude intermediate in water/AcOH (1:4) was stirred for 30 min at 80 °C. The mixture was 
then cooled down and concentrated. The residue was recrystallized from hot ethanol to give 
the product (3.53g, 83%) as a white powder. 1H NMR (500 MHz, CD3OD): δ = 8.0–7.45 (m, 
12H; Ar-H), 5.47 (t, J=9.7 Hz, 1H), 5.30 (t, J=9.7 Hz, 1H), 5.26 (dd, J=8, 9.7 Hz, 1H), 4.96 
(d, J=8 Hz, 1H), 4.94 (ABq, 2H; CH2Ar), 4.64 (d, J=8.4 Hz, 1H), 4.31 (d, J= 10.0 Hz, 1H), 
4.25 (dd, J=8.4, 10.8 Hz, 1H), 4.12 (ABq, 2H; COCH2Cl), 4.08 (d, J=3.2 Hz, 1H), 4.02 (dd, 
J=3.2, 10.8 Hz, 1H), 3.84(m, 2H), 3.75 (s, 3H; COOCH3), 3.57 (m, 1H), 2.66–2.32 (m, 4H), 
2.01 (s, 3H). 
2-Naphthylmethyl O-(methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-6-O-chloroacetyl-2-deoxy-2-trichloroacetamido-β-D-
galactopyranoside (18).  
A solution of chloroacetic anhydride (37 mg, 0.22 mmol) in dry CH2Cl2 (0.7 ml) was 
added slowly at -20 °C within 50 min to a solution of 17 (137 mg, 0.16 mmol) in dry 
pyridine/CH2Cl2 (1:10, 3.3 ml). Methanol (0.1 ml) was then added and stirred for 5 min. The 
mixture was diluted with CH2Cl2 and washed with water, saturated aqueous NaHCO3, and 
water, dried with MgSO4, and concentrated. Flash silica chromatography (EtOAc/CH2Cl2 
1:9, containing 0.5% triethylamine) gave the product (105 mg, 71%) as a white solid. 1H 
NMR (500 MHz, CDCl3): δ = 8.00–7.35 (m, 12H; Ar-H), 6.93 (d, J=7.3 Hz, 1H; NH), 5.45 
(t, J=9.3 Hz, 1H), 5.38 (dd, J=9.3 Hz, 1H), 5.22 (dd, J=7.5, 9.3 Hz, 1H), 4.94 (d, J=8.4 Hz, 
1H), 4.90 (ABq, 2H; CH2Ar), 4.88 (d, J=7.5 Hz, 1H), 4.52 (m, 3H), 4.16 (m, 2H), 4.11 (s, 
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2H; COCH2Cl), 3.95 (ABq, 2H; COCH2Cl), 3.81 (m, 2H), 3.76 (s, 3H; COOCH3), 2.90 (s, 
1H), 2.65-2.30 (m, 4H; CH2CO), 2.04 ppm (s, 3H; COCH3). 
2-Naphthylmethyl O-(methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-4-O-benzoyl-6-O-chloroacetyl-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside (19).  
Benzoyl chloride (1.51 ml, 13.0 mmol)) was added slowly to a solution of the 18 
(3.80 g, 3.76 mmol) in dry pyridine/CH2Cl2 (3:5, 40 ml) and stirred for 1 h at 0 °C. Methanol 
(2 ml) was then added and stirred for 5 min at 0 °C. The mixture was diluted with CH2Cl2 
(80 ml) and washed with water, saturated aqueous NaHCO3, and water, dried with MgSO4, 
and concentrated. Flash silica chromatography (EtOAc/CH2Cl2 5:95, containing 0.5% 
triethylamine) gave the product (3.83 g, 91%) as a white solid. 1H NMR (500 MHz, CDCl3): 
δ = 8.10–7.30 (m, 17H; Ar-H), 6.94 (d, J=7.7 Hz, 1H; NH), 5.67 (dd, J=3.3 Hz, 1H; GalNAc 
H-4), 5.38 (t, J=9.5 Hz, 1H; GlcA H-3), 5.31 (t, J=9.5 Hz, 1H; GlcA H-4), 5.10 (m, 1H; GlcA 
H-2), 4.97 (ABq, 2H; CH2Ar), 4.96 (d, J1,2=8.3 Hz, 1H; GalNAc H-1), 4.85 (d, J=8.0 Hz, 
1H; GlcA H-1), 4.65 (dd, J=3.3, 11.0 Hz, 1H; GalNAc H-3), 4.35 (m, 2H; 2GalNAc H-6), 
4.11 (s, 2H; COCH2Cl), 4.08 (m, 3H; GlcA H-5 GalNAc H-2, H-5), 3.92 (ABq, 2H; 
COCH2Cl), 3.72 (s, 3H; COOCH3), 2.65–2.30 (m, 4H; CH2CO), 2.02 (s, 3H; COCH3).  
O-(Methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-glucopyranosyluronate)-
(1→3)-4-O-benzoyl-6-O-chloroacetyl-2-deoxy-2-trichloroacetamido-1-O-
trichloroacetimidoyl-α-D-galactopyranose (5).   
A mixture of 19 (3.60 mg, 3.23 mmol) and DDQ (2.3 g, 10 mmol) in MeOH/CH2Cl2 
(1:9, 43 ml) was stirred for 24 h, then was diluted with CH2Cl2 (10 ml), washed with water, 
saturated aqueous NaHCO3, and water, dried with MgSO4, and concentrated. Flash silica 
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chromatography (EtOAc/CH2Cl2 2:8, containing 0.5% triethylamine) gave the intermediate 
alcohol as a pale yellow solid. A mixture of the intermediate alcohol (2.70 g, 2.89 mmol), 
CCl3CN (2.9 ml, 29 mol) and DBU (92 µl, 0.62 µmol) in CH2Cl2 (23.4 ml) was stirred for 1 
h. Then more DBU (92 µl, 0.62 µmol) was added and stirred until TLC showed completion. 
The solvent was removed. Flash silica chromatography (EtOAc/CH2Cl2 1:10, containing 
0.5% triethylamine) gave the product (1.94 g, 54%) as a white solid. 1H NMR (500 MHz, 
CDCl3): δ = 8.83 (s, 1H; NH), 8.10–7.30 (m, 10H; Ar-H), 7.09 (d, J=7.8 Hz, 1H; NH), 6.69 
(d, J=3.5 Hz, 1H; GalNAc H-1), 5.64 (d, J3,4=3.0 Hz, 1H; GalNAc H-4), 5.47 (t, J=9.5 Hz, 
1H; GlcA H-3), 5.30 (m, 2H; GlcA H-2, H-4), 4.97 (d, J=8.5 Hz, 1H; GlcA H-1), 4.77 (m, 
1H; GalNAc H-2), 4.60 (dd, J=3.0, 11.0 Hz, 1H; GalNAc H-3), 4.53 (d, J=6.7 Hz, 1H; 
GalNAc H-5), 4.34-4.16 (m, 3H; 2GalNAc H-6 GlcA H-5), 4.09 (ABq, 2H; COCH2Cl), 4.08 
(s, 2H; COCH2Cl), 3.73 (s, 3H; COOCH3), 2.68–2.30 (m, 4H; CH2CO), 2.05 ppm (s, 3H; 
COCH3). 
Allyl O-(methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-4-O-benzoyl-6-O-chloroacetyl-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside (21).  
A mixture of acetimidate 5 (320 mg, 0.286 mmol), allyl alcohol (24.3 µl, 0.357 
mmol), and 4 Å molecular sieves (270 mg) in CH2Cl2 (8.8 ml) was stirred under argon at RT 
for 1 h. The mixture was then cooled down to -10 °C and TMSOTf in CH2Cl2 (1 M, 72 µl) 
was added. The mixture was slowly warmed to 10 °C within 1 h and then filtered and 
concentrated. Flash silica chromatography (EtOAc/CH2Cl2 1:10) and gave the product (250 
mg, 86%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 8.05–7.35 (m, 10H; Ar-H), 7.00 
(d, J=7.5 Hz, 1H; NH), 5.88 (m, 1H; OCH2CHCH2), 5.69 (d, J=3.0 Hz, 1H; GalNAc H-4), 
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5.41 (t, J=9.5 Hz, 1H; GlcA H-3), 5.33 (t, J=9.5 Hz, 1H; GlcA H-4), 5.27 (m, 2H; 
OCH2CHCH2), 5.12 (dd, J= 8.0, 9.5 Hz, 1H; GlcA H-2), 4.96 (d, J = 8.0 Hz, 1H, GlcA H-
1), 4.89 (d, J = 7.9 Hz, 1H; GalNAc H-1), 4.76 (dd, J = 10.9, 3.0 Hz, 1H; GalNAc H-3), 4.38 
(m, 1H; OCH2CHCH2), 4.36 – 4.25 (m, 2H; GalNAc 2H-6), 4.13 (m, 1H; OCH2CHCH2), 
4.12 (d, J = 9.5 Hz, 1H, GlcA H-5), 4.10 (s, 2H; COCH2Cl), 4.06 (m, 1H; GalNAc H-5), 
3.95 (m, 1H; GalNAc H-2), 3.93 (ABq, 2H; COCH2Cl), 3.75 (s, 3H; COOCH3), 2.65–2.30 
(m, 4H; CH2CO), 2.03 (s, 3H; COCH3). 
13C NMR (126 MHz, CDCl3): δ = 205.55, 171.02, 
166.91, 166.53, 165.96, 165.55, 165.54, 162.23, 133.67, 133.48, 133.08, 133.03, 129.91, 
129.11, 128.53, 128.48, 128.41, 118.70, 99.05, 98.24, 73.21, 72.66, 72.18, 72.00, 71.16, 
70.64, 69.14, 68.87, 63.49, 55.59, 53.14, 40.64, 40.51, 37.57, 29.54, 27.59. HRMS: m/z calcd 
for [C37H40Cl3NO16 +Cl]
-: 1046.0533; found: 1046.0544. 
Allyl O-(methyl 3-O-benzoyl-4-O-levulinoyl-β-D-glucopyranosyluronate)-(1→3)-4-O-
benzoyl-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (23).  
A mixture of 21 (26.7 mg, 0.0263 mmol) and thiourea (8.0 mg 0.105 mmol) in 
pyridine/EtOH (1:1, 0.4 ml) was stirred for 2 h at 80 °C, then was cooled down and 
concentrated. A solution of the residue in CH2Cl2 (5 ml) was washed with water, saturated 
aqueous NaHCO3, and water, dried with MgSO4, and concentrated. Flash silica 
chromatography (MeOH/CH2Cl2 1:19, containing 0.5% triethylamine) gave the product (20 
mg, 88%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 8.13 – 7.36 (m, 10H; Ar-H), 
7.16 (d, J = 7.6 Hz, 1H, 1H; NH), 5.88 (m, 1H; OCH2CHCH2), 5.67 (d, J = 3.4 Hz, 1H; 
GalNAc H-4), 5.45 – 5.06 (m, 4H; GlcA H-3, H-4, OCH2CHCH2), 4.91 (d, J = 8.3 Hz, 1H; 
GlcA H-1), 4.67 (d, J = 7.9 Hz, 1H; GalNAc H-1), 4.65 (dd, J = 11.0, 3.4 Hz, 1H; GalNAc 
H-3), 4.39 (m, 1H; OCH2CHCH2), 4.19 – 3.98 (m, 3H; GlcA H-5, GalNAc H-2, 
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OCH2CHCH2), 3.85 (m, 1H; GalNAc H-5), 3.80 – 3.65 (m, 5H; GlcA H-2, GalNAc H-6, 
COOCH3), 3.55 (m, 1H; GalNAc H-6), 2.65–2.30 (m, 4H; CH2CO), 2.00 (s, 3H; COCH3). 
13C NMR (126 MHz, CDCl3): δ = 205.55, 171.02, 166.91, 166.53, 165.96, 165.55, 165.54, 
162.23, 133.67, 133.48, 133.08, 133.03, 129.91, 129.11, 128.53, 128.48, 128.41, 118.70, 
99.05, 98.24, 73.21, 72.66, 72.18, 72.00, 71.16, 70.64, 69.14, 68.87, 63.49, 55.59, 53.14, 
40.64, 40.51, 37.57, 29.54, 27.59. HRMS: m/z calcd for [C37H40Cl3NO16 +Cl]
-: 894.1101; 
found: 894.1116. 
Allyl O-(methyl 3-O-benzoyl-β-D-glucopyranosyluronate)-(1→3)-4-O-benzoyl-2-deoxy-
2-acetamido-β-D-galactopyranoside (24).  
A mixture of tributylstannane (34 µl, 0.126 mmol), AIBN (2.1 mg, 12.6 µmol) and 
23 (10.0 mg, 11.6 µmol) in toluene (0.75 ml) was) was purged with dry Ar gas for 1 hour. 
The mixture was then heated to 110 °C and stirred for 1 h. The mixture was cooled down, 
diluted with acetonitrile, and washed with pentane. The acetonitrile layer was concentrated. 
Flash silica chromatography (MeOH/CH2Cl2 1:15, containing 0.5% triethylamine) gave the 
product (6.5 mg, 74%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 8.18 – 7.36 (m, 
10H; Ar-H), 5.98 (d, J = 7.3 Hz, 1H, 1H; NH), 5.90 (m, 1H; OCH2CHCH2), 5.61 (d, J = 
3.3 Hz, 1H; GalNAc H-4), 5.41 – 5.15 (m, 4H; GlcA H-3, H-4, OCH2CHCH2), 4.87 (d, J 
= 8.3 Hz, 1H; GalNAc H-1), 4.67 – 4.58 (m, 2H; GlcA H-1, GalNAc H-3), 4.37 (m, 1H; 
OCH2CHCH2), 4.14 (m, 1H; OCH2CHCH2), 4.09 (d, J = 9.7 Hz, 1H; GlcA H-5), 4.04 (m, 
1H; GalNAc H-2), 3.90 (m, 1H; GalNAc H-2), 3.82 (m, 1H; GalNAc H-5), 3.77 – 3.62 (m, 
5H; GlcA H-2, GalNAc H-6, COOCH3), 3.53 (m, 1H; GalNAc H-6), 3.10 (m, 1H; OH), 
2.62–2.32 (m, 5H; CH2CO, OH), 2.01 (s, 3H; COCH3), 1.99 (s, 3H; NHCOCH3). 13C NMR 
(126 MHz, CDCl3): δ = 205.61, 171.73, 171.24, 167.63, 166.97, 166.39, 133.66, 133.63, 
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133.48, 130.21, 129.96, 129.11, 129.07, 128.46, 128.44, 117.95, 103.35, 99.66, 76.27, 
74.60, 73.53, 72.45, 71.67, 70.28, 70.19, 68.92, 60.24, 54.18, 52.91, 37.67, 29.50, 27.73, 
23.70. HRMS: m/z calcd for [C37H43NO16 +H]
+: 758.2660; found: 758.2661. 
Allyl (2-O-sulfonato-β-D-glucopyranosyluronate)-(1→3)-6-O-sulfonato-2-deoxy-2-
acetamido-β-D-galactopyranoside trisodium salt. (3)  
A mixture of diol (6.4 mg, 8.4 μmol) and sulfur trioxide/trimethylamine complex 
(29.5 mg, 211 μmol) was azeotroped with toluene 5 times and dried under high vacuum 
overnight. The mixture was then dissolved in anhydrous DMF (0.2 ml) and stirred for 48 h 
at 60 °C. After the mixture was cooled down, methanol (0.1 ml) was added, and the mixture 
was stirred for another 30 min. The mixture was then directly applied and eluted from a 
column (3x30 cm) of Sephadex LH-20 with 1:1 CH2Cl2/MeOH. Flash silica chromatography 
(MeOH/CH2Cl2 1:5, containing 0.5% triethylamine) followed by a column (1x15 cm) of 
Amberlite® IR120 Sodium form resin (1:1 CH2Cl2/MeOH) then gave the sulfate 
disaccharide as a white solid (5.9 mg, 77%). NMR (500 MHz, CD3OD): δ = 8.13 – 7.32 (m, 
10H; Ar-H), 5.91 (m, 1H; OCH2CHCH2), 5.84 (d, J = 2.8 Hz, 1H; GalNAc H-4), 5.55 (dd, J 
= 9.1, 8.1 Hz, 1H;GlcA H-3), 5.32 (dq, J = 17.3, 1.8 Hz, 1H; OCH2CHCH2), 5.22 – 5.13 (m, 
2H; OCH2CHCH2,GlcA H-4), 5.04 (d, J = 6.8 Hz, 1H; GalNAc H-1), 4.71 (d, J = 8.4 Hz, 
1H; GlcA H-1), 4.47 (dd, J = 8.1, 6.8 Hz, 1H; GlcA H-2), 4.41 – 4.33 (m, 2H; OCH2CHCH2, 
GalNAc H-3), 4.29 (d, J = 9.8 Hz, 1H; GlcA H-5), 4.22 – 4.06 (m, 4H; GalNAc H-2, H-5, 
2GalNAc H-6), 3.97 (dd, J = 10.8, 7.7 Hz, 1H; GlcA H-4), 3.60 (s, 3H; COOCH3), 2.66–
2.29 (m, 4H; CH2CO), 2.05 (s, 3H; NHCOCH3), 2.02 (s, 3H; COCH3). 
13C NMR (126 MHz, 
CD3OD): δ = 208.55, 174.73, 172.78, 169.54, 167.33, 167.18, 135.43, 134.19, 134.01, 
131.25, 131.14, 131.07, 129.38, 129.22, 117.20, 102.20, 101.29, 78.82, 78.67, 74.41, 73.69, 
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73.45, 71.32, 70.97, 69.72, 67.95, 58.32, 53.79, 53.28, 38.36, 29.45, 28.83, 23.43. HRMS: 
m/z calcd for [C37H41NNa2O22S - Na]
-: 948.0165; found: 948.0153. 
The sulfated disaccharide (1.8 mg, 2.0 µmol) was dissolved in THF (133 µL) and 
H2O (67 µL) and cooled to 0 °C. To this were added 1 M aq. LiOH (18 µL) and 30% H2O2 
(8 µL). The reaction was stirred at 0 °C for 1 h and at rt for 12 h. At this time, 4 M NaOH 
(20 µL) and MeOH (130 µL) were added and the reaction stirred for another 12 h. It was 
then neutralized with Amberlite® IR120 Hydrogen form resin, filtered, and lyophilized to 
afford a white solid. The product was purified by a Sephadex G-10 column (0.5x30 cm) 
and lyophilized to give the CS-D disaccharide 3 (0.9 mg, 71%). 1H NMR (400 MHz, D2O): 
δ = 5.87 (m, 1H; OCH2CHCH2), 5.29 (dq, J = 17.3, 1.6 Hz, 1H; OCH2CHCH2), 5.23 (dq, 
J = 10.5, 1.4 Hz, 1H; OCH2CHCH2), 4.70 (d, J = 7.7 Hz, 1H; GlcA H-1), 4.60 (d, J = 8.0 
Hz, 1H; GalNAc H-1), 4.31 (ddt, J = 13.2, 5.2, 1.4 Hz, 1H; OCH2CHCH2), 4.25 – 4.12 (m, 
4H; OCH2CHCH2, GalNAc H-3, 2GalNAc H-6), 4.07 (dd, J = 9.0, 7.7 Hz, 1H; GlcA H-2), 
3.98 – 3.86 (m, 3H;GalNAc H-2, H-4, H-5), 3.77 – 3.63 (m, 2H; GlcA H-3, H-5), 3.57 (t, 
J = 9.5 Hz, 1H;GlcA H-4). 13C NMR (100 MHz, D2O): δ = 175.72, 174.75, 133.42, 118.32, 
101.26, 100.38, 79.89, 79.71, 76.06, 74.64, 73.56, 72.63, 71.52, 70.53, 67.81, 67.25, 51.18, 
22.49. HRMS: m/z calcd for [C17H25NNa2O18S2 - 2Na]
2-: 297.5262; found: 297.5272. 
Allyl O-(methyl 3-O-benzoyl-2-O-chloroacetyl-β-D-glucopyranosyluronate)-(1→3)-4-
O-benzoyl-6-O-chloroacetyl-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (6).  
A mixture of pyridine/AcOH/hydrazine hydate (6:4:0.5, 5 ml) was added to a 
solution of 21 (250 mg, 0.247 mmol) in pyridine (0.83 ml) and stirred for 2.5 min at RT. The 
mixture was then diluted with CH2Cl2 (50 ml), washed with water, saturated aqueous 
NaHCO3, and water, dried with MgSO4, and concentrated. Flash silica chromatography 
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(EtOAc/CH2Cl2 2:8, containing 0.5% triethylamine) gave the 6 (185 mg, 90%) as a white 
solid. 1H NMR (500 MHz, CDCl3): δ = 8.16 – 7.30 (m, 10H), 7.01 (d, J = 7.3 Hz, 1H; NH), 
5.89 (m, 1H; OCH2CHCH2), 5.73 (d, J = 3.3 Hz, 1H; GalNAc H-4), 5.35 – 5.19 (m, 3H; 
GlcA H-3, OCH2CHCH2), 5.07 (dd, J = 9.6, 7.7 Hz, 1H; GlcA H-2), 5.02 (d, J = 8.2 Hz, 1H; 
GalNAc H-1), 4.85 (d, J = 7.8 Hz, 1H; GlcA H-1), 4.79 (dd, J = 10.9, 3.3 Hz, 1H; GalNAc 
H-3), 4.44 – 4.23 (m, 3H, GalNAc 2H-6, OCH2CHCH2), 4.14 (m, 1H; OCH2CHCH2), 4.08 
(s, 2H; COCH2Cl), 4.10-4.04 (m, 2H; GlcA H-4, GalNAc H-5), 3.99 (d, J=9.8 Hz, 1H; GlcA 
H-5), 3.93 (ABq, 2H; COCH2Cl), 3.90 (m, 1H; GalNAc H-2), 3.85 (s, 3H; COOCH3), 3.26 
(s, 1H; OH). 13C NMR (126 MHz, CDCl3): δ = 168.56, 166.92, 166.42, 165.92, 165.68, 
162.26, 133.68, 133.48, 133.10, 130.00, 129.93, 129.19, 128.62, 128.52, 128.49, 118.72, 
99.78, 97.94, 92.19, 74.64, 74.37, 73.49, 72.03, 71.33, 70.65, 70.14, 69.32, 63.86, 55.93, 
53.08, 40.60, 40.47. HRMS: m/z calcd for [C36H36Cl5NO16 +Cl]
-: 948.0165; found: 
948.0153. 
Allyl (methyl 3-O-benzoyl-2-O-chloroacetyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-(4-O-benzoyl-6-O-chloroacetyl-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside)-(1→4)-(methyl 3-O-benzoyl-2-O-
chloroacety-β-D-glucopyranosyluronate)-(1→3)-4-O-benzoyl-6-O-chloroacetyl-2-
deoxy-2-trichloroacetamido-β-D-galactopyranoside (26).  
TMSOTf in CH2Cl2 (100 µl, 0.23 M) was added to a mixture of 5 (134 mg, 0.12 
mmol) and 6 (92 mg, 0.10 mmol) in CH2Cl2 (2 ml) and stirred for 2 hours. The mixture was 
quenched by triethylamine (0.05 ml) and concentrated. Flash silica chromatography 
(EtOAc/hexane/CH2Cl2 3:2:1) containing 0.5% triethylamine) gave the product (110 mg, 
58%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 8.05 – 6.98 (m, 20H), 7.06 (d, J = 
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7.2 Hz, 1H; NH), 6.93 (d, J = 7.8 Hz, 1H; NH), 5.87 (m, 1H; OCH2CHCH2), 5.71 (d, J = 3.3 
Hz, 1H; GalNAcI H-4), 5.41 (d, J = 3.3 Hz, 1H; GalNAcII H-4), 5.38 – 5.21 (m, 5H; 2GlcA 
H-3, GlcAII H-4, 2OCH2CHCH2), 5.08 – 5.00 (m, 3H; 2GlcA H-2, GalNAc H-1), 4.98 (d, J 
= 8.4 Hz, 1H; GalNAc H-1), 4.85 (d, J = 7.8 Hz, 1H; GlcA H-1), 4.79 (dd, J = 10.5, 3.3 Hz, 
1H; GalNAcI H-3), 4.76 (d, J = 7.9 Hz, 1H; GlcA H-1), 4.41 – 4.35 (m, 3H; GalNAcII H-3, 
GalNAc H-6, OCH2CHCH2), 4.26 – 4.19 (m, 2H; GlcAI H4 GalNAc H-6, OCH2CHCH2), 
4.15 – 3.99 (m, 10H; 4CH2Cl, OCH2CHCH2, 2GalNAc H-2, 2GlcA H-5, GalNAc H-5), 3.94 
– 3.70 (m, 12H; 4CH2Cl, 6COOCH3, GalNAc H-5), 3.38 (m, 1H; GalNAc H-6), 3.13 (m, 
1H; GalNAc H-6), 2.62 – 2.30 (m, 4H; CH2CO), 2.01 (s, 3H; COCH3). 13C NMR (126 MHz, 
CDCl3): δ = 205.57, 170.95, 168.03, 166.91, 166.54, 166.46, 165.89, 165.81, 165.70, 165.50, 
165.19, 165.18, 162.28, 161.71, 133.60, 133.52, 133.43, 133.40, 133.05, 130.01, 129.96, 
129.85, 129.41, 129.17, 129.05, 128.93, 128.51, 128.47, 128.43, 128.40, 128.18, 118.78, 
100.22, 99.25, 98.84, 97.68, 92.48, 92.11, 75.49, 74.10, 73.77, 73.65, 72.58, 72.08, 72.02, 
71.90, 71.75, 71.41, 71.01, 70.63, 69.47, 69.20, 68.53, 64.11, 62.26, 55.98, 54.87, 53.39, 
53.04, 40.69, 40.56, 40.44, 40.36, 37.54, 29.52, 27.55. HRMS: m/z calcd for 
[C74H72Cl10N2O33 -H]
-: 1865.0824; found: 1865.0750. 
Allyl (methyl 3-O-benzoyl-4-O-levulinoyl-β-D-glucopyranosyluronate)-(1→3)-(4-O-
benzoyl-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside)-(1→4)-(methyl 3-O-
benzoyl-β-D-glucopyranosyluronate)-(1→3)-4-O-benzoyl-2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside (29).  
A mixture of 26 (11.2 mg, 6.0 µmol), thiourea (3.7 mg, 48 µmol) in 
pyridine/ethanol (1:1, 0.2 ml) was stirred at 80 °C for 2 h. The mixture was cooled down 
and concentrated. The residue was dissolved in CH2Cl2 and washed with water and 
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saturated aqueous NaHCO3.The organic layer was dried with MgSO4, filtered, and 
concentrated. Flash silica chromatography (CH2Cl2/MeOH 24:1) containing 0.5% 
triethylamine) gave the product (6.9 mg, 70%) as a white solid. 1H NMR (500 MHz, 
CDCl3): δ = 8.12 – 6.93 (m, 20H), 7.13 (d, J = 7.4 Hz, 1H; NH), 7.08 (d, J = 7.6 Hz, 1H; 
NH), 5.87 (m, 1H; OCH2CHCH2), 5.73 (d, J = 3.3 Hz, 1H; GalNAc
I H-4), 5.39 (d, J = 3.2 
Hz, 1H; GalNAcII H-4), 5.32 – 5.16 (m, 5H; 2GlcA H-3, GlcAII H-4, 2OCH2CHCH2), 4.94 
(d, J = 8.4 Hz, 1H; GalNAcI H-1), 4.91 (d, J = 8.4 Hz, 1H; GalNAcII H-1), 4.67 (d, J = 7.7 
Hz, 1H; GlcAII H-1), 4.64 (dd, J = 11.0, 3.3 Hz, 1H; GalNAcI H-3), 4.51 (d, J = 7.7 Hz, 
1H; GlcAI H-1), 4.37 (m, 1H; OCH2CHCH2), 4.19 (dd, J = 10.8, 3.3 Hz, 1H; GalNAc
II H-
3), 4.15 – 3.91 (m, 6H; GlcAI H-4, 2GlcA H-5, 2GalNAc H-2, OCH2CHCH2), 3.85 (s, 3H; 
COOCH3), 3.83 (m, 1H; GalNAc
I H-5), 3.73 (m, 1H; GalNAcI H-6), 3.69 (s, 3H; 
COOCH3), 3.68 – 3.58 (m, 2H; 2Glc H-2), 3.56 – 3.42 (m, 2H; GalNAcII H-5, GalNAcI H-
6), 3.24 (dd, J = 9.5, 5.8 Hz, 1H; GalNAcI OH), 2.98 – 2.90 (m, 2H; GalNAcII H-6, GlcA 
OH), 2.79 (dd, J = 8.6, 6.5 Hz, 1H; GalNAcII OH), 2.62 – 2.20 (m, 6H; GalNAcII H-6, 
4CH2CO, GlcA OH), 2.00 (s, 3H; COCH3). 
13C NMR (126 MHz, CDCl3): δ = 205.62, 
171.11, 168.72, 167.59, 167.01, 166.70, 166.00, 165.81, 162.56, 162.50, 133.79, 133.72, 
133.34, 133.19, 133.00, 130.18, 129.90, 129.59, 129.51, 129.14, 128.97, 128.84, 128.56, 
128.37, 128.00, 118.46, 103.69, 103.56, 99.23, 98.76, 92.55, 92.32, 75.29, 74.75, 73.94, 
73.77, 73.61, 73.58, 72.58, 71.57, 71.46, 70.51, 70.26, 70.24, 69.56, 69.12, 59.91, 59.29, 
55.35, 54.87, 53.21, 52.84, 37.66, 29.49, 27.71. HRMS: m/z calcd for [C66H68Cl6N2O29 -
H]-: 1561.1961; found: 1561.1893. 
Allyl (methyl 3-O-benzoyl-4-O-levulinoyl-β-D-glucopyranosyluronate)-(1→3)-(2-
acetamido-4-O-benzoyl-2-deoxy-β-D-galactopyranoside)-(1→4)-(methyl 3-O-benzoyl-
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β-D-glucopyranosyluronate)-(1→3)-2-acetamido-4-O-benzoyl-2-deoxy-β-D-
galactopyranoside (30).  
A mixture of tributylstannane (44.0 µl, 0.162 mmol), AIBN (3.0 mg, 18.0 µmol) and 
29 (14.0 mg, 9.0 µmol) in toluene (1.1 ml) was purged with dry Ar gas for 1 hour. The 
mixture was then heated to 110 °C and stirred for 1 h. The mixture was cooled down, diluted 
with acetonitrile, and washed with pentane. The acetonitrile layer was concentrated. Flash 
silica chromatography (MeOH/CH2Cl2 1:15, containing 0.5% triethylamine) gave the 
product (10.0 mg, 82%). 1H NMR (500 MHz, CD3OD): δ = 8.15 – 6.98 (m, 20H), 5.92 (m, 
1H; OCH2CHCH2), 5.65 (d, J = 3.4 Hz, 1H; GalNAc
I H-4), 5.44 (d, J = 3.2 Hz, 1H; GalNAcII 
H-4), 5.36 – 5.20 (m, 3H; 2GlcA H-3, OCH2CHCH2), 5.17 (m, 1H; OCH2CHCH2), 5.10 (t, 
J = 9.8 Hz, 1H; GlcAII H-4), 4.65 – 4.56 (m, 4H; 2GalNAc H-1, 2GlcA H-1), 4.37 (m, 1H; 
OCH2CHCH2), 4.29 (dd, J = 11.0, 3.3 Hz, 1H; GalNAc
II H-2), 4.23 – 4.02 (m, 6H; 2GalNAc 
H-3, 2 GlcA H-5, GlcI H-4, OCH2CHCH2), 3.89 (s, 3H; COOCH3), 3.86 – 3.76 (m, 2H; 
GalNAcI H-2, GalNAcI H-5), 3.68 (s, 3H; COOCH3), 3.67 – 3.42 (m, 5H; 2Glc H-2, 
GalNAcII H-5, 2GalNAcI H-6), 2.77 (m, 2H; 2GalNAcII H-6), 2.58 – 2.25 (m, 4H; 4CH2CO), 
1.97 (s, 3H; COCH3), 1.96 (s, 3H; NHCOCH3), 1.94 (s, 3H; NHCOCH3). 
13C NMR (126 
MHz, CDCl3): δ = 208.36, 174.28, 174.16, 172.90, 169.64, 169.15, 167.43, 167.32, 167.31, 
167.28, 135.46, 134.38, 134.36, 134.34, 133.78, 131.58, 131.27, 131.09, 131.04, 131.01, 
130.96, 130.87, 130.80, 129.52, 129.48, 129.47, 129.01, 117.22, 105.97, 105.21, 102.09, 
101.71, 80.06, 78.43, 76.95, 76.43, 75.92, 75.89, 75.59, 75.28, 73.50, 72.59, 72.47, 71.55, 
71.16, 70.97, 70.86, 62.34, 61.08, 54.28, 53.50, 53.43, 53.27, 38.28, 29.38, 28.75, 23.36, 
23.09. HRMS: m/z calcd for [C66H74N2O29 +Na]
+: 1381.4275; found: 1381.4285. 
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Allyl (methyl 3-O-benzoyl-4-O-levulinoyl-2-O-sulfonato-β-D-glucopyranosyluronate)-
(1→3)-(2-acetamido-4-O-benzoyl-2-deoxy-6-O-sulfonato-β-D-galactopyranoside)-
(1→4)-(methyl 3-O-benzoyl-2-O-sulfonato-β-D-glucopyranosyluronate)-(1→3)-2-
acetamido-4-O-benzoyl-6-O-sulfonato-2-deoxy-β-D-galactopyranoside tetrasodium salt 
(31).  
A mixture of 30 (3.5 mg, 2.6 μmol) and sulfur trioxide/trimethylamine complex 
(13.2 mg, 95 μmol) was azeotroped with toluene 5 times and dried under high vacuum 
overnight. The mixture was then dissolved in anhydrous DMF (0.1 ml) and stirred for 48 h 
at 60 °C. After the mixture was cooled down, methanol (0.05 ml) was added and the mixture 
was stirred for another 30 min. The mixture was then directly applied and eluted from a 
column (3x30 cm) of Sephadex LH-20 with 1:1 CH2Cl2/MeOH. Flash silica chromatography 
(MeOH/CH2Cl2 1:5, containing 0.5% triethylamine) followed by a column (1x15 cm) of 
Amberlite® IR120 Sodium form resin (1:1 CH2Cl2/MeOH) then gave the product as a white 
solid (3.8 mg, 83%). 1H NMR (400 MHz, CD3OD): δ = 8.18 – 7.02 (m, 20H; Ar-H), 6.00 – 
5.87 (m, 1H; OCH2CHCH2), 5.83 (d, J = 3.2 Hz, 1H; GalNAc
I H-4), 5.67 (d, J = 3.2 Hz, 1H; 
GalNAcII H-4), 5.57 – 5.44 (m, 2H; 2GlcA H-3), 5.39 – 5.28 (m, 1H; OCH2CHCH2), 5.22 – 
5.12 (m, 2H; OCH2CHCH2, GlcA
II H-4), 5.03 (d, J = 6.5 Hz, 1H; GlcA H-1), 4.95 (d, J = 
6.8 Hz, 1H; GlcA H-1), 4.73 (d, J = 8.4 Hz, 1H; GalNAcII H-1), 4.57 (d, J = 8.4 Hz, 1H; 
GalNAcI H-1), 4.48 – 4.36 (m, 3H; OCH2CHCH2; 2GlcA H-2), 4.36 – 4.29 (m, 2H; 
2GalNAc H-3), 4.29 – 4.09 (m, 7H; OCH2CHCH2; GalNAcI H-5, H-6, GalII H-2, GlcAI H-
4, 2GlcA H-5), 3.98 (dd, J = 10.6, 7.7 Hz, 1H;GalNAcI H-6), 3.85 – 3.79 (m, 2H; GalNAcI 
H-2, GalNAcII H-5), 3.77 (s, 3H; COOCH3), 3.61 (s, 3H; COOCH3), 2.65 – 2.30 (m, 
4H;CH2CO), 2.07 (s, 3H; COCH3), 2.05 (s, 3H; NHCOCH3), 2.03 (s, 3H; NHCOCH3). 
13C 
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NMR (101 MHz, CD3OD): δ = 208.60, 174.79, 174.75, 172.90, 170.05, 169.80, 167.70, 
167.31, 167.18, 167.04, 135.40, 134.32, 134.11, 134.02, 133.81, 131.41, 131.19, 131.17, 
131.15, 131.12, 131.08, 131.04, 129.55, 129.32, 129.22, 129.09, 117.26, 102.30, 102.15, 
101.86, 101.11, 78.81, 78.56, 78.41, 77.97, 77.22, 75.30, 74.74, 74.37, 73.64, 73.29, 73.00, 
71.28, 70.98, 69.94, 68.85, 67.93, 66.08, 53.98, 53.66, 53.63, 53.40, 38.31, 29.44, 28.79, 
23.64, 23.52. HRMS: m/z calcd for [C66H70N2Na4O41S4 - 4Na]
4-: 418.5590; found: 418.5597. 
Allyl (2-O-sulfonato-β-D-glucopyranosyluronate)-(1→3)-(2-acetamido-2-deoxy-6-O-
sulfonato-β-D-galactopyranoside)-(1→4)-(2-O-sulfonato-β-D-glucopyranosyluronate)-
(1→3)-2-acetamido-6-O-sulfonato-2-deoxy-β-D-galactopyranoside hexasodium salt (1).  
31 (5.5 mg, 3.1 µmol) was dissolved in THF (320 µL) and H2O (230 µL) and 
cooled to 0 °C. To this were added 1 M aq. LiOH (46 µL) and 30% H2O2 (23 µL). The 
reaction was stirred at 0 °C for 1 h and at rt for 12 h. At this time, 4 M NaOH (32 µL) and 
MeOH (230 µL) were added and the reaction stirred for another 12 h. It was then 
neutralized with Amberlite® IR120 Hydrogen form resin, filtered, and lyophilized to 
afford a white solid. The product was purified by a Sephadex G-25 column (0.5x30 cm) 
and lyophilized to give the product (3.1 mg, 79%). 1H NMR (900 MHz, D2O) δ = 5.91 – 
5.84 (m, 1H; OCH2CHCH2), 5.31 – 5.27 (m, 1H; OCH2CHCH2), 5.26 – 5.22 (m, 1H; 
OCH2CHCH2), 4.71 (d, J = 7.6 Hz, 1H; Glc
II H-1), 4.71 (d, J = 7.3 Hz, 1H;GlcAI H-1), 
4.60 (d, J = 8.4 Hz, 1H; GalNAcI H-1), 4.57 (d, J = 7.7 Hz, 1H; GalNAcII H-2), 4.34 – 4.28 
(m, 1H; OCH2CHCH2), 4.24 (s, 1H; GalNAc
II H-4), 4.23 – 4.13 (m, 6H; OCH2CHCH2, 
GalNAcI H-4, 2GalNAcI H-6, 2GalNAcII H-6), 4.12 (t, J = 8.3 Hz, 1H;GlcAI H-2), 4.06 (t, 
J = 8.3 Hz, 1H; GlcAII H-2), 3.98 – 3.87 (m, 6H; GalNAcI H-2, H-3, H-5, GalNAcII H-2, 
H-3, H-5), 3.84 (t, J = 9.0 Hz, 1H;GlcAI H-4), 3.79 (t, J = 8.7 Hz, 1H; GlcAI H-3), 3.75 – 
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3.69 (m, 3H; GlcAI H-5, GlcAII H-3, H-5), 3.57 (t, J = 9.6 Hz, 1H; GlcAII H-4). 13C NMR 
(101 MHz, D2O): δ = 175.74, 174.92, 174.80, 174.29, 133.41, 118.31, 101.73, 101.22, 
101.17, 100.42, 79.73, 79.69, 79.56, 79.52, 76.56, 76.02, 74.69, 72.85, 72.64, 72.32, 71.54, 
70.53, 67.89, 67.42, 67.16, 66.99, 51.21, 50.78, 22.78, 22.50. HRMS: m/z calcd for 
[C31H42N2Na6O35S4 - 2Na]
2-: 611.0026; found: 611.0010.  
Allyl O-(methyl 2,3,4-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-4,6-O-benzylidene-
2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (33).  
A mixture of acetimidate 5 (800.0 mg, 0.87 mmol), allyl alcohol (80.0 µl, 1.2 mmol) 
and 4 Å molecular sieves (600.0 mg) in CH2Cl2 (30 ml) was stirred under argon at RT for 1 
h. The mixture was then cooled down to -60 °C and TMSOTf (50 µl, 0.26) was added. The 
mixture was slowly warmed to RT within 1 h and then filtered and concentrated. Flash silica 
chromatography (EtOAc/CH2Cl2 1:10) and gave the product (686.0 mg, 95%) as a white 
solid. 1H NMR (400 MHz, CDCl3): δ = 7.54 – 7.32 (m, 5H;Ar-H), 7.15 (d, J = 6.8 Hz, 
1H;NH), 5.91 – 5.80 (m, 1H; OCH2CHCH2), 5.57 (s, 1H;CHPh), 5.28 – 5.12 (m, 4H; 
2OCH2CHCH2,GlcA H-3, H-4 ), 5.07 (d, J = 8.3 Hz, 1H;GalNAc H-1), 5.03 (t, J = 8.1 Hz, 
1H;glcA H-2), 4.90 (d, J = 7.6 Hz, 1H; GlcA H1), 4.69 (dd, J = 11.2, 3.5 Hz, 1H; GalNAc 
H-3), 4.43 (dd, J = 3.5, 0.9 Hz, 1H; GalNAc H-4), 4.37 (m, 1H; OCH2CHCH2), 4.32 (dd, J 
= 12.4, 1.6 Hz, 1H;GalNAc H-6), 4.12 – 4.04 (m, 2H; OCH2CHCH2, GalNAc H-6), 4.01 (d, 
J = 9.6 Hz, 1H; GlcA H-5), 3.77 (ddd, J = 11.2, 8.2, 6.8 Hz, 1H; GalNAc H-2), 3.70 (s, 3H; 
COOCH3), 3.49 (d, J = 1.1 Hz, 1H; GalNAc H-5), 2.00 (s, 3H; COCH3), 1.99 (s, 3H; 
COCH3), 1.98 (s, 3H; COCH3). 
13C NMR (101 MHz, CDCl3): δ = 169.99, 169.39, 169.17, 
167.06, 162.15, 137.60, 133.51, 128.78, 128.03, 126.12, 118.08, 100.57, 100.16, 97.46, 
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92.16, 75.66, 74.02, 72.30, 71.86, 71.13, 70.27, 68.97, 66.51, 55.12, 52.87, 20.76, 20.52, 
20.44. HRMS: m/z calcd for [C31H36Cl3NO15 +NH4]
+: 785.1495; found: 785.1481.  
Allyl O-(methyl 2,3-O-isopropylidene-β-D-glucopyranosyluronate)-(1→3)-4,6-O-
benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (34).  
0.5 M Methanolic sodium methoxide (0.23 ml, 0.0115 mmol) was added to a solution 
of 33 (700.0 mg, 0.91 mmol) in dry THF/methanol (1:4, 9 ml) and the solution was stirred 
for 30 mins. The mixture was then neutralized with Amberlite IR-120 [H+] resin, filtered, 
and concentrated to give the crude triol. 2-Methoxypropene (95 µl, 1.0 mmol) were added 
every 20 min to a solution of the crude triol 20 and CSA (56.0 mg, 0.24 mmol) in DMF (6.5 
ml). Triethylamine (0.5 ml) was added and the mixture was concentrated. The residue was 
dissolved in EtOAc (30 ml) and washed with saturated aqueous NaHCO3, brine, and water, 
dried with MgSO4, and concentrated. Flash silica chromatography (EtOAc/Hexane 4:6 to 
6:4, containing 0.5% triethylamine) gave the product as a white solid (310.0 mg, 50%). 1H 
NMR (500 MHz, CDCl3): δ = 7.56 – 7.30 (m, 5H;Ar-H), 7.22 (d, J = 6.6 Hz, 1H;NH), 5.93 
– 5.84 (m, 1H; OCH2CHCH2), 5.58 (s, 1H;CHPH), 5.30 – 5.25 (m, 1H; OCH2CHCH2), 5.22 
(d, J = 8.2 Hz, 1H;GalNAc H-1), 5.21 – 5.17 (m, 1H; OCH2CHCH2), 4.94 (d, J = 7.7 Hz, 
1H;GlcA H-1), 4.76 (dd, J = 11.2, 3.5 Hz, 1H;GalNAc H-3), 4.46 (dd, J = 3.5, 1.0 Hz, 
1H;GalNac H-4), 4.43 – 4.37 (m, 1H; OCH2CHCH2), 4.35 (dd, J = 12.3, 1.6 Hz, 1H;GalNAc 
H-6), 4.15 – 4.05 (m, 3H; OCH2CHCH2;GalNAc H-6, GlcA H-6), 3.87 – 3.78 (m, 
5H;COOCH3, GalNAc H-3, GlcA H-5), 3.56 – 3.54 (m, 1H;GalNAc H-5), 3.52 (t, J = 9.5 
Hz, 1H; GlcA H-3), 3.43 (dd, J = 9.3, 7.7 Hz, 1H; GlcA H-2), 3.24 (d, J = 2.2 Hz, 1H; GlcA 
4-OH), 1.43 (s, 3H;CH3), 1.40 (s, 3H;CH3). 
13C NMR (126 MHz, CDCl3): δ = 169.71, 
162.34, 137.66, 133.62, 128.88, 128.01, 126.26, 118.08, 112.30, 102.64, 100.74, 97.39, 
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92.21, 79.34, 76.03, 75.68, 75.56, 74.59, 70.77, 70.41, 69.16, 66.57, 55.50, 52.95, 26.65, 
26.47. HRMS: m/z calcd for [C28/H34Cl3NO12 +NH4]
+: 699.1491; found: 699.1460.  
Allyl O-(methyl 2,3-O-isopropylidene-4-O-levulinoyl-β-D-glucopyranosyluronate)-
(1→3)-4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (35).  
DCC (305 mg, 1.48 mmol) was added portionwise to a mixture of 34 (805.6 mg, 1.18 
mmol), levulinic acid (150 µl, 1.48 mmol) and DMAP (36 mg, 0.3 mmol) in dry CH2Cl2 (23 
ml) and stirred for 5 h. The solids were filtered off and washed with CH2Cl2/hexane (1:1) 
several times. The filtrate was washed with saturated aqueous NaHCO3 and water, dried with 
MgSO4, and concentrated. Flash silica chromatography (EtOAc/CH2Cl2 1:10, containing 
0.5% triethylamine) gave the product (971 mg, 99%) as a white solid. 1H NMR (400 MHz, 
CDCl3): δ = 7.57 – 7.30 (m, 5H;Ar-H), 7.18 (d, J = 6.6 Hz, 1H;NH), 5.94 – 5.82 (m, 1H; 
OCH2CHCH2), 5.60 (s, 1H), 5.32 – 5.23 (m, 2H; OCH2CHCH2, GlcA H-4), 5.23 – 5.15 (m, 
2H; OCH2CHCH2, GalNAc H-1), 4.90 (d, J = 7.3 Hz, 1H; GlcA H-1), 4.73 (dd, J = 11.2, 3.4 
Hz, 1H; GalNAc H-3), 4.43 – 4.36 (m, 2H; OCH2CHCH2, GalNAc H-4), 4.32 (dd, J = 12.4, 
1.6 Hz, 1H; GalNAc H-6), 4.14 – 4.07 (m, 2H; OCH2CHCH2, GalNAc H-6), 3.94 (d, J = 8.3 
Hz, 1H;GlcA H-5), 3.85 – 3.78 (m, 1H;GalNAc H-2), 3.70 (s, 3H; COOCH3), 3.65 – 3.51 
(m, 3H;GalNAc H-5, GlcA H-2, H-3), 2.86 – 2.53 (m, 4H; CH2O), 2.18 (s, 3H;COCH3), 
1.40 (s, 3H;CH3), 1.37 (s, 3H;CH3). 
13C NMR (101 MHz, CDCl3) δ = 206.06, 171.58, 167.71, 
162.39, 137.68, 133.61, 128.90, 128.03, 126.39, 118.16, 112.46, 102.48, 100.81, 97.37, 
92.18, 75.87, 75.78, 74.46, 74.39, 70.93, 70.44, 69.06, 66.59, 55.55, 52.97, 37.58, 29.89, 
27.64, 26.64, 26.50. HRMS: m/z calcd for [C33H40Cl3NO14 +NH4]
+: 797.1859; found: 
797.1823.  
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Allyl O-(methyl 4-O-levulinoyl-β-D-glucopyranosyluronate)-(1→3)-4,6-O-benzylidene-
2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (36).  
A solution of 35 (916.8 mg, 1.2 mmol) in CH2Cl2/AcOH/water (5:4:1, 20 ml) was 
stirred for 60 h at RT. The solution was then concentrated and azeotroped with toluene three 
times. Flash silica chromatography (MeOH/CH2Cl2 1:19, containing 0.5% triethylamine) 
gave the product (613.5 mg, 71%) as a white solid. 1H NMR (400 MHz, CDCl3): δ = 7.57 – 
7.30 (m, 5H; Ar-H), 7.23 (d, J = 6.8 Hz, 1H; NH), 5.95 – 5.81 (m, 1H; OCH2CHCH2), 5.57 
(s, 1H; CHPh), 5.33 – 5.24 (m, 1H; OCH2CHCH2), 5.22 – 5.15 (m, 1H; OCH2CHCH2), 5.09 
(d, J = 8.2 Hz, 1H; GalNAc H-1), 5.02 (dd, J = 10.0, 9.2 Hz, 1H; GlcA H-4), 4.65 (dd, J = 
11.1, 3.5 Hz, 1H; GalNAc H-3), 4.51 (d, J = 7.7 Hz, 1H; GlcA H-1), 4.43 – 4.36 (m, 2H; 
GalNAc H-4, OCH2CHCH2), 4.33 (dd, J = 12.4, 1.6 Hz, 1H; GalNAc H-6), 4.15 – 4.05 (m, 
2H; GalNAc H-6, OCH2CHCH2), 3.93 (d, J = 10.0 Hz, 1H; GlcA H-5), 3.83 (ddd, J = 11.2, 
8.2, 6.8 Hz, 1H; GalNAc H-2), 3.73 (s, 3H; COOCH3), 3.65 (t, J = 9.3 Hz, 1H; GlcA H-3), 
3.58 – 3.48 (m, 2H; GalNAc H-5, GlcA H-2), 2.92 – 2.39 (m, 4H; CH2O), 2.17 (s, 3H; 
COCH3). 
13C NMR (101 MHz, CDCl3): δ = 207.23, 171.98, 167.65, 162.43, 137.59, 133.50, 
129.00, 128.12, 126.43, 118.33, 103.29, 101.02, 97.50, 92.20, 75.75, 74.91, 73.90, 73.07, 
72.32, 71.43, 70.40, 69.03, 66.58, 55.37, 52.84, 38.04, 29.83, 27.86. HRMS: m/z calcd for 
[C30H36Cl3NO14 +NH4]
+: 757.1546; found: 757.1516. 
Allyl O-(methyl 2,3-O-benzoyl-β-D-glucopyranosyluronate)-(1→3)-4,6-O-benzylidene-
2-deoxy-2-trichloroacetamido-β-D-galactopyranoside (32).  
Benzoyl chloride (37 µl, 0.32 mmol)) was added slowly to a solution of the 36 (99.0 
mg, 0.13 mmol) in dry pyridine/CH2Cl2 (5:8, 1.04 ml) and stirred for 1 h at 0 °C. Methanol 
(0.1 ml) was then added and stirred for 5 min at 0 °C. The mixture was diluted with CH2Cl2 
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and washed with water, saturated aqueous NaHCO3, and water, dried with MgSO4, and 
concentrated. Flash silica chromatography (EtOAc/CH2Cl2 1:9, containing 0.5% 
triethylamine) gave the dibenzoylated product (109.0 mg, 86%) as a white solid. 1H NMR 
(400 MHz, CDCl3): δ = 7.95 – 7.29 (m, 15H; Ar-H), 7.00 (d, J = 6.6 Hz, 1H; NH), 5.94 – 
5.73 (m, 1H; OCH2CHCH2), 5.62 (t, J = 9.2 Hz, 1H; GlcA H-3), 5.56 (s, 1H; CHPh), 5.53 
– 5.42 (m, 2H; GlcA H-2, H-4), 5.28 – 5.19 (m, 1H; OCH2CHCH2), 5.18 (d, J = 7.4 Hz, 
1H; GlcA H-1), 5.17 – 5.12 (m, 1H; OCH2CHCH2), 5.11 (d, J = 8.2 Hz, 1H; GalNAc H-
1), 4.78 (dd, J = 11.2, 3.5 Hz, 1H; GalNAc H-3), 4.47 (dd, J = 3.5, 0.9 Hz, 1H; GalNAc 
H-4), 4.39 – 4.28 (m, 2H; GalNAc H-6, OCH2CHCH2), 4.21 (d, J = 9.9 Hz, 1H; GlcA H-
5), 4.06 (m, 2H; GalNAc H-6, OCH2CHCH2), 3.80 – 3.69 (m, 4H; COOCH3, GalNAc H-
2), 3.51 (d, J = 1.2 Hz, 1H; GalNAc H-5), 2.65 – 2.32 (m, 4H; CH2O), 2.04 (s, 3H; COCH3). 
13C NMR (101 MHz, CDCl3) δ = δ 205.62, 171.21, 167.18, 165.49, 164.80, 162.22, 137.66, 
133.54, 133.40, 133.37, 129.84, 129.79, 128.87, 128.73, 128.62, 128.38, 128.04, 126.10, 
117.99, 100.51, 100.19, 97.44, 92.05, 75.74, 73.48, 72.45, 72.07, 71.37, 70.32, 69.38, 68.98, 
66.53, 55.29, 53.06, 37.50, 29.58, 27.60. HRMS: m/z calcd for [C44H44Cl3NO16 +NH4]
+: 
965.2070; found: 965.2035.  
A mixture of pyridine/AcOH/hydrazine hydate (6:4:0.5, 1.1 ml) was added to a 
solution of the dibenzoylated product (53.9 mg, 0.57 mmol) in pyridine (0.21 ml) and 
stirred for 2.5 min at RT. The mixture was then diluted with CH2Cl2 (10 ml), washed with 
water, saturated aqueous NaHCO3, and water, dried with MgSO4, and concentrated. Flash 
silica chromatography (EtOAc/CH2Cl2 12:88, containing 0.5% triethylamine) gave the 
product (39.0 mg, 81%) as a white solid. 1H NMR (500 MHz, CDCl3): δ = 7.96 – 7.29 (m, 
15H; Ar-H), 7.01 (d, J = 6.6 Hz, 1H; NH), 5.93 – 5.77 (m, 1H; OCH2CHCH2), 5.53 (s, 1H; 
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CHPh), 5.52 – 5.43 (m, 2H; GlcA H-2, H-3), 5.27 – 5.19 (m, 2H; GlcA H-1, OCH2CHCH2), 
5.19 – 5.11 (m, 2H; GalNAc H-1, OCH2CHCH2), 4.76 (dd, J = 11.2, 3.5 Hz, 1H; GalNAc 
H-3), 4.44 (d, J = 3.4 Hz, 1H; GalNAc H-4), 4.39 – 4.31 (m, 2H; GalNAc H-6, 
OCH2CHCH2), 4.21 (t, J = 9.2 Hz, 1H; GlcA H-4), 4.14 – 4.00 (m, 2H; GalNAc H-6, 
OCH2CHCH2), 3.85 (s, 3H; COOCH3), 3.73 (ddd, J = 11.2, 8.1, 6.5 Hz, 1H; GalNAc H-
2), 3.51 (s, 1H; GalNAc H-5), 3.39 (s, 1H; GlcA 4-OH). 13C NMR (126 MHz, CDCl3): δ 
= 169.11, 166.43, 165.06, 162.15, 137.58, 133.55, 133.42, 133.37, 129.86, 129.83, 128.96, 
128.85, 128.40, 128.37, 128.12, 125.98, 117.98, 100.48, 97.40, 92.09, 75.85, 75.07, 74.04, 
73.75, 71.09, 70.35, 69.05, 66.51, 55.30, 53.05. HRMS: m/z calcd for [C39H38Cl3NO14 
+NH4]
+: 867.1702; found: 867.1696.  
Allyl (methyl 2,3,4-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-(4,6-O-benzylidene-2-
deoxy-2-trichloroacetamido-β-D-galactopyranoside)-(1→4)-(methyl 2,3-O-benzoyl-β-
D-glucopyranosyluronate)-(1→3)-4,6-O-benzylidene-2-deoxy-2-trichloroacetamido-β-
D-galactopyranoside (37).  
A mixture of donor 7 (39 mg, 0.045 mmol), acceptor 32 (19 mg, 0.022 mmol) was 
dissolved in CH2Cl2 (30 ml). The mixture was then cooled down to -60 °C and TMSOTf was 
added. The mixture was slowly warmed to RT within 1 h and then filtered and concentrated. 
Flash silica chromatography (EtOAc/CH2Cl2 1:10) and gave the product (17.5 mg, 50%) as 
a white solid. 1H NMR (400 MHz, CDCl3): δ = 7.93 – 7.13 (m, 20H; Ar-H), 6.93 (d, J = 7.1 
Hz, 1H; NH), 6.90 (d, J = 6.7 Hz, 1H; NH), 5.83 (s, 1H; OCH2CHCH2), 5.62 (t, J = 8.5 Hz, 
1H; GlcAI H-3), 5.52 (s, 1H; CHPh), 5.40 (dd, J = 8.4, 7.0 Hz, 1H; GlcAI H-2), 5.34 (s, 1H; 
CHPh), 5.25 – 5.05 (m, 7H; 2GalNAc H-1, GlcAI H-1, GlcAII H-3, H-4, 2OCH2CHCH2, ), 
4.95 (dd, J = 8.7, 7.4 Hz, 1H; GlcAII H-2), 4.82 (d, J = 7.4 Hz, 1H; GlcAII H-1), 4.72 (dd, J 
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= 11.1, 3.5 Hz, 1H; GalNAc H-3), 4.57 (t, J = 9.0 Hz, 1H; GlcAI H-4), 4.44 – 4.30 (m, 4H; 
GalNAc H-3, H-4, H-6, OCH2CHCH2), 4.22 (d, J = 3.5 Hz, 1H; GalNAc H-4), 4.17 (d, J = 
9.4 Hz, 1H; GlcAI H-5), 4.10 – 4.01 (m, 2H; GalNAc H-6, OCH2CHCH2), 3.95 (d, J = 9.9 
Hz, 1H; GlcAII H-5), 3.86 – 3.78 (m, 4H; GalNAc H-6, COOCH3), 3.76 – 3.67 (m, 6H; 
GalNAc 2H-2, H-6, COOCH3), 3.50 (s, 1H; GalNAc H-5), 3.14 (s, 1H; GalNAc H-5), 1.99 
(s, 3H; COCH3), 1.98 (s, 3H; COCH3), 1.96 (s, 3H; COCH3). 
13C NMR (101 MHz, CDCl3): 
δ = 170.03, 169.38, 169.11, 168.44, 167.15, 165.37, 165.06, 162.13, 161.78, 137.71, 137.66, 
133.55, 133.43, 133.38, 133.27, 132.95, 129.90, 129.84, 129.74, 129.18, 129.01, 128.83, 
128.56, 128.34, 128.21, 128.12, 127.83, 126.26, 126.14, 125.99, 118.01, 100.47, 100.35, 
100.32, 99.86, 98.10, 97.43, 92.40, 92.03, 75.53, 75.33, 74.77, 73.93, 73.89, 73.76, 73.03, 
72.30, 71.82, 71.10, 70.35, 69.07, 69.04, 68.23, 66.66, 66.51, 20.79, 20.56, 20.47. HRMS: 
m/z calcd for [C67H68Cl6N2O28 +NH4]
+: 1576.2435; found: 1576.2409. 
Allyl (methyl 2,3,4-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-(2-deoxy-2-
trichloroacetamido-β-D-galactopyranoside)-(1→4)-(methyl 2,3-O-benzoyl-β-D-
glucopyranosyluronate)-(1→3)-2-deoxy-2-trichloroacetamido-β-D-galactopyranoside 
(38).  
A mixture of 37 (32.5 mg, 6.0 µmol), CSA (11.1 mg, 48 µmol) in DCM/methanol 
(1:1, 4 ml) was stirred at rt for 10 h. The mixture was cooled down and concentrated. The 
residue was dissolved in CH2Cl2 and washed with water and saturated aqueous 
NaHCO3.The organic layer was dried with MgSO4, filtered, and concentrated. Flash silica 
chromatography (CH2Cl2/MeOH 19:1) containing 0.5% triethylamine) gave the product 
(19.9 mg, 78%) as a white solid. 1H NMR (400 MHz, CDCl3): δ = 7.96 – 7.35 (m, 10H; 
Ar-H), 5.94 – 5.74 (m, 1H; OCH2CHCH2), 5.57 (t, J = 7.8 Hz, 1H; GlcAI H-3), 5.33 (t, J 
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= 7.6 Hz, 1H; GlcAI H-2), 5.22 – 5.16 (m, 3H; GlcAI H-1,GlcAII H-3, OCH2CHCH2), 5.11 
– 5.03 (m, 2H; GlcAII H-4, OCH2CHCH2), 4.96 (dd, J = 9.5, 8.0 Hz, 1H; GlcAII H-2), 4.85 
(d, J = 8.0 Hz, 1H; GlcAII H-1), 4.79 (d, J = 8.1 Hz, 1H; GalNAc H-1), 4.56 – 4.49 (m, 2H; 
GalNAc H-1, GlcAI H-4), 4.34 (d, J = 7.9 Hz, 1H; GlcAI H-5), 4.30 (m, 1H; OCH2CHCH2), 
4.19 (d, J = 9.9 Hz, 1H; GlcAII H-5), 4.17 (dd, J = 2.9, 1.0 Hz, 1H; GalNAc H-4), 4.13 – 
3.97 (m, 4H; GalNAc, 2H-2, H-3, OCH2CHCH2), 3.94 – 3.89 (m, 2H; GalNAc H-3, H-4), 
3.77 (d, J = 6.1 Hz, 5H; GalNAc 2H-6, COOCH3), 3.69 (s, 3H; COOCH3), 3.53 (m, 1H; 
GalNAc H-5), 3.27 – 3.16 (m, 2H; GalNAc 2H-6), 2.03 (s, 3H; COCH3), 1.99 (s, 3H; 
COCH3), 1.96 (s, 3H; COCH3). 
13C NMR (126 MHz, CDCl3): δ = 169.38, 169.25, 168.99, 
168.04, 166.96, 164.87, 162.00, 161.74, 133.15, 132.30, 132.23, 129.13, 128.81, 128.75, 
128.37, 127.29, 127.23, 115.19, 100.14, 99.84, 99.51, 99.48, 92.13, 91.82, 78.78, 77.18, 
74.18, 74.13, 73.57, 72.52, 71.27, 70.92, 70.13, 68.82, 68.70, 66.82, 66.23, 60.13, 59.03, 
52.93, 52.27, 51.49, 51.22, 18.90, 18.32, 18.24. HRMS: m/z calcd for [C53H60Cl6N2O28 + 
Na]+: 1405.1361; found: 1405.1639. 
Allyl (methyl 2,3,4-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-(2-deoxy-2-
acetamido-β-D-galactopyranoside)-(1→4)-(methyl 2,3-O-benzoyl-β-D-
glucopyranosyluronate)-(1→3)-2-deoxy-2-acetamido-β-D-galactopyranoside (39).  
A mixture of tributylstannane (52.0 µl, 0.19 mmol), AIBN (3.0 mg, 18.0 µmol) and 
38 (12.7 mg, 9.2 µmol) in toluene (1.6 ml) and N,N-dimethylacetamide was purged with dry 
Ar gas for 1 hour. The mixture was then heated to 110 °C and stirred for 20 min. The mixture 
was cooled down, diluted with acetonitrile and washed with pentane. The acetonitrile layer 
was concentrated. Flash silica chromatography (MeOH/CH2Cl2 1:11, containing 0.5% 
triethylamine) gave the product (9.2 mg, 85%). 1H NMR (400 MHz, CD3OD): δ = 8.10 – 
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7.31 (m, 10H; Ar-H), 5.88 – 5.74 (m, 1H; OCH2CHCH2), 5.65 (t, J = 8.6 Hz, 1H; GlcAI H-
3), 5.33 (dd, J = 8.8, 7.8 Hz, 1H; GlcAI H-2), 5.27 (t, J = 9.4 Hz, 1H; GlcAII H-3), 5.24 – 
5.16 (m, 1H; OCH2CHCH2), 5.13 – 5.00 (m, 3H; GlcAI H-1, GlcAII H-4, OCH2CHCH2), 
4.93 (dd, J = 9.5, 8.0 Hz, 1H; GlcAII H-2), 4.84 (d, J = 8.0 Hz, 1H; GlcAII H-1), 4.55 (d, J = 
8.2 Hz, 1H; GalNAc H-1), 4.46 – 4.37 (m, 2H; GalNAc H-1, GlcAI H-4), 4.32 – 4.23 (m, 
2H; GlcAI H-5, OCH2CHCH2), 4.20 (d, J = 10.0 Hz, 1H; GlcA
II H-5), 4.12 (dd, J = 2.8, 1.1 
Hz, 1H; GalNAc H-4), 4.05 – 3.94 (m, 2H; GalNAc H-2, OCH2CHCH2), 3.90 (dd, J = 2.8, 
1.0 Hz, 1H; GalNAc H-4), 3.88 – 3.77 (m, 5H; GalNAc H-2, H-3, COOCH3), 3.77 – 3.70 
(m, 3H; GalNAc H-3, 2H-6), 3.68 (s, 3H; COOCH3), 3.54 – 3.46 (m, 1H; GalNAc H-5), 3.26 
– 3.14 (m, 2H; GalNAc H-5, H-6), 3.10 – 3.02 (m, 1H; GalNAc H-6), 2.02 (s, 3H, COCH3), 
1.99 (s, 3H; COCH3), 1.97 (s, 6H; 2COCH3), 1.26 (s, 3H; COCH3). 
13C NMR (101 MHz, 
CDCl3): δ = 173.29, 173.21, 171.45, 171.16, 171.14, 169.77, 169.19, 166.91, 166.54, 135.55, 
134.54, 134.43, 131.06, 130.93, 130.85, 130.62, 129.54, 129.45, 116.84, 103.38, 102.72, 
102.35, 102.07, 82.81, 81.96, 80.87, 77.64, 76.19, 75.80, 75.57, 74.81, 73.42, 72.93, 72.51, 
70.80, 70.49, 69.14, 68.09, 62.33, 60.80, 53.60, 53.34, 52.95, 52.23, 23.57, 22.42, 20.77, 
20.47, 20.39. HRMS: m/z calcd for [C53H66N2O28 +Na]
+: 1201.3701; found: 1201.3696. 
Allyl (methyl 2,3,4-O-acetyl-β-D-glucopyranosyluronate)-(1→3)-(2-acetamido-2-
deoxy-4,6-O-sulfonato-β-D-galactopyranoside)-(1→4)-(methyl 2,3-O-benzoyl-2-O-
sulfonato-β-D-glucopyranosyluronate)-(1→3)-2-acetamido-4,6-O-sulfonato-2-deoxy-β-
D-galactopyranoside tetrasodium salt (40).  
A mixture of 39 (5.6 mg, 4.8 μmol) and sulfur trioxide/trimethylamine complex 
(33.5 mg, 24 μmol) was azeotroped with toluene 5 times and dried under high vacuum 
overnight. The mixture was then dissolved in anhydrous DMF (0.37 ml) and stirred for 48 
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h at 60 °C. After the mixture was cooled down, methanol (0.05 ml) was added and the 
mixture was stirred for another 30 min. The mixture was then directly applied and eluted 
from a column (3x30 cm) of Sephadex LH-20 with 1:1 CH2Cl2/MeOH. Flash silica 
chromatography (MeOH/CH2Cl2 1:5, containing 0.5% triethylamine) followed by a 
column (1x15 cm) of Amberlite® IR120 Sodium form resin (1:1 CH2Cl2/MeOH) then gave 
the product as a white solid (6.1 mg, 78%). 1H NMR (400 MHz, CD3OD): δ = 8.03 – 7.32 
(m, 10H; Ar-H), 5.88 – 5.76 (m, 1H; OCH2CHCH2), 5.73 (t, J = 8.9 Hz, 1H; GlcAI H-3), 
5.44 (dd, J = 8.6, 7.4 Hz, 1H; GlcAI H-2), 5.27 (t, J = 9.4 Hz, 1H; GlcAII H-3), 5.24 – 5.15 
(m, 2H; GlcAII H-4, OCH2CHCH2), 5.13 – 5.06 (m, 2H; GlcAI H-1, OCH2CHCH2), 5.03 
(dd, J = 9.3, 8.1 Hz, 1H; GlcAII H-2), 4.99 (d, J = 2.9 Hz, 1H; GalNAc H-4), 4.75 (d, J = 
2.9 Hz, 1H; GalNAc H-4), 4.67 (d, J = 8.3 Hz, 1H; GalNAc H-1), 4.63 (t, J = 9.5 Hz, 1H; 
GlcAI H-4), 4.48 (d, J = 9.8 Hz, 1H; GlcAI H-5), 4.45 – 4.37 (m, 2H; GalNAc H-1, H-6), 
4.33 – 4.24 (m, 2H; GalNAc H-6, OCH2CHCH2), 4.20 (d, J = 9.9 Hz, 1H; GlcAII H-5), 
4.13 – 4.00 (m, 3H; GalNAc H-2, H-6, OCH2CHCH2), 3.99 – 3.78 (m, 9H; GalNAc H-2, 
2H-3, 2H-5, H-6, COOCH3), 3.73 (s, 3H; COOCH3), 2.00 (s, 3H; COCH3), 2.00 (s, 3H; 
COCH3), 1.95 (s, 3H; COCH3), 1.88 (s, 3H; COCH3), 1.42 (s, 3H; COCH3). 
13C NMR (101 
MHz, CD3OD): δ = 173.66, 173.59, 171.65, 171.52, 171.25, 170.69, 169.88, 167.44, 
167.16, 135.42, 134.63, 134.33, 131.23, 131.01, 130.73, 130.48, 129.58, 129.48, 117.08, 
103.16, 102.18, 101.94, 101.07, 80.12, 77.89, 77.04, 76.80, 76.09, 75.32, 74.28, 74.03, 
73.72, 73.53, 73.01, 72.69, 70.72, 70.65, 69.17, 68.14, 53.81, 53.58, 53.39, 52.39, 23.41, 
22.56, 20.90, 20.49, 20.43. HRMS: m/z calcd for [C53H62N2Na4O40S4 + Na]
+: 1609.1250; 
found: 1609.1287. 
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 Allyl (β-D-glucopyranosyluronate)-(1→3)-(2-acetamido-2-deoxy-4,6-O-sulfonato-β-D-
galactopyranoside)-(1→4)-(β-D-glucopyranosyluronate)-(1→3)-2-acetamido-4,6-O-
sulfonato-2-deoxy-β-D-galactopyranoside hexasodium salt (2).  
Tetrasaccharide 40 (6.1 mg, 4.1 µmol) was dissolved in THF (450 µL) and H2O (225 µL) 
and cooled to 0 °C. To this were added 1 M aq. LiOH (64 µL) and 30% H2O2 (32 µL). The 
reaction was stirred at 0 °C for 1 h and at rt for 12 h. At this time, 4 M NaOH (70 µL) and 
MeOH (475 µL) were added and the reaction stirred for another 12 h. It was then neutralized 
with Amberlite® IR120 Hydrogen form resin, filtered, and lyophilized to afford a white 
solid. The product was purified by a Sephadex G-25 column (0.5x30 cm) and lyophilized to 
give the product (3.9 mg, 81%). 1H NMR (900 MHz, D2O, 286 K) δ = 5.88 (m, 1H; 
OCH2CHCH2), 5.30 (m, 1H; OCH2CHCH2), 5.27 – 5.23 (m, 1H; OCH2CHCH2), 4.83 (s, 
1H; GalNAcII H-4), 4.77 (d, J = 3.0 Hz, 1H; GalNAcI H-4), 4.58 (d, J = 8.0 Hz, 1H; GalNAcII 
H-1), 4.57 (d, J = 8.4 Hz, 1H; GalNAcI H-1), 4.47 (d, J = 7.8 Hz, 1H; GlcAI H-1), 4.45 (d, J 
= 7.8 Hz, 1H; GlcAII H-1), 4.35 – 4.31 (m, 1H; OCH2CHCH2), 4.27 (m, 2H; GalNAcI H-6, 
GalNAcII H-6), 4.23 – 4.16 (m, 3H; OCH2CHCH2, GalNAcI H-6, GalNAcII H-6), 4.12 (dd, 
J = 8.8, 2.7 Hz, 1H; GalNAcII H-5), 4.09 – 4.03 (m, 3H; GalNAcI H-2, H-5, GalNAcII H-3), 
4.01 (dd, J = 11.0, 3.0 Hz, 1H; GalNAcI H-3), 3.74 (dd, J = 11.1, 7.4 Hz, GlcAI H-4), 3.66 
(d, J = 9.6 Hz, 1H; GlcAI H-5), 3.66 – 3.63 (d, J = 9.4 Hz 1H; GlcAII H-5), 3.59 (dd, J = 
11.0, 7.2 Hz, 1H; GlcAI H-3), 3.50 (t, J = 9.5 Hz, 1H; GlcII H-4), 3.45 (t, J = 9.2 Hz, 1H; 
GlcI H-3), 3.39 (dd, J = 9.5, 7.9 Hz, 1H; GlcAII H-2), 3.32 (dd, J = 9.4, 7.8 Hz, 1H; GlcAI 
H-2), 2.02 (s, 3H; NHCOCH3), 1.99 (s, 3H; NHCOCH3). 
13C NMR (101 MHz, D2O): δ = 
175.87, 174.93, 174.76, 174.07, 133.08, 118.58, 103.44, 103.40, 101.55, 99.83, 82.21, 76.63, 
76.25, 76.08, 76.01, 75.02, 74.82, 73.75, 72.47, 72.29, 72.22, 71.86, 71.80, 70.53, 67.87, 
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67.62, 51.44, 51.36, 22.55, 22.15. HRMS: m/z calcd for [C31H42N2Na6O35S4 - Na]
 -: 
1244.9945; found: 1244.9948. 
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C h a p t e r  3  
NMR SOLUTION STRUCTURE OF THE CS-D AND CS-E TETRASACCHARIDE* 
Introduction 
To better elucidate the complex interactions between GAGs and proteins, 
understanding of the solution structure of GAGs is of great importance. The 3D-structural 
properties of GAGs can be examined by three major analytical methods: (1) molecular 
dynamics that utilizes a self-consistent set of physically realistic equations and semi-
empirical parameters to simulate atomic and molecular motions; (2) X-ray crystallography 
of free or protein-bound GAG oligosaccharides; and (3) liquid or media-aligned NMR 
spectroscopy. While the majority of protein structures are determined by X-ray 
crystallography, most of the recent structural studies on GAGs are NMR based. NMR as a 
technique for conformational studies has several advantages: (1) samples can be studied 
under physiologically relevant environment with adjustable pH, salt concentration and 
temperature; (2) a wide range of structural properties can be obtained with different NMR 
experiments; and (3) samples are easy to prepare and usually recoverable. Although NMR 
methods are usually unfeasible for structure determination of large molecules (>60 kDa), 
they are suitable and have been used for GAGs with the length of 2 to 12 monosaccharide 
units1-3. 
                                              
* The NMR structure determination was done in collaboration with Dr. Andrew almond at University of Manchester.  
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Typical NMR parameters utilized for structure determination include the nuclear 
Overhauser effect (NOE), scalar couplings (J), residual dipolar couplings (RDC) and 
chemical shift anisotropy (CSA). NOE signals resulted from through-space contacts of nuclei 
provide inter-nuclei distance information and are the base of NMR structural determination. 
Inter-residual NOE signals in particular provide information regarding glycosidic linkage 
torsion angles. As for scalar couplings, the most commonly used type is the three-bond 
proton coupling. The coupling constants provide information regarding the dihedral angle 
between vicinal protons and therefore are useful for determining the ring pucker. RDC and 
CSA signals are obtained from anisotropic conditions, usually when the target molecules are 
partially aligned in lipid, liquid crystal or filamentous phage media. RDC and CSA provides 
information regarding relative orientation of the magnetic field and nucleus-nucleus vectors, 
and hence the relative orientation between nucleus-nucleus vectors can be obtained. Other 
NMR parameters such as one-bond or three bond C-H coupling can provide valuable 
structural information as well but are much less commonly adopted.  
For GAGs, the important structure features include conformations around the 
glycosidic linkages, orientations of the exocyclic groups and ring puckering states. 
Conformation around a glycosidic linkages are characterized by a pair of torsion angles φ 
and ψ (figure 3.1). There are three definitions of φ and ψ, preferred by groups of different 
academic background. In this study, we will use the conventional definition unless otherwise 
specified. The conventional definition defines φ as O5-C1-O1-Cx and ψ as C1-O1-Cx-
C(x+1) for a (1→x) glycosidic linkage. Orientations of the exocyclic groups are described 
quantitatively with torsion angles or qualitatively respect to an atom. The hydroxymethyl 
group in a GalNAc unit can be defined by the ω torsion angle (O5-C5-C6-O6) and categorized 
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in the gauche-gauche, gauche-trans, and trans-gauche orientation (ω close to -60°, 60° and 
180°, respectively). Orientation of the O-sulfate group at position x is defined by µx torsion 
angle (C(x-1)-Cx-Ox-S). Since the oxygen atoms on the carboxylate groups are equivalent, 
we will define µ5 as the torsion angle between the O6-C6-O6 plane and the C4-C5-C6 plane. 
Orientation of the acetamido group will be defined with respect to H2 as µN (HN-N2-C2-
H2).  
  
Figure 3.1. Schematic representation of the torsion angles of interest. 
The puckering states of a sugar ring can be described with a set of Cremer-Pople 
polar coordinate (θ, ψ, Q)4, as illustrated in Figure 3.2. For example, the 4C1 chair 
corresponds to θ = 0° and the B3,O boat corresponds to θ = 90° and ψ = 180°. The definitions 
of the 38 canonical pyranose ring puckers are listed in the appendix for Chapter 3.  
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Figure 3.2. Spherical mapping of pyranose conformations represented by the Cremer–Pople 
polar coordinates. The closest canonical puckers of the IUPAC name is used here to 
concisely specify sugar ring puckers. 
Due to the repetitive nature of GAGs, resonance overlap is often serious and prevents 
the measurement of sufficient structurally important parameters. Direct structure 
determination with NMR data only is therefore usually challenging. Semi-empirical force 
field such as MM35, AMBER6 or GLYCAM7 are often employed in the form of restrained 
molecular dynamics to compensate the lack of sufficient NMR data.  
To the best of our knowledge, five NMR structural studies of chondroitin sulfate has 
been published. The four recent studies are briefly introduced below. In the work by 
Kamerling and coworkers8, the glycosidic linkage torsion angles of 8 disaccharide units were 
described by the potential energy map calculated with the MM35 force field in a grid search 
manner. One inter-residual NOE signal was measured for each glycosidic linkage. The NOE 
derived distances were consistent with the distances measured from global minimum 
conformation on the energy map of each disaccharide unit. The glycosidic linkage torsion 
angles at the global minimum were reported for each disaccharide unit. Scalar coupling 
constants and ring puckering were not measured or discussed.  
Solera and coworkers9 investigated the structure of a CS-E tetrasaccharide and a 
heptasulfated non-natural CS tetrasaccharide with NMR methods and molecular dynamics 
simulation. The AMBER10 and GLYCAM11 force field was used for the simulation. A total 
of two inter-residual NOE signals were measured for the CS-E tetrasaccharide and compared 
against distance measured over the trajectory of molecular dynamics simulation. 
Superimposition of structures along the simulation was presented, but no value of glycosidic 
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linkage torsion angles were reported. The experimentally derived distances were consistent 
with the simulated distances. Scalar coupling constants suggested 4C1 pucker for all the 
monosaccharide units, which is consistent with the molecular dynamics simulation.  
Sattelle and coworkers12, studied an unsulfated chondroitin hexasaccharide with 
restrained molecular dynamics. Scalar coupling constants of the hexasaccharide 
were consistent with the 4C1 pucker of GalNAc and GlcA units, justifying the use of 
endocyclic torsional restraints to preclude the formation of non-4C1 pucker during the 
simulation. Eight inter-residual distance restraints derived from NOE signals were 
supplemented to the GLYCAM7 force field as energy penalty functions. A molecular 
dynamics simulated annealing protocol was performed for 250 rounds to generate energy 
minimized structures. The top 10% most energetically favorable model conformers were 
accepted as the final structure ensemble and the ensemble was deposited in the PDB with 
code 2KQO, which is the only CS NMR structure available in the PDB.  
Yu and coworkers13 used RDC and CSA offsets to determine the conformational 
preferences of a CS pentasaccharide. The inherent acetyl groups were replaced with 13C 
labeled acetyl groups by a series of chemical reactions to enhance sensitivity for the RDC 
and CSA experiments. Inter-residual NOE signals and JH2-HN values were also measured to 
serve as distance and torsional restraints. Structure of the pentasaccharide was determined 
using an iterative calculation of alignment parameters from an assumed structure with the 
REDCAT software14 and optimization of the structure using a simulated annealing protocol 
with the XPLOR-NIH software15-16. 10 structures with lowest energy were selected for the 
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final ensemble and the average glycosidic linkage torsion angles were reported. Endocyclic 
scalar coupling constants or the puckering states were not reported.   
 Here, we report the solution structure determination of the CS-D and CS-E 
tetrasaccharide. To the best of our knowledge, this is the first NMR structural study of a CS-
D tetrasaccharide. On the other hand, our work of the CS-E tetrasaccharide is the most 
thorough study to date. This is also the first CS structural study that determined the glycosidic 
linkage torsion angles of GAGs and resolved a second conformer for CS based on NMR data 
and chemical information only, without molecular mechanics.  
To aid the NMR structure determination, we performed free molecular dynamics of 
10 µs for the CS-D and CS-E tetrasaccharide to provide structural insights. However, the 
free molecular dynamics was not directly involved in our structure determination. As for the 
NMR experiments, we utilized the NOE and scalar coupling data to determine the glycosidic 
linkage torsion angles and ring puckering states. Orientation of the exocyclic moieties such 
as the carboxylate or hydroxymethyl groups was modeled with the GLYCAM7 force field, 
as no definitive NMR data was available.  
Structures of the CS-D and CS-E tetrasaccharides are shown in figure 3.3. From the 
reducing end, the monosaccharides are referred to as GalNAc1, GlcA1, GalNAc2, and 
GlcA2 throughout in this chapter.  
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Figure 3.3. Structure of the CS-D and CS-E tetrasaccharides.  
Free molecular dynamics and analysis 
We performed a 10 µs molecular dynamics simulation with the GLYCAM force 
field7 in explicit water. Molecular dynamics simulation performed at microsecond timescale 
is suggested to be sufficient to reproduce conformational equilibrium in monosaccharides 
and linear sulfated glycosaminoglycans containing up to ten pyranoses1. The glycosidic 
linkage torsion angles, ring puckering states, and orientation of the exocyclic groups were 
extracted from the trajectory. The data is briefly presented here. Further analysis will be 
presented and compared along with the NMR-based structures.  
Distribution of glycosidic linkage torsion angles of the CS-D and CS-E 
tetrasaccharide are shown below as a scatter plot in figure 3.4, respectively. The average 
values of the angles are summarized in table 3.1 and table 3.2. These values will be further 
analyzed along with the NMR calculated structure.  
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Figure 3.4. Distribution of glycosidic torsion angles of the CS-D (top) and CS-E (bottom) 
tetrasaccharide.  
.  
Torsion 
β(1→3) 
GlcA2-GalNAc2 
β(1→4) 
GalNAc2-GlcA1 
β(1→3) 
GlcA1-GalNAc1 
φ -90 -80 -81 
Ψ 99 -122 113 
Table 3.1. Average glycosidic linkage torsion angles of the CS-D tetrasaccharide. 
 
Torsion 
β(1→3) 
GlcA2-GalNAc2 
β(1→4) 
GalNAc2-GlcA1 
β(1→3) 
GlcA1-GalNAc1 
φ -71 -77 -72 
Ψ 133 -132 130 
Table 3.2. Average glycosidic linkage torsion angles of CS-E tetrasaccharide. 
The ring puckering state was analyzed with the Cremer-Pople parameters and 
summarized as shown in table 3.3 and 3.4. For the CS-D tetrasaccharide, the simulation 
suggests that both GalNAc units have a dominant (>99.9%) 4C1 pucker. GlcA2 is mostly 
4C1 
but not as rigid as the GalNAc units. On the other hand, GlcA1 is predicted to be very flexible 
in that it does not have a dominant pucker. On the contrary, all monosaccharide units in the 
CS-E tetrasaccharide units have a dominant (>99%) 4C1 pucker.  
GalNAc1 GlcA1 GalNAc2 GlcA2 
4C1 99.94% 1C4 30.81% 4C1 99.96% 4C1 87.46% 
1S3 0.03% 4C1 27.04% 1S3 0.01% 1S3 5.54% 
4E 0.01% 1S3 20.66% 4H5 0.01% 1C4 2.21% 
4H3 0.01% B3O 13.86% 4E 0.01% 14B 2.12% 
4H5 0.01% 14B 3.80% 14B 0.01% B3O 1.48% 
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Table 3.3. Population of the 5 most-populated puckers of the CS-D tetrasaccharide from 
molecular dynamics simulation.  
GalNAc1 GlcA1 GalNAc2 GlcA2 
4C1 99.69% 4C1 99.29% 4C1 99.83% 4C1 99.66% 
1S3 0.204% 1C4 0.21% 1S3 0.06% 1S3 0.09% 
4H3 0.03% 1S3 0.12% 4H5 0.03% 1C4 0.07% 
4E 0.03% B3O 0.10% 4E 0.03% 14B 0.06% 
4H5 0.01% OS2 0.06% 14B 0.02% B3O 0.02% 
Table 3.4. Population of the 5 most-populated puckers of the CS-E tetrasaccharide from 
molecular dynamics simulation. 
As for orientations of the exocyclic groups, the 4-O-sulfate group in CS-E and the 
carboxylate groups in both CS-D and CS-E are rather rigid and adopt an eclipsed orientation 
with regard to H4 and H5 (µ4  ≈ -120°; µ5 ≈ 60°) respectively. The 2-O-sulfate groups of CS-
D favors an eclipsed orientation (µ2  ≈ 120°) over an anti orientation (µ2  ≈ -60°) with respect 
to H2 with the eclipsed/anti ratio ≈5. The acetamido groups in both tetrasaccharides favor 
the trans orientation with respect to H2 (µN ≈ 180°). The hydroxymethyl groups in both 
tetrasaccharides are flexible and adopt both trans-gauche and gauche-trans orientation (ω ≈ 
180° or 60°). While the hydroxymethyl groups in the CS-D tetrasaccharide have a trans-
gauche/gauche-trans ratio about 2.5, the trans-gauche orientation is less preferred (trans-
gauche/gauche-trans ratio = 1.25) in CS-E due to the repulsive interaction with the 4-O-
sulfate groups. The 6-O-sulfate groups in both the CS-D and CS-E tetrasaccharide virtually 
rotate freely, exploring all the conformational space except the eclipsed orientation with 
respect to C5 (µ6 = 0°).  
NMR experiments and data analysis 
With the synthesized CS-D and CS-E tetrasaccharides in hand, we decide to 
determine the structure with liquid NMR methods. High quality NMR spectra were recorded 
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with a 900 MHz Bruker instrument equipped with a cryoprobe at University of California, 
Berkeley. 1D and 2D spectra include proton, double quantum filtered homonuclear 
correlation spectroscopy (DQF-COSY), 1H-13C heteronuclear single quantum coherence 
(HSQC), total correlation spectroscopy (TOCSY), and NOESY were recorded in D2O and/or 
10% D2O in H2O solvent. Three-bond homonuclear coupling constants and NOE intensities 
were extracted from the 1H, DQF-COSY and NOESY spectra for structure determination. 
The rotating-frame Overhauser spectroscopy (ROESY) was also recorded for CS-D, because 
the ROESY experiment produced better spectra than the NOESY experiment when recorded 
with a local 600 MHz instrument. We suspected that the molecular weight of the 
tetrasaccharide may fall in the unfavorable range of NOESY with the 900 MHz instrument, 
too. However, the increased magnetic field moved the NOE unfavorable range down and 
away from the molecular weight of the CS-D tetrasaccharide. The NOESY spectra turned 
out to be better than the ROESY spectra, so the data measured from ROESY was not used 
for the CS-D tetrasaccharide.  
The NOE intensities were obtained by measuring the integral of a given proton-
proton cross-peak. All possible cross-peak positions were measured. If integral of a position 
where a correlation is possible was found to be below the noise level, a “no-NOE” was 
assigned. While a NOE signal provides more structural information by designating a certain 
distance between the source proton pair, a no-NOE signal can indicate that the proton pair is 
not close enough to have an identifiable peak. After careful examination of the spectra, we 
observed 16 and 16 coupling constants, 11 and 29 inter-residual NOE signals, 53 and 36 
inter-residual “no-NOE” signals, and 16 intra-residual NOE signals for CS-D and CS-E 
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respectively. The measured coupling constants summarized in the table 3.5 and 3.6. NOE 
data are shown in the appendix.  
 
GalNAc1 GlcA1 GalNAc2 GlcA2 
3JH1,H2 8.4 7.3 8.0 7.6 
3JH2,H3 13.1
a 8.9 13.1a 9.0 
3JH3,H4 4.4a 8.7 4.4a 9.6 
3JH4,H5 n/ab 9.6 n/ab 9.6 
3JHN,H2
 9.2  9.5  
Table 3.5. Experimental scalar coupling constants of CS-D. All couplings are reported in 
units of hertz. a Coupling constants measured from DQF-COSY spectrum. 
b Not available 
due to resonance overlap.  
 
GalNAc1 GlcA1 GalNAc2 GlcA2 
3JH1,H2 8.5 7.9 7.3 7.8 
3JH2,H3 11.0
a 9.4 12.9a 9.4 
3JH3,H4 3.0 8.7 4.3a 9.1 
3JH4,H5 n/ab 9.7 n/ab 9.8 
3JHN,H2
 10.3  10.2  
Table 3.6. Experimental scalar coupling constants of CS-E. All couplings are reported in 
units of hertz. a Coupling constants measured from DQF-COSY spectrum. 
b Not available 
due to resonance overlap.  
Pucker analysis 
Since the coupling constants provides information about the torsional angle between 
vicinal protons, they are often employed to determine the puckering state of the 
monosaccharide units. Fortunately, every coupling constant on every GlcA unit of both 
tetrasaccharides are available, providing unambiguous evidence for pucker determination. 
The large coupling constants of every vicinal proton pairs in every GlcA unit suggest that 
the GlcA units in both tetrasaccharides are in the 4C1 form. The large NOE signals of the 
diaxial proton pairs H1-H3, H1-H5, H3-H5, and H2-H4 further support the 4C1 assignment. 
On the other hand, while 3JH4,H5 are not available on the GalNAc units due to peak 
overlapping, the large coupling constants between the axial protons and the characteristic 
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small coupling constants of the axial-equatorial pair H3-H4 all indicate the 4C1 form. The 
intra-residual NOE data also points toward the 4C1 pucker, such as the large NOE signal of 
the diaxial proton pairs H1-H3, H1-H5 and H3-H5, and the small NOE signal of the axial-
equatorial proton pair H1-H4. The GalNAc units in dermatan sulfate has also been reported17 
to be exclusively in the 4C1 form based on coupling constants and NOE data.   
The large 3JHN,H2 in all GalNAc units suggest the µN torsion angle to be close to either 
0° or 180°. The large intra-residual NOE signal of the HN-H1 and HN-H3 pair further 
indicate the acetamido group to be trans oriented with respect to H2.  
The puckering states of each monosaccharide unit and µN of CS-E determined by 
NMR is consistent with the free molecular dynamics simulation. However, while puckering 
states of the GalNAc units and µN of CS-D as determined by NMR and simulation are 
consistent, the simulation and NMR data suggests different puckering states for the GlcA 
units. Although the experimental values clearly indicate the 4C1 pucker, in principle it is still 
possible that coupling constants of a single pucker to coincidentally be similar to coupling 
constants averaged from a combination of puckers. Therefore, quantitative comparison 
necessary to reject the inconsistent prediction.  
To directly and quantitatively compare the puckering states determined by 
experimental values and predicted by simulation, we calculated the average coupling 
constants of each monosaccharide over the trajectory with the Haasnoot-de Leeuw-Altona 
equation18. The Haasnoot-de Leeuw-Altona equation considers effect of electronegativity of 
atoms bonded to the proton-bearing carbon, and hence is more suitable than the original 
Karplus equation19 for determining coupling constants in carbohydrates.  
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Since molecular dynamics simulation predicted virtually exclusive 4C1 pucker for all 
the monosaccharide units in the CS-E tetrasaccharide and both GalNAc units in CS-D, 
simulated coupling constants were fully consistent with the experimental coupling constant 
as expected (Table 3.7 and Table 3.8). The slightly larger deviation of the coupling constants 
measured from the DQF-COSY experiment should not be considered as involvement of non-
4C1 pucker. Instead, it has been suggested that larger constants measured in DQF-COSY 
experiments are normal when the linewidths are somewhat broad due to the cancellation of 
overlapping of the antiphase peaks. 
For CS-D, the large deviation between the simulated and experimental values of the 
GlcA units in CS-D demonstrated that the puckers observed from molecular dynamics 
trajectory did not produce similar experimental value as the 4C1 pucker (Table 3.7), 
suggesting that the prediction was off. To further determine whether the most abundant non-
4C1 puckers predicted by simulation is present but in smaller quantities, we extracted the 
three most abundant puckers from the trajectory and calculated the coupling constants of 
each pucker (Table 3.9). Then we performed a linear least-square fitting of the experimental 
values with the three sets of coupling constants with MATLAB R2016a Optimization App. 
The experimental values were still best fitted by the 4C1 pucker without mixing with the 
1C4 
and 1S4 pucker. Multiple starting points were used to ensure that the optimization wasn’t 
trapped in the local minimum. Therefore, by demonstrating that the experimental value could 
not be better fitted with the introduction of non-4C1 puckers, the GlcA units of CS-D is 
exclusively 4C1 like other monosaccharide units in CS-D and CS-E.  
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.  GalNAc1 GlcA1 GalNAc2 GlcA2 
 Exp. Sim. Exp. Sim. Exp. Sim. Exp. Sim. 
3JH1,H2 8.4 8.3 7.5 3.2 8.0 8.3 7.6 6.6 
3JH2,H3 13.1
a 10.5 8.9 5.8 13.1a 10.5 9.0 7.9 
3JH3,H4 4.4a 2.6 8.7 6.6 4.4a 2.6 8.8 8.0 
3JH4,H5 n/ab 0.9 9.6 6.1 n/ab 0.9 10.5 9.9 
Table 3.7. Comparison of coupling constants of the CS-D tetrasaccharide from experiments 
and simulation. All couplings are reported in units of hertz. aCoupling constants measured 
from DQF-COSY spectrum. b Not available due to resonance overlap. 
 GalNAc1 GlcA1 GalNAc2 GlcA2 
 Exp. Sim. Exp. Sim. Exp. Sim. Exp. Sim. 
3JH1,H2 8.5 8.2 7.9 7.4 7.3 8.3 7.8 7.4 
 JH2,H3 11.0
a 10.5 9.4 8.5 12.9a 10.6 9.4 8.5 
3JH3,H4 3.0 2.4 8.7 8.4 4.3
a 2.4 9.1 8.2 
3JH4,H5 n/a
b 0.8 9.7 9.9 n/ab 0.9 9.8 9.8 
Table 3.8. Comparison of coupling constants of the CS-E tetrasaccharide from experiments 
and simulation. All couplings are reported in units of hertz. a Coupling constants measured 
from DQF-COSY spectrum. b Not available due to resonance overlap. 
 GlcA1 GlcA2 
 Exp. 1C4 
4C1 
1S3 Exp. 
4C1 
1S3 
1C4
 
3JH1,H2 7.5 1.5 7.4 1.3 7.6 7.3 1.3 1.5 
3JH2,H3 8.9 1.9 8.5 6.5 9.0 8.4 6.2 2.0 
3JH3,H4 8.7 2.5 8.4 9.3 8.8 8.2 9.2 2.7 
3JH4,H5 9.6 1.0 9.9 8.1 10.5 9.8 8.2 1.1 
Table 3.9. Coupling constants of the three most abundant puckers predicted in the molecular 
dynamics simulation. All couplings are reported in units of hertz. 
Aside from our results, available X-ray structures20-22 of free or protein-bound CS 
also agree with the above conclusions that every monosaccharide unit in CS is in the 4C1 
form and that the acetamido groups adopt a trans orientation. Similar to our molecular 
dynamics simulation, previous simulation studies23-24 also predicted dominant 4C1 form in 
the GalNAc units, the trans orientation of the acetamido group, and the presence of non-4C1 
puckers of GlcA units.   
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Structure determination of CS-E 
Based on the data available, we decided to determine the solution structure of the two 
tetrasaccharides in two stages: (1) Determine the backbone conformation (i.e., torsion angles 
of the glycosidic linkages) with NOE data. (2) Model the exocyclic groups with the 
GLYCAM7 force field. We need to utilize the GLYCAM force field to model the exocyclic 
groups such as the –COO- and –CH2OSO3- groups since we don’t have experimental data 
regarding orientation of the exocyclic groups. As for the backbone, we calculated the 
structure without involving molecular mechanics. Although the force fields are constantly 
improving, they are still far from perfect and do not always give good prediction on every 
aspect. Therefore, we aim to determine the structure by experimental data as much as 
possible and model the rest with a force field.  
To determine the backbone structure with the NMR data, we decided to employ a 
distance geometry approach without molecular mechanics. Each monosaccharide unit was 
treated as a rigid body and fixed in the 4C1 pucker based on the pucker analysis. Only the φ 
and ψ glycosidic linkage torsion angles were allowed to rotate. The acetamido groups were 
fixed at the trans orientation (µN = 180°) in order to apply the inter-residual NOE signals 
from amide protons (HN). We chose not to model the monosaccharide rings and the 
acetamido groups as flexible units because only a moderate amount of inter-residual signals 
was available. If we allowed the rings and acetamido groups to be flexible, the increased 
degrees of freedom can very possibly lead to poorly-defined structures.  
Distance geometry was implemented as a score function. The distance between an 
inter-residual proton pair m (rNOE,m) and smallest possible distance between inter-residual 
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pair n (rno_NOE,n) was derived from the NOE and “no-NOE” data. The square of difference 
between the distances measured from calculated structure (rcalc,m and rcalc,n) and experimental 
distances (rNOE,m and rno_NOE,n) were then calculated to give the score (S) (equation 3.1). The 
weighing factor km,NOE is assigned for each cross-peak based on quality of the NOE signal. 
Note that for the “no-NOE” signals, the square of difference was only calculated when the 
rcalc,n was smaller than rno_NOE,n (equation 3.3). A uniform weighing factor knoise is used for all 
no-NOE signals. Basically, the score function is composed of a series of harmonic potential 
wells that constrain interproton distances in the calculated structure (rcalc) to the experimental 
values. 
 S = ∑ SNOE,m + ∑ SnoNOE,n  (𝐞𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟑. 𝟏) 
SNOE,m = km,NOE(rm,NOE − rm,calc.)
2
 (𝐞𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟑. 𝟐) 
Sno_NOE,n = {
 knoise(r𝑛,noise − rn,calc.)
2
    if rn,noise >  r𝑛,calc.
0                                                 if rn,noise < rn,calc.
  (𝐞𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟑. 𝟑) 
Since the NOE spectrum is measured for both the D2O and 10% D2O in 90% H2O 
sample, both data sets are incorporated in the score function. Generally speaking, the D2O 
spectrum has a better quality than the 10% D2O in 90% H2O spectrum, so the km,NOE is 
typically larger for the NOE signals measured in the D2O spectrum. Minimization of the 
score function was then performed by exploring the conformational space composed of the 
six torsion angles by simulated annealing with the SimTK molecular modeling API 
(molmodel).  
It should be noted that NOE data assignment and structure calculation is an iterative 
process. In the beginning only high-quality and unambiguous NOE cross-peaks were used 
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for calculation. The calculated structure was then used to help the assignment of ambiguous 
cross-peaks. For ambiguous cross-peaks, the assignments were first made by assumptions 
and then validated (or rejected) after structure calculation. In the end, the calculated ensemble 
of structures must meet the following criteria to be accepted as ideal final structures. First of 
all, the ensemble of structures must satisfy all the experimentally derived restraints. Second, 
the structures must be physically allowed. Any two atoms should not be clashing into each 
other in space. The van der Waals radii will be used to evaluate the steric conflict. Finally, 
the ensemble of structures should be converged. If an ensemble of converged structures is 
not obtained, more structural restraints or re-assignment of NMR data will be required.  
For the CS-E tetrasaccharide, the data assignment-structure calculation iterations 
were performed for about twenty rounds before the simulated annealing generates a 
converged ensemble of structures. The distance restraints were nicely represented in the 
ensemble except for a few larger deviations of the long-distance restraints. Interatomic 
distances were then compared with the van der Waals radii and no gross violation was found. 
Therefore, we are satisfied with this ensemble calculated from NMR restraints.  
Exocyclic groups were then modeled with the GLYCAM force field with the 
backbone structure restrained at all times. 25 structures with the best scores were selected as 
the final ensemble of structures, shown in figure 3.5. Average glycosidic torsions of the 
ensemble is shown in table 3.10. Molecular mechanics modeling of the exocyclic groups 
suggested that the hydroxymethyl group of GalNAc units is flexible and adopts both the 
gauche-trans and trans-gauche orientation. The 6-O-sulfate group of GalNAc units is also 
flexible, as it either presents an anti orientation or an eclipsed orientation with respect to C6 
or H6, respectively. On the other hand, the 4-O-sulfate group of GalNAc units is rigid and 
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adopts an eclipsed orientation with respect to H4. The oxygens of carboxylate group in the 
GlcA units are also rigid and found to be in the eclipsed and anti orientation with respect to 
H5.  
  
Torsion 
β(1→3) 
GlcA2-GalNAc2 
β(1→4) 
GalNAc2-GlcA1 
β(1→3) 
GlcA1-GalNAc1 
φ -71 (2) -74 (2) -60 (1) 
Ψ 147 (2) -120 (3) 132 (2) 
Table 3.10. Average glycosidic torsions in the ensemble of the top 25 CS-E conformers. 
Values are reported in units of degrees. Standard deviations are given in parentheses.  
 
Figure 3.5. Ensemble of the top 25 structure of the CS-E tetrasaccharide.  
Structure determination of CS-D 
We utilized the same distance geometry/simulated annealing approach to determine 
the glycosidic linkage angles of CS-D. The data assignment/structure calculation iterations 
were performed for about thirty rounds before the simulated annealing generates a 
convergent ensemble of structures. The distance restraints for the GlcA2-GalNAc2 and 
GlcA1-GalNAc1 linkages were nicely represented in the ensemble, however, a few restraints 
were violated in the GalNAc2-GlcA1 linkage. Interatomic distances were compared to the 
van der Waals radii and no gross violation was found between the GlcA2-GalNAc2 and 
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GlcA1-GalNAc1 linkages. However, the C3 and O3 atom of GlcA1 was found to be very 
close to the C1 atom of GalNAc2, with the distance of 2.6 and 2.4 Å, respectively (figure 
3.6). The van der Waals radius of carbon and oxygen atom is 1.70 Å and 1.52 Å, respectively. 
This ensemble of structure was therefore not accepted due to the unsatisfied experimental 
restraints and violated van der Waals radii of the GalNAc2-GlcA1 linkage.  
 
Figure 3.6. The GalNAc2-GlcA1 (1→4) linkage of the calculated structure of CS-D. The C1 
of GalNAc2 is in close proximity to the C3 and O3 of GlcA1, causing steric clashes that 
make this structure physically unacceptable.  
In order to resolve this problem, we looked into the free molecular dynamics we 
performed for insights. As seen in figure 3.3, a minor population around (-80,60) was clearly  
observed aside from the major population around (-80,-120). The two conformations are 
referred as the I (invert) and N (normal) conformation in this study, respectively, since the 
minor conformation is nearly 180° opposite from N in the ψ angle. Based on this observation 
in molecular dynamics, we hypothesized that an equilibrium of two conformations does exist 
in reality and caused a significant effect in the measured NOE signal, resulting in the 
unacceptable structures.  
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Since the intensity of a NOE signal is proportional to r-6, the NOE signal will reflect 
the population of smaller distance more strongly than that of larger distance even with a much 
smaller population. For example, for a given proton pair with the distance of 2 Å in 10% of 
population and 4 Å in the other 90%. The NOE derived distance will not be close to 4 Å, but 
will be (2-6 x 0.1 + 4-6 x 0.9)-1/6 = 2.87 Å. Therefore, a small population of shorter distance is 
possible to contribute significantly to the measured NOE signal and make the experimentally 
derived distance unrealistic, if the difference of distance in the two populations is large.  
We then aim to reconstruct the original contribution of each conformation from the 
averaged experimental data and then back-calculate the NOE signals that would be 
observed from a sample composed of exclusive N or exclusive I conformation. The first 
step is to obtain the population of the two conformations, which can be calculated using 
two suitable NOE cross-peaks. Proton pairs of the cross-peaks used in the calculation must 
have interproton distances that are significantly different in the N and I conformation, 
otherwise the two conformations will contribute similarly to the signal, providing no 
information regarding the relative population. The cross-peaks also need to be strong and 
of high quality (i.e., have a clear peak shape and not overlapping with other peaks) to avoid 
measurement error. Cross-peaks of the two proton pairs GlcA1H3-GalNAc2H1 and 
GlcA1H4-GalNAc2H1 fit the above criteria and were used to calculate the population of 
N and I.  
To utilize the two signals to calculate population of the N conformation (PN), we 
first assumed the N and I conformations have torsion angles (φN,ψN) and (φI,ψI) of (80,-
120) and (80,60), as observed in molecular dynamics. The distances between the proton 
pairs GlcA1H3-GalNAc2H1 (r1) and GlcA1H4-GalNAc2H1 (r2) were then measured. 
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Again, the distances (r1, r2) will depend on the N and I conformation chosen. The ratio of 
NOE intensity of GlcA1H3-GalNAc2H1 (I1) and GlcA1H4-GalNAc2H1(I2) was the used 
to calculate PN as shown in equation 3.4.  
 
𝐼1
𝐼2
=
𝑃𝑁𝑟𝑁,1
−6 + (1 − 𝑃𝑁)𝑟𝐼,1
−6
𝑃𝑁𝑟𝑁,2−6 + (1 − 𝑃𝑁)𝑟𝐼,2−6
 (equation 3.4) 
𝐼𝑁,𝑥 =
𝐼𝑥𝑟𝑁,𝑥
−6
(𝑟𝑁,𝑥
−6 + 𝑟𝐼,𝑥−6)𝑃𝑁
 (equation 3.5) 
With the population calculated, the signal intensity of proton pair x that would be 
measured from the N conformation (IN,x) without the presence of I conformation (or vice 
versa) can then be back-calculated from experimentally measured intensity (Ix),  by 
equation 3.5. The back-calculated data was then used as the input for distance geometry. 
Although the back-calculation of signal can be performed for any choice of two 
conformations, the output conformations obtained from distance geometry calculation 
must resemble the choice of input conformations as a validation. To our delight, when the 
N and I conformation observed from molecular dynamics was chosen to back-calculate the 
signals, distance geometry based on the back-calculated data did produce conformations 
resembling to the input conformations.  
It should be noted that a total of 8 NOE and 9 no-NOE data points were involved 
in the calculation of the (1→4) linkage. Because only the ratio of two NOE signals (I1/I2) 
was used to calculate PN, the absolute value (I1 and I2) and rest of the data points still 
provides enough structural information for unbiased calculation and validation. Three 
randomly assumed test pairs of (ψN, φN) and (ψI, φI) were used to reconstruct the NOE data. 
Structural calculation based on these sets of reconstructed NOE data generated very 
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different output conformations (i.e., (ψN, φN) and (ψI, φI) are inconsistent to the input 
values).  
We then aim to find the optimal input conformations by minimizing the difference 
between the choice of input conformations and output conformations through exploring the 
search space composed of 4 variables, namely the φ and ψ angle of the N and I conformation. 
About 100 pairs of conformation were used for back-calculation and distance geometry 
calculation until the output φ and ψ angles of the N and I conformation were in good 
agreement with the input. The distance restraints were also nicely represented in the output 
conformations. Furthermore, the van der Waals radii are no longer violated in the output 
conformations.  
We therefore accepted the backbone structure and performed the exocyclic group 
modeling for both the N conformer and I conformer with the GLYCAM force field. 25 
structures with the best scores were selected as the final ensemble of structures, shown in 
figure 3.6 and 3.7. Average glycosidic torsions of the CS-D N and CS-D I ensemble is shown 
in table 3.10 and 3.11. The calculated population of the N and I conformer is 95.5% and 
4.5%, respectively. As can be seen in figure 3.6 and 3.7, the two conformers present very 
distinct structural feature. While the N conformer is in an extended conformation, the I 
conformer presents a concaved structure that has a kink in the GalNAc2-GlcA1 linkage due 
to the nearly 180° flip in the ψ angle of the (1→4) linkage. 
Molecular mechanics modeling suggested that exocyclic groups of the CS-D N 
conformer adopt similar orientations with that of the CS-E tetrasaccharide. The 
hydroxymethyl group of GalNAc units is flexible and adopts both the trans-gauche and 
gauche-trans orientation. The 6-O-sulfate group of GalNAc units is also flexible and presents 
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either an anti orientation or an eclipsed orientation with respect to C6 or H6, respectively. 
On the other hand, the 2-O-sulfate group and the carboxylate oxygens of GlcA units are more 
rigid and adopt an eclipsed orientation and an anti/eclipsed orientation with regard to H2 and 
H5, respectively.  
As for the CS-D I conformer, the orientations of exocyclic groups of the terminal 
monosaccharide units are similar to the CS-D N conformer. However, change of the ψ angle 
in the (1→4) linkage brings the two internal units in proximity. The hydroxymethyl group 
and carboxylate of the internal monosaccharide units therefore exhibit different behaviors to 
prevent steric clashes with the neighbor internal monosaccharide unit. The hydroxymethyl 
group of GalNAc2 becomes more rigid and only adopts the trans-gauche orientation, 
avoiding the GlcA1 unit. The carboxylate group on GlcA1 occurs in an eclipsed orientation 
with respect to C4, as opposed to be eclipsed with H5. The internal 2-O-sulfate and 6-O-
sulfate group are not affected by the change of ψ angle.  
 
 
Torsion 
β(1→3) 
GlcA2-GalNAc2 
β(1→4) 
GalNAc2-GlcA1 
β(1→3) 
GlcA1-GalNAc1 
φ -109(3) -72(2) -93(3) 
ψ 119(2) -120(2) 112(3) 
Table 3.11. Average glycosidic linkage torsion angles of the CS-D N conformer.  
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Figure 3.6. Ensemble of the top 25 structure of the CS-D tetrasaccharide N conformer.  
 
Torsion 
β(1→3) 
GlcA2-GalNAc2 
β(1→4) 
GalNAc2-GlcA1 
β(1→3) 
GlcA1-GalNAc1 
φ -108(3) -81(2) -95(3) 
ψ 118(3) 55(1) 112(3) 
Table 3.12. Average glycosidic linkage torsion angles of the CS-D I conformer.  
 
 
Figure 3.7. Ensemble of the top 25 structure of the CS-D tetrasaccharide I conformer.  
 
Free energy landscape of each linkages in CS-D and CS-E 
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After obtaining the NMR structures of the CS-D and CS-E tetrasaccharide, the 
immediate question is: Does a second conformer exist in other linkages of CS-D or CS-E as 
well?  
We first looked into the molecular dynamics simulation for insights. As 
aforementioned, the I conformer of CS-D is observed in the simulation. However, the same 
conformational space is occupied in CS-E in the same GalNAc2-GlcA1 linkage, too, with a 
lower relative population than that in CS-D. This population is referred to as the CS-E I 
conformer and the major population is referred as the CS-E N conformer in this study. 
Observation of the CS-E I conformer in the simulation suggests the CS-E I conformer is not 
sterically forbidden and that the free energy gap between the N and I conformer in CS-E is 
larger than that in CS-D. To visualize the relative energy between conformations, we derived 
the free energy landscape for each linkage from the molecular dynamics simulation by 
Boltzmann’s factor. We binned the population with a 5° interval and calculated the energy 
relative to the most populated (lowest energy) region by the following equation: 
∆𝐺 =  −𝑘𝐵𝑇𝑙𝑛 (
𝑃
𝑃0
) (equation 3.6) 
 where kB is the Boltzmann constant, T is the temperature of the simulations (298 K), and P 
and P0 are the number of frames with the φ and ψ binned in a given 5° x 5° space and in the 
most populated 5° x 5° space, respectively. Because the simulation trajectories contain non-
4C1 puckers, especially in CS-D, only the frames with every monosaccharide units in the 
4C1 
form were extracted and analyzed. The derived free energy landscape of each linkage in CS-
D and CS-E is shown in figure 3.8 and the local minima are summarized in table 3.13 and 
3.14.   
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Linkage minimum Φ Ψ ∆Ga 
GlcA1-GalNAc1 a -70 135 0.0 
 b 50 120 2.1 
 c -135 100 1.1 
GalNAc2-GlcA1 N -70 -125 0.0 
 I -75 70 2.0 
GlcA2-GalNAc2 a -70 135 0.0 
 c -155 80 1.6 
Table 3.13. Low-energy conformers of each linkage in the CS-D tetrasaccharide. aRelative 
energy in kcal/mol with respect to global minimum.  
Linkage minimum φ1 Ψ1 ∆Ga 
GlcA1-GalNAc1 a -70 140 0.0 
 b 60 120 1.1 
 c -155 105 2.3 
GalNAc2-GlcA1 N -75 -130 0.0 
 I -65 80 2.8 
GlcA2-GalNAc2 a -70 140 0.0 
 b 60 115 1.6 
 c -155 105 2.5 
Table 3.14. Low-energy conformers of each linkage in the CS-E tetrasaccharide. aRelative 
energy in kcal/mol with respect to global minimum.  
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Figure 3.8. Free energy landscape contour maps of each linkage in the CS-D (left) and CS-
E (right) tetrasaccharide. Glycosidic torsion angles of experimentally determined structures 
are marked with triangles. Isocontour levels are drawn at 0.4 kcal/mol increments from 0.4 
kcal/mol above the global energy minimum. Codes a, b, c, N, and I represent the energy 
minima. 
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The free energy landscape suggested that the energy gap between the CS-D N and 
CS-D I conformer is 2.0 kcal/mol, which is close to the experimental energy gap 1.8 kcal/mol 
derived from the relative population 95.5% and 4.5% observed by NMR-based calculation. 
The larger energy gap between the CS-E conformers (2.8 kcal/mol) suggested by simulation 
may explain why the CS-E I conformer was not observed experimentally; however, we 
believe the real energy gap to be larger than 2.8 kcal/mol.  
The energy gap 2.8 kcal/mol was used to calculate the expected relative population 
of CS-E N and CS-E I conformers, which is 99.1% and 0.9%, respectively. This population 
along with the distances measured from the CS-E N and CS-E I conformer (rN and rI) was 
then used to back-calculate the expected NOE signal and expected NOE-derived interproton 
distance. The expected distance can next be compared with the experimentally observed 
distance to validate the relative population suggested by simulation. The proton pair that is 
the most sensitive to the relative population (i.e., the proton pair with the largest (rN - rI) 
value) was GalNAc2H1-GlcA1H3, with the rN and rI of 4.5 Å and 2.2 Å, respectively. The 
back-calculated expected distance of GalNAc2H1-GlcA1H3 turned out to be 3.7 Å, which 
is inconsistent with the experimentally observed distance 4.7 Å. Since the observed distance 
is in very good consistency with rN, we conclude that the CS-E I conformer is practically 
non-existent.  
As for the GlcA1-GalNAc1 linkage, the free energy landscape suggested an isolated 
second conformer “b” in both linkages with a low energy gap of 1.1 kcal/mol. We then 
calculated the expected NOE distance of the proton pair most sensitive to the population of 
the “b” conformer, which is GlcA1H2-GalNAc1H3. The expected NOE distance derived 
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from the relative population of “b” (13.5%), ra (4.5 Å) and rb (2.0 Å) was calculated to be 2.8 
Å. The experimentally observed distance (r) is 3.9 Å, suggesting a potential equilibrium of 
the “a” and “b” conformer but with a population of “b” lower than 13.5%. If we use r, ra, and 
rb, to calculate the relative population of “a” and “b”, we will obtain 98.9% and 1.1%, 
respectively. The fact that the glycosidic torsion angles of the calculated ensemble fell 
slightly off-center of the energy minimum may also imply that the NMR data is slightly 
affected by a second conformer, however, this implication relies on accuracy of the 
simulation.  
On the other hand, while the equilibrium potentially exists, it is insufficient to fully 
confirm the existence of this “b” conformer with our current NMR data since we did 
determine a physically allowed structure without the inclusion of a second conformer. Also, 
the rest of the NMR restraints still agree very well with the “a” conformer, including the 
restraints somewhat sensitive to the “b” conformer. Lastly, the experimentally observed 
distance (3.9 Å) is relatively long and may suffer from error more significantly compared to 
the experimentally observed distance (3.0 Å) of GalNAc2H1-GlcA1H3 in CS-D, which is 
the most sensitive to the I conformer and used to determine the relative population of CS-D 
I. To sum up, although a small population (~ 1%) of a second conformer potentially exists, 
our NMR data is not sufficient to fully confirm or reject the possibility.  
The GlcA2-GalNAc2 linkage of CS-E is similar to the GlcA2-GalNAc2 linkage, 
with “b” conformer having a 1.6 kcal/mol energy gap. The expected NOE distance of 
GlcA2H2-GalNAc2H3 was calculated accordingly with the relative population of “b” 
(6.3%), ra (4.5 Å) and rb (2.1 Å). The calculated expected distance is 2.8 Å, which is very 
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inconsistent with the experimentally observed distance (r) 4.2 Å. Since the distance measured 
in the “a” conformer (4.5 Å) is already in good agreement with the experimentally observed 
distance (4.2 Å), it is unlikely that a second conformer with a strong effect on the signal 
exists.  
We next looked to the GlcA1-GalNAc1 and GlcA2-GalNAc2 linkage of CS-D. The 
free energy landscape suggested a relative broad conformational space for both linkages. No 
significant isolated conformer is observed in both linkages. Although a “c” local minimum 
can be found in the landscape, it is not an isolated conformer separated with the major 
conformer by a significant energy barrier like CS-D I. Instead, the “c” local minimum can 
be considered as a demonstration of flexibility of the “a” conformer. As previously 
mentioned, the NMR data represents an averaged measurement. The fact that the glycosidic 
torsion angles of the calculated ensembles do not overlap perfectly with the energy minimum 
may be accounted for by the non-symmetrical shape of the conformational space around the 
“a” conformer (figure 3.8).  
The flexibility of the “a” conformer in CS-D may also account for the difference of 
glycosidic torsion angles between the GlcA-GalNAc linkages of CS-D and CS-E. Although 
the “c” minima are also observed in CS-E, the energy gaps between “c” and “a” are smaller 
in CS-D (1.1 and 1.6 kcal/mol) than in CS-E (2.3 and 2.5 kcal/mol). The energy barriers 
between “c” and “a” are lower in CS-D, too, as can be observed from the continuously 
occupied conformational space (figure 3.8). Since both the energy gaps and barriers are lower 
in CS-D, the simulation suggests that the GlcA-GalNAc linkages of CS-E are more rigid. As 
a result, the NMR determined the φ and ψ angles in CS-D are more affected by the “c” 
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minima (i.e., the flexibility of “a”) and shifted more towards the “c” minima. But again, this 
rationalization relies on the accuracy of the simulations.  
To sum up, while a minor conformer CS-D I is clearly observed and determined by 
NMR and calculation for the GalNAc2-Glc1 linkage of CS-D, the CS-E I conformer is 
practically non-existent as determined by NMR data and simulation. As for the Glc1-
GalNAc1 linkage in CS-E, our NMR data is not sufficient to fully confirm or reject a 
potential second conformer “b” with ~1% of population. For the Glc2-GalNAc2 linkage, the 
combination of NMR data and simulation suggests that a second conformer does not exist. 
On the other hand, a second isolated conformer with low energy is not observed in free 
energy landscape of the GlcA-GalNAc linkages of CS-D and NMR data does not indicate a 
second conformer, either.  
Inter-residual interactions of the CS-D and CS-E tetrasaccharide 
After exploring the energy of each conformers, we then investigated the calculated 
structure to find potential interactions that may account for structural difference between CS-
D and CS-E.   
As shown in figure 3.9, there is an inter-residual hydrogen bond between O3 of 
GalNAc2 and the 3-hydroxyl hydrogen in the GalNAc2-GlcA1 linkage of both CS-D and 
CS-E. However, in CS-D the 3-hydroxyl hydrogen can also form an intra-residual hydrogen 
bond with the 2-O-sulfate group, weakening the stabilizing force of the linkage. In the top 
25 structures, 11 of the 3-hydroxyl hydrogens point to the 2-O-sulfate group in CS-D, but 
only one of the 3-hydroxyl hydrogens point to the 2-position in CS-E. One other inter-
residual hydrogen bond can be observed between the amide proton and the carboxylate 
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group. This hydrogen bond is similarly weak in both the CS-D N and CS-E N conformers, 
and therefore will not affect the difference between energy gaps of the N and I conformer in 
CS-D and CS-E. Both hydrogen bonds have also been proposed with previous molecular 
dynamics study of non-sulfated chondroitin12,24.  
 
Figure 3.9. Comparison of inter-residual interaction in NMR-based GalNAc2-GlcA1 
linkage structure for CS-D (left) and CS-E (right). For clarity, the 6-O-sulfate groups and all 
hydrogen atoms are hidden except for the 3-hydroxyl hydrogen of GlcA1 and the amide 
proton of GalNAc2. Indicated distances (Å) are measured for GalNAc2O5-GlcA1HO3, 
GlcA1HO3-GlcA1OS2, and GalNAc2HN-GlcAO6.   
After locating a potential difference between the CS-D N and CS-E N conformers, 
we next examined the CS-D I conformer. As can been seen in figure, no 3-hydroxyl hydrogen 
points to the carbonyl oxygens, which are the closest hydrogen bond acceptor in GalNAc2, 
suggesting that no inter-residual hydrogen bond is formed. The distance between the 3-
hydroxyl oxygen and the carbonyl oxygen (4.9 Å) is also larger than the maximum distance 
(4.0 Å) that allows the formation of a hydrogen bond25. Although we don’t have a NMR-
determined structure for the CS-E I conformer, molecular dynamics simulations suggest that 
the CS-D I and CS-E I conformer share very similar glycosidic linkage torsion angles. 
Therefore, we do not expect an inter-residual hydrogen bond for the CS-E I conformer, 
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either. On the other hand, a repulsive electrostatic interaction between the 6-O-sulfate groups 
and carboxylate groups can be observed in the CS-D I conformer, causing the carboxylate 
group to adopt an orientation unseen in other structures. Since the 6-O-sulfate group is also 
present in CS-E I conformer along with an additional 4-O-sulfate group, the repulsive 
interaction is expected to be stronger in CS-E I than in CS-D I, destabilizing the CS-E I 
conformer.  
 
Figure 3.10. Structure of the NMR-based GalNAc2-GlcA1 linkage of CS-D I . For clarity, 
all hydrogen atoms are hidden except for the 3-hydroxyl hydrogen of GlcA1. Indicated 
distances (Å) are measured for GalNAc2ON2-GlcA1O3 and GlcA1HO3-GlcA1OS2. 
To sum up the above observations, the CS-E N conformer stabilizes the GalNAc2-
GlcA1 linkage more strongly than the CS-D N conformer, through a stronger hydrogen bond. 
On the other hand, the CS-E I conformer is more destabilized than the CSD I conformer by 
having an extra 4-O-sulfate group. Therefore, the energy gap between the CS-E N and I 
conformers are expected to be larger than the CS-D N and I conformer. As a result, while the 
equilibrium of the N and I conformer can be observed in CS-D experimentally, the CS-E I 
conformer is practically non-existent.  
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We then looked in the GlcA1-GalNAc1 and GlcA2-GalNAc2 linkages of CS-D and 
CS-E. For both linkages, the φ and ψ angles are both smaller in CS-D, which may be 
explained by the extended conformational space in CS-D as aforementioned (figure 3.8). We 
believe that the loss of the hydrogen bond donor on the 2-position of CS-D and/or the extra 
negatively charged group on the 4-O-position of CS-E contributed to this observation. An 
inter-residual hydrogen bond between the 2-hydroxyl hydrogen of GlcA and carbonyl 
oxygen of GalNAc has been proposed in previous studies for unsulfated chondroitins12,24, 
which will be abolished in the GlcA-GalNAc linkages of CS-D.  
We then built the model of the “a” and “c” minima of both GlcA-GalNAc linkages 
in CS-D and CS-E based the corresponding glycosidic torsion angles (table 3.13 and 3.14) 
to explore the potential cause of the more flexible conformational space in CS-D. As shown 
in figure 3.11, and 3.12 the “c” conformer in both the GlcA1-GalNAc1 and GlcA2-GalNAc2 
linkages of CS-D have an inter-residual hydrogen that can not be observed in the “a” 
conformer, which may explain the smaller energy gap in CS-D.  
  
Figure 3.11. The “a” (left) and “c” (right) conformer of the GlcA1-GalNAc1 linkage in CS-
D. All hydrogen atoms except for the amide proton are hidden for clarity. Indicated distances 
(Å) are measured for GlcA1OS2-GalNAc1HN. 
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Figure 3.12. The “a” (left) and “c” (right) conformer of the GlcA2-GalNAc2 linkage in CS-
D. All hydrogen atoms except for the amide proton are hidden for clarity. Indicated distances 
(Å) are measured for GlcA2OS2-GalNAc2HN. 
As for CS-E, a hydrogen bond between the 2-hydroxyl hydrogen of GlcA and the 
carbonyl oxygen of GalNAc could be observed, albeit weak. Since the cutoff of X---A 
distance in a hydrogen bond X-H--A is 4.0 Å25, the “a” conformer have a borderline 
hydrogen bond and the “c” conformer do not, as seen in figure 3.13 and 3.14. On the other 
hand, the extra 4-O-sulfate groups in CS-E are also closer to the carboxylate groups in the 
“c” conformer than in the “a” conformer, which may lead to electrostatic repulsion that 
destabilizes the “c” conformer. Together the hydrogen bond and the electrostatic interaction 
may partly account for why the “c” conformer is less favored in CS-E than in CS-D.  
To sum up, we identified the inter-residual interactions that may account for the 
higher flexibility of the GlcA-GalNAc linkage in CS-D. The higher flexibility can potentially 
in turn explain the difference between the NMR-based glycosidic torsion angles of the GlcA-
GalNAc linkage in CS-D and CS-E.  
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Figure 3.13. The “a” (left) and “c” (right) conformer of the GlcA1-GalNAc1 linkage in CS-
E. All hydrogen atoms except for the amide proton are hidden for clarity. Indicated distances 
(Å) are measured for GlcA1HO2-GalNAc1ON2 and GlcA1O6-GalNAc1OS6. 
 
Figure 3.14. The “a” (left) and “c” (right) conformer of the GlcA2-GalNAc2 linkage in CS-
E. All hydrogen atoms except for the amide proton are hidden for clarity. Indicated distances 
(Å) are measured for GlcA2HO2-GalNAc2ON2 and GlcA2O6-GalNAc2OS6. 
 
Comparison of the glycosidic torsion angles with published structures 
The glycosidic torsion angles of CS-D N, CS-D I and CS-E determined by the NMR 
data and distance geometry/simulated annealing calculation in this study are compared with 
selected published structures (table 3.15). Our glycosidic torsion angles of the β(1→4) 
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linkages are in general consistent with the published structures. As for the β(1→3) linkages, 
the φ angles of CS-D and the ψ angles are different from the published structures. However, 
we must bear in mind that while our glycosidic is NMR-based without the involvement of 
molecular mechanics, the published structures utilized molecular mechanics along with less 
NMR data points. Also, the sulfation pattern is different between our molecules with the 
published structures. We envisioned that future study of CS-A, CS-C and unsulfated 
chondroitin with the current method will offer more direct comparison and methodological 
insights for GAG structure determination.   
Method Length
a 
Structure torsion β(1→3) β(1→4) 
NMR/DGb/SAc 4 CS-D N φ -101 -72 
   ψ 116 -120 
NMR/DG/SA  4 CS-D I φ -102 -82 
   ψ 115 55 
NMR/DG/SA  4 CS-E φ -66 -74 
   ψ 140 -120 
NMR/rMDd/SA12 6 CS-0e φ -72 -73 
   ψ 108 -117 
NMR/rMD/SA13 5 CS-A φ -61 -67 
   ψ 109 -124 
NMR/MMf,8 8 CS-A φ -80 -80 
   ψ 90 -110 
X-ray20 8 CS-A φ -80 -98 
   ψ 128 -129 
Table 3.15. Comparison of glycosidic torsion angles in the present study with selected 
published CS structures. Values are reported in units of degrees. aLength is presented in the 
number of monosaccharide units. bDistance geometry. cSimulated annealing. dRestrained 
molecular dynamics. eUnsulfated chondroitin. fMolecular mechanics.  
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Electrostatic potential map of CS-D and CS-E 
To better understand how the solution structure may interact with proteins, we chose 
a representative structure from the ensembles and calculated its electrostatic surface by the 
Adaptive Poisson-Boltzmann Solver (APBS)26. APBS is a popular free macromolecular 
electrostatics calculation program that has been continually updated since its release in 2001. 
As can be seen in figure, each structure exhibits a characteristic electrostatic surface. 
The CS-D N has an extended structure with the negatively charged group in plane with the 
backbone. The CS-D I is concaved and presents the negatively charged groups on the convex 
side. The CS-E structure is also extended but has the negatively charge groups pointing to 
the same direction, perpendicular to the backbone. With the characteristic electrostatic 
surfaces, we expect these CS structures to demonstrate different protein binding specificity 
and have unique biological functions. The calculated surfaces may also aid the protein 
docking study of CS.  
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Figure 3.15. Stick representation (top) and electrostatic potential surface (bottom) of the CS-
D N (left), CS-D I (middle) and CS-E (right). The charged areas are colored on the surface 
from blue (+20 kT/e) to red (–20 kT/e). 
Conclusion 
The solution structure of CS-D and CS-E has been determined with high quality data 
obtained from a state-of-the-art 900 MHz instrument and distance geometry coupled with 
simulated annealing. A second conformer of the β(1→3) GalNAc-GlcA linkage was also 
observed and determined experimentally for the first time. Together our NMR data and free 
molecular dynamics simulation suggests that a second conformer does not exist for other 
linkages in CS-D and CS-E, with the exception of GlcA1-GalNAc1 linkage of CS-E. Our 
current data is not sufficient to fully confirm or reject a potential second conformer with ~1% 
of the overall population. Potential inter-residual interactions that may account for the 
structural difference between the CS-D and CS-E are also identified in the calculated 
structures. 
  
Experimental Methods 
NMR Spectroscopy. For NMR analysis, the CS-D and CS-E tetrasaccharide samples were 
dissolved in 300 μL of solvent (D2O or 10% D2O in H2O) and adjusted to pH 6.0 before 
transferred into a Shigemi tube. The [1H]-1D, [1H,13C]-HSQC, [1H,1H]-DQF-COSY and 
[1H,1H]-NOESY were recorded with a 21.1 Tesla Bruker Avance II NMR spectrometer 
(Bruker Corporation, Billerica, MA) equipped with a CP TCI multinuclear cryoprobe. [1H]-
1D, [1H]-DQF-COSY and [1H,13C]-HSQC spectra were standard experiments. The [1H,1H]-
NOESY spectra recorded with a 1H frequency of 900.25 MHz and a mixing time of 600 ms. 
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2048 and 1536 complex points were collected in the direct and indirect dimensions, 
respectively. Spectra were processed and analyzed with TopSpin and MestraNova. 
Appropriate linear prediction, window functions, and zero-filling were used to achieve the 
maximum possible resolution from each dataset.  
Molecular dynamics preparation. Necessary parameters for the allyl moiety were imported 
from the GAFF (generalized AMBER force-field) parameter sets; partial charges were 
estimated for the allyl moiety by performing multi-conformer RESP fitting27-28 by fitting 
to these electrostatic potentials with a restraint weight (qwt) of 0.0005 to electrostatic 
potential maps calculated using GAUSSIAN09 at the HF/6-31G(*) level of theory for 
20 separate conformers of allyl β-D-glucopyranoside (extracted at equal intervals over a 
50 ns molecular dynamics trajectory total based on an initial guess of partial charges 
from a single conformer). To maintain compatibility with GLYCAM non-polar 
(aliphatic) hydrogen atoms were fixed at zero charge and the glucose atoms were fixed 
at the GLYCAM version 06j-1 partial charges of residue name 0GB).  
The starting structures of the CS-D and CS-E tetrasaccharides were modeled using 
the standard GLYCAM (version 06j-1)7 and sulfate parameter sets29. Adjustments to the 
sulfonate oxygen partial charges were made to maintain the correct overall charge as 
described previously29. Each molecule was minimized in vacuo using 1,000 steps of steepest 
descent. They were then solvated into cubic boxes of water leaving 1.2 nm of water between 
the van der Waals extent of each molecule and the box edge and charge neutralized using 
sodium ions. Any water molecules overlapping the van der Waals surface were deleted using 
the AMBER leap tool. Each carbohydrate was solvated in explicit TIP3P water molecules 
with a cubic box of equal side length using the leap program from AmberTools28, resulting 
Commented [KY1]:  
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in water boxes of ≈55 Å. Solute atoms were positioned at least 12 Å from the solvent box 
edge and the assemblies were neutralized by adding explicit Na+ ions.  
 
Molecular dynamics simulations. Free molecular dynamics simulations of the 
tetrasaccharides were performed for 10 μs each using the AMBER16 GLYCAM force field 
and NVIDIA GeForce GTX 980 graphics processors (Kepler architecture) using methods 
described previously30. Briefly, following initial conjugate-gradient energy minimization 
(1000 steps in water) the assemblies were heated from 0 to 298 K and then equilibrated in 
the NPT ensemble for 20 ns, and the first 300 ns were discarded, prior to 10 μs of NVT 
production dynamics; 3D-coordinate data were recorded at 100 ps intervals. The velocity-
Verlet integration algorithm and a hydrogen mass repartitioning scheme enabled a 4 fs time-
step to be used without affecting the equilibrium distribution31-32. Hydrogen atoms were 
constrained using M-SHAKE33 and electrostatic interactions were calculated via the particle 
mesh Ewald method, with a grid spacing of less than or equal to 1.0 Å (in the X, Y and Z 
dimensions). Electrostatic and van der Waals interactions were truncated at 9 Å and the 
recommended scaling factor for GLYCAM carbohydrate 1–4 interactions (1.0) was 
employed.  
Structure calculations. Reference intra-residual NOE signals were used to build a model 
relating cross-peak intensity (I) to proton–proton distance (r) using the relationship I = cr-
6. The constant of proportionality (c) was then derived from a linear plot of r-6 and I of the 
Commented [KY4]: We used GLYCAM right? Typo? 
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reference NOEs. This was employed to compute experimental distance restraints from the 
inter-residual NOEs and “no-NOEs”.  
Starting conformation of the tetrasaccharides used for structure calculation was 
generated using online GLYCAM tools34 and input into the SimTK molecular modeling API 
(molmodel). The H2-C2-N2-HN torsion angle was fixed at 180°. Each sugar residue was 
in a fixed pucker geometry (the 4C1 pucker) and modeled as a rigid body, while the 
glycosidic degrees of freedom between the sugar residue rigid bodies were modeled as pin 
joints (rotation about the bond axis, but no translation), corresponding to the ψ and φ angles 
involved in each glycosidic linkages. 250 rounds of simulated annealing were performed 
with 500,000 steps for a given input of NMR data. The starting conformation of the pin 
joints was randomized and then subjected to simulated annealing performed by applying 
molecular velocities appropriate to the temperature. The simulated annealing was designed 
to provide minimum solutions to the score function (equation 3.1), by applying forces to 
the model during simulated annealing that are proportional to the squared distance 
deviation from a desired measured value.  
After the backbone conformation was calculated and accepted, simulated annealing 
with the GLYCAM force field was employed to determine the orientation of the exocyclic 
groups. Briefly, the tetrasaccharide was prepared as described in the molecular dynamics 
methods (including solvent TIP3P explicit water molecules and ions). Each structure was 
heated to 298 K for 500 ps and then cooled to 0 K over 3 ns. During the whole 3.5 ns, the 
backbone conformation and the acetamido was restrained to the result of SIMTK calculation 
with a weighing factor of 1,000 to maintain the backbone conformation determined with 
NMR data. The structures are analyzed with VMD35 and visualized with PYMOL36.  
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Electrostatic surface calculation 
The representative structure was chosen by measuring the RMSD of the ensemble. 
The structure that gives the lowest average heavy-atom (non-hydrogen) RMSD of the 
ensemble when used as the reference structure was selected be the representative structure. 
The PQR files required by the APBS software26 were manually prepared with the atomic 
charges used in free molecular dynamics simulation and atomic coordinates of the 
representative structures. PYMOL and the PYMOL plugin ABPS tools 2.1 were used to 
generate and visualize the electrostatic surfaces.  
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Appendix for Chapter 3 
RELEVENT DATA FOR NMR STRUCTURE DETERMINATION  
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4C1 0 <= θ° <  36          
OE 36 <= θ° <  72 & -15 <= φ° <  15 
OH1 36 <= θ° <  72 & 15 <= φ° <  45 
E1 36 <= θ° <  72 & 45 <= φ° <  75 
2H1 36 <= θ° <  72 & 75 <= φ° <  105 
2E 36 <= θ° <  72 & 105 <= φ° <  135 
2H3 36 <= θ° <  72 & 135 <= φ° <  165 
E3 36 <= θ° <  72 & 165 <= φ° <  195 
4H3 36 <= θ° <  72 & 195 <= φ° <  225 
4E 36 <= θ° <  72 & 225 <= φ° <  255 
4H5 36 <= θ° <  72 & 255 <= φ° <  285 
E5 36 <= θ° <  72 & 285 <= φ° <  315 
OH5 36 <= θ° <  72 & 315 <= φ° <  345 
3OB 72 <= θ° <  108 & 345 <= φ° <  15 
3S1 72 <= θ° <  108 & 15 <= φ° <  45 
B14 72 <= θ° <  108 & 45 <= φ° <  75 
5S1 72 <= θ° <  108 & 75 <=  ° <  105 
25B 72 <= θ° <  108 & 105 <= φ° <  135 
2SO 72 <= θ° <  108 & 135 <= φ° <  165 
B3O 72 <= θ° <  108 & 165 <= φ° <  195 
1S3 72 <= θ° <  108 & 195 <= φ° <  225 
14B 72 <= θ° <  108 & 225 <= φ° <  255 
1S5 72 <= θ° <  108 & 255 <= φ° <  285 
B25 72 <= θ° <  108 & 285 <= φ° <  315 
OB2 72 <= θ° <  108 & 315 <= φ° <  345 
EO 108 <= θ° <  144 & 345 <= φ° <  15 
1HO 108 <= θ° <  144 & 15 <= φ° <  45 
1E 108 <= θ° <  144 & 45 <= φ° <  75 
1H2 108 <= θ° <  144 & 75 <= φ° <  105 
E2 108 <= θ° <  144 & 105 <= φ° <  135 
3H2 108 <= θ° <  144 & 135 <= φ° <  165 
3E 108 <= θ° <  144 & 165 <= φ° <  195 
3H4 108 <= θ° <  144 & 195 <= φ° <  225 
E4 108 <= θ° <  144 & 225 <= φ° <  255 
5H4 108 <= θ° <  144 & 255 <= φ° <  285 
5E 108 <= θ° <  144 & 285 <= φ° <  315 
5HO 108 <= θ° <  144 & 315 <= φ° <  345 
1C4 144 <= θ° <  180          
Table A3.1. Ring puckering definitions of the 38 canonical pyranose ring puckers. 
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Inter-residual pair restraints Result 
2:H3->3:H1 0.19 0.18 
2:H4->3:H1 0.39 0.36 
2:H5->3:H1 0.24 0.22 
2:H3->3:H1 0.17 0.18 
2:H4->3:H1 0.36 0.36 
2:H5->3:H1 0.21 0.22 
3:HN->2:H3 0.32 0.32 
3:HN->2:H4 0.46 0.5 
1:HN->2:H2 0.49 0.49 
1:HN->2:H1 0.33 0.32 
1:H4->2:H1 0.34 0.35 
3:HN->4:H2 0.45 0.45 
3:HN->4:H1 0.32 0.33 
3:H4->4:H1 0.33 0.34 
1:H4->2:H1 0.36 0.35 
3:H4->4:H1 0.35 0.34 
Table A3.2. Inter-residual NOE restraints used for CS-D N structure calculation and result. 
Values are reported in nm.  
 
Inter-residual pair restraints Result 
2:H2->3:H4 0.24 0.86 
2:H2->3:H1 0.24 0.46 
2:H3->3:H4 0.25 0.59 
2:H4->3:H4 0.25 0.72 
2:H5->3:H4 0.23 0.51 
3:H1->2:H1 0.23 0.36 
3:H2->2:H2 0.23 0.68 
3:H3->2:H2 0.23 0.71 
3:H5->2:H2 0.23 0.67 
1:H1->2:H1 0.38 0.43 
1:H2->2:H2 0.38 0.5 
1:H2->2:H1 0.38 0.43 
1:H3->2:H2 0.38 0.44 
1:H5->2:H2 0.38 0.66 
1:H5->2:H1 0.38 0.43 
2:H2->1:H2 0.4 0.5 
2:H2->1:H5 0.4 0.66 
2:H2->1:H1 0.4 0.66 
2:H2->1:H4 0.4 0.5 
2:H3->1:H1 0.43 0.68 
2:H3->1:H2 0.43 0.65 
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2:H3->1:H5 0.43 0.7 
2:H3->1:H4 0.43 0.61 
2:H4->1:H1 0.43 0.83 
2:H4->1:H2 0.43 0.73 
2:H4->1:H5 0.43 0.77 
2:H4->1:H4 0.38 0.59 
2:H5->1:H2 0.38 0.67 
2:H5->1:H5 0.38 0.58 
2:H5->1:H1 0.38 0.65 
2:H5->1:H4 0.38 0.47 
3:H1->4:H1 0.38 0.43 
3:H2->4:H2 0.38 0.48 
3:H3->4:H2 0.38 0.43 
3:H5->4:H2 0.38 0.66 
4:H2->3:H1 0.4 0.64 
4:H2->3:H4 0.4 0.51 
4:H3->3:H2 0.38 0.64 
4:H3->3:H1 0.38 0.66 
4:H3->3:H4 0.38 0.61 
4:H4->3:H1 0.43 0.83 
4:H4->3:H2 0.43 0.72 
4:H4->3:H3 0.43 0.58 
4:H4->3:H4 0.43 0.61 
4:H4->3:H5 0.43 0.78 
4:H5->3:H2 0.38 0.67 
4:H5->3:H1 0.38 0.66 
4:H5->3:H4 0.38 0.48 
Table A3.3. Inter-residual “no-NOE” restraints used for CS-D N structure calculation and 
result. Values are reported in nm.  
 
Inter-residual pair restraints Result 
2:H3->3:H1 0.19 0.18 
2:H4->3:H1 0.39 0.36 
2:H5->3:H1 0.24 0.22 
1:H4->2:H1 0.36 0.35 
3:H4->4:H1 0.35 0.34 
2:H3->3:H1 0.17 0.18 
2:H4->3:H1 0.36 0.36 
2:H5->3:H1 0.21 0.22 
3:HN->2:H3 0.32 0.32 
3:HN->2:H4 0.46 0.5 
1:HN->2:H2 0.49 0.49 
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1:HN->2:H1 0.33 0.32 
1:H4->2:H1 0.34 0.35 
3:HN->4:H2 0.45 0.46 
3:HN->4:H1 0.32 0.33 
3:H4->4:H1 0.33 0.34 
Table A3.4. Inter-residual NOE restraints used for CS-D I structure calculation and result. 
Values are reported in nm.  
 
Inter-residual pair restraints Result 
2:H2->3:H4 0.24 0.86 
2:H2->3:H1 0.24 0.46 
2:H3->3:H4 0.25 0.59 
2:H4->3:H4 0.25 0.72 
2:H5->3:H4 0.23 0.51 
3:H1->2:H1 0.23 0.36 
3:H2->2:H2 0.23 0.68 
3:H3->2:H2 0.23 0.71 
3:H5->2:H2 0.23 0.67 
1:H1->2:H1 0.38 0.43 
1:H2->2:H2 0.38 0.5 
1:H2->2:H1 0.38 0.43 
1:H3->2:H2 0.38 0.44 
1:H5->2:H2 0.38 0.66 
1:H5->2:H1 0.38 0.43 
2:H2->1:H2 0.4 0.5 
2:H2->1:H5 0.4 0.66 
2:H2->1:H1 0.4 0.66 
2:H2->1:H4 0.4 0.5 
2:H3->1:H1 0.43 0.68 
2:H3->1:H2 0.43 0.65 
2:H3->1:H5 0.43 0.7 
2:H3->1:H4 0.43 0.61 
2:H4->1:H1 0.43 0.83 
2:H4->1:H2 0.43 0.73 
2:H4->1:H5 0.43 0.77 
2:H4->1:H4 0.38 0.59 
2:H5->1:H2 0.38 0.67 
2:H5->1:H5 0.38 0.58 
2:H5->1:H1 0.38 0.65 
2:H5->1:H4 0.38 0.47 
3:H1->4:H1 0.38 0.43 
3:H2->4:H2 0.38 0.48 
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3:H3->4:H2 0.38 0.43 
3:H5->4:H2 0.38 0.66 
4:H2->3:H1 0.4 0.64 
4:H2->3:H4 0.4 0.51 
4:H3->3:H2 0.38 0.64 
4:H3->3:H1 0.38 0.66 
4:H3->3:H4 0.38 0.61 
4:H4->3:H1 0.43 0.83 
4:H4->3:H2 0.43 0.72 
4:H4->3:H3 0.43 0.58 
4:H4->3:H4 0.43 0.61 
4:H4->3:H5 0.43 0.78 
4:H5->3:H2 0.38 0.67 
4:H5->3:H1 0.38 0.66 
4:H5->3:H4 0.38 0.48 
Table A3.5. Inter-residual “no-NOE” restraints used for CS-D I structure calculation and 
result. Values are reported in nm.  
 
Inter-residual pair restraints Result 
2:H2->1:H3 0.35 0.43 
2:H2->1:H4 0.36 0.44 
2:H3->1:H3 0.37 0.51 
2:H5->1:H3 0.34 0.38 
2:H4->1:H4 0.51 0.54 
1:H3->2:H1 0.25 0.26 
2:H1->1:H4 0.48 0.43 
2:H2->3:H1 0.41 0.49 
2:H2->3:H5 0.48 0.6 
2:H3->3:H1 0.39 0.44 
2:H5->3:H1 0.35 0.4 
2:H4->3:H5 0.35 0.39 
2:H4->3:H1 0.22 0.22 
2:H4->3:H4 0.55 0.58 
4:H2->3:H3 0.35 0.44 
4:H2->3:H2 0.35 0.52 
4:H2->3:H4 0.43 0.47 
3:H3->4:H1 0.27 0.25 
3:H2->4:H1 0.27 0.37 
4:H1->3:H4 0.54 0.44 
1:HN->2:H1 0.3 0.26 
1:HN->2:H2 0.5 0.55 
1:HN->2:H3 0.48 0.51 
164 
 
1:HN->2:H5 0.43 0.43 
1:HN->2:H4 0.66 0.65 
3:HN->4:H1 0.27 0.23 
3:HN->4:H2 0.52 0.53 
3:HN->2:H2 0.76 0.72 
3:HN->4:H3 0.48 0.47 
3:HN->4:H4 0.61 0.62 
3:HN->2:H3 0.7 0.59 
3:HN->4:H5 0.41 0.4 
3:HN->2:H5 0.51 0.47 
3:HN->2:H4 0.41 0.44 
2:H2->1:H3 0.39 0.43 
2:H2->1:H4 0.42 0.44 
2:H3->1:H3 0.44 0.51 
2:H5->1:H3 0.35 0.38 
1:H3->2:H1 0.25 0.26 
1:H4->2:H1 0.42 0.43 
2:H4->1:H4 0.61 0.54 
2:H1->1:H4 0.45 0.43 
2:H2->3:H1 0.44 0.49 
2:H2->3:H5 0.51 0.6 
2:H3->3:H1 0.47 0.44 
2:H5->3:H1 0.42 0.4 
2:H4->3:H5 0.37 0.39 
2:H4->3:H1 0.25 0.22 
3:H4->2:H4 0.6 0.58 
4:H2->3:H3 0.42 0.44 
4:H2->3:H2 0.42 0.52 
3:H3->4:H1 0.26 0.25 
3:H2->4:H1 0.26 0.37 
3:H4->4:H1 0.46 0.44 
3:H4->4:H2 0.52 0.47 
3:H4->4:H5 0.57 0.56 
Table A3.6. Inter-residual NOE restraints used for CS-E structure calculation and result. 
Values are reported in nm.  
 
Inter-residual pair restraints Result 
2:H2->1:H3 0.35 0.43 
2:H2->1:H4 0.36 0.44 
2:H3->1:H3 0.37 0.51 
2:H5->1:H3 0.34 0.38 
2:H4->1:H4 0.51 0.54 
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4:H2->3:H1 0.46 0.67 
4:H2->3:H5 0.46 0.65 
2:H2->1:H1 0.46 0.68 
2:H2->3:H4 0.46 0.8 
4:H3->3:H1 0.46 0.7 
4:H3->3:H2 0.46 0.61 
4:H3->3:H3 0.46 0.51 
4:H3->3:H4 0.46 0.66 
4:H3->3:H5 0.46 0.76 
4:H4->3:H1 0.46 0.78 
4:H4->3:H2 0.46 0.72 
4:H4->3:H3 0.46 0.53 
4:H4->3:H4 0.46 0.59 
4:H4->3:H5 0.46 0.74 
2:H3->1:H1 0.46 0.72 
2:H3->1:H4 0.46 0.64 
2:H3->3:H4 0.46 0.73 
2:H3->3:H5 0.46 0.6 
4:H5->3:H1 0.46 0.57 
4:H5->3:H4 0.46 0.56 
4:H5->3:H5 0.46 0.61 
2:H5->1:H1 0.46 0.58 
2:H5->1:H4 0.46 0.54 
2:H5->3:H4 0.46 0.78 
2:H5->3:H5 0.46 0.64 
2:H4->1:H1 0.46 0.76 
2:H4->1:H3 0.46 0.51 
2:H4->1:H4 0.46 0.54 
2:H4->3:H4 0.46 0.58 
3:H5->2:H1 0.46 0.78 
3:H5->4:H1 0.46 0.5 
Table A3.7. Inter-residual “no-NOE” restraints used for CS-E structure calculation and 
result. Values are reported in nm.  
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Introduction 
As mentioned in chapter 1, CSs are the most abundant GAGs in brain and play critical roles 
in the developing CNS and in CNS injury. Paradoxically, CSs are found to exhibit both stimulatory 
and inhibitor effect on neuronal growth, however, the seeming conflicting results appear to be 
context-dependent. Factors include the neuronal lineage, neuronal age, expression of specific 
receptors, extracellular growth factors, and presentation of the CSs may all contribute to the observed 
effect.  
 Although CSs are traditionally thought as inhibitory cues to neuronal outgrowth or 
regeneration, they are also observed in developing axon pathways and in tissues that do not exclude 
axon entry1 . Numerous studies also suggested that CSs can act as stimulatory cues to neuronal 
outgrowth for a range of neurons in vitro. Furthermore, the outgrowth promoting activity of CSs is 
sulfation pattern dependent. The idea of “sulfation code” was therefore proposed.  
CSs in the form of CSPGs or polysaccharides enriched with a specific sulfation pattern has 
been shown to promote the outgrowth of embryonic neurons2-9. For example, the DSD-1-PG 
containing the CS epitope DSD-1 promotes neurite outgrowth from rat embryonic day 14 (E14) 
mesencephalic and E18 hippocampal neurons2-3. It has been further demonstrated that the promotion 
is DSD-1 dependent, because it can be blocked specifically by the monoclonal antibody (mAb) 
473HD the only recognizes DSD-1 but not the core protein or by enzymatic digestion of the CS with 
chondroitinases ABC3,6. While polysaccharide enriched with the CS-D motif blocked the interaction 
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between mAb 473HD6,8-9, the CS-D recognizing mAb CS-56 and mAb MO-225 also bind to DSD-
110, suggesting that the DSD-1 epitope contains the D sulfation pattern. Indeed, the CS-D enriched 
polysaccharide also exerted neurite outgrowth activity in rat E18 hippocampal neurons that can be 
inhibited by mAb 473HD9. Polysaccharides enriched with the other disulfated motif, CS-E, also 
exhibited neurite outgrowth activity in the same setting, but the CS-A and CS-C enriched 
polysaccharide did not9. Importantly. the activity from CS-E enriched polysaccharide was not 
inhibited by mAb 473HD, suggesting that the CS-D and CS-E enriched polysaccharides function 
through different structural motifs9. Interestingly, although both the CS-D and CS-E enriched 
polysaccharide stimulated neurite outgrowth, the morphology of the neurons were different. While 
the CS-D enriched polysaccharides stimulated the outgrowth of dendrite-like neurite, 
polysaccharides enriched in the other disulfated motif, CS-E, stimulated the elongation of a 
prominent long axon-like neurite4, suggesting again a sulfation pattern specific effect.  
While the literature suggests that the outgrowth promotion activity is sulfation pattern 
dependent, the polysaccharides or PGs used is far from being homogenous. For example, the CS-D 
and CS-E enriched polysaccharide contained only 20% and 56% of the desired CS-D and CS-E motif, 
respectively4, with the CS-A and CS-C motif being the major undesired component.  Although the 
contribution from the CS-D and CS-E motif can be inferred by the fact that the CS-A and CS-C 
enriched polysaccharide does not promote neurite outgrowth significantly, the heterogeneity still 
complicated the detailed analysis.  
Our group envisioned that chemically synthesized CS oligosaccharides can answer the urgent 
need of homogenous material and synthesized CS-A, CS-C, and CS-E tetrasaccharides. We 
demonstrated that the homogenous CS-E tetrasaccharide, but not the CS-A and CS-C 
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tetrasaccharides, promotes the neurite outgrowth of hippocampal, cortical, and dopaminergic 
neurons11-13, which further supported the existence of sulfation code.    
In this study, we present the neuritogenic effect of the chemically synthesized CS-D and CS-
E tetrasaccharides. We demonstrated that the CS-D tetrasaccharide specifically promotes dendritic 
outgrowth and the CS-E tetrasaccharide selectively promotes axonal outgrowth by the use of 
dendrite- and axon-specific markers.  
 
Neuritogenic activity of the CS-D and CS-E tetrasaccharides 
To explore the abilities of the CS-D and CS-E tetrasaccharides to modulate neuronal 
growth, primary rat E18 hippocampal neurons were cultured on a substratum coated with poly-D-
lysine (control) and the CS-D and CS-E tetrasaccharides. As opposed to previous studies where a 
short culture time (24 h to 48h) was used, we chose to culture the neuron for 4 days to allow axons 
and dendrites to be developed. After 4 days in vitro (DIV), the neurons were fixed and doubly 
immunostained with the axon-specific anti-Tau and dendrite-specific anti-microtubule associated 
protein 2 (MAP2) antibodies and examined by confocal microscopy.  
As shown in figure 3.1 and 3.2, the CS-D and CS-E tetrasaccharide exhibited distinct neurite 
outgrowth promoting activity. Total dendritic length of neurons cultured on CS-D tetrasaccharide 
substratum was increased by 83.0 ± 1.2%, relative to the poly-D-lysine control. The CS-D 
tetrasaccharide also enhanced the formation of a greater number of dendrites by 42.8 ± 2.0%. 
Surprisingly, the CS-D did not exhibit significant effect on axonal outgrowth, suggesting that the 
CS-D sulfation motif specifically stimulated dendritic growth. On the other hand, although the CS-
E tetrasaccharide stimulated dendritic growth by 24.7 ± 2.6%, it preferentially simulated the axonal 
outgrowth with much greater potency, by a relative increase of 72.1 ± 2.2%. Also, the CS-E did not 
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exert significant effect on dendrite number. While the CS-D and CS-E tetrasaccharides specifically 
promotes dendritic development and preferentially stimulated axonal growth, respectively, the CS-
D disaccharide showed no appreciable neuritogenic activity, demonstrating that a minimum length 
of tetrasaccharide is required for activity.  
This is the first study that demonstrated direct evidence of CS exhibiting dendrite- and axon-
specific activity with the immunostaining of dendrite- and axon-specific marker. This is also the first 
time a tetrasaccharide with homogeneous D pattern has been used in biological studies, which 
allowed us to observe activities that cannot be observed with just a disaccharide with D motif. The 
synthetic CS-D tetrasaccharide is also particularly valuable, since the available CS-D enriched 
polysaccharide has only 20% of the CS-D motif4 and may not allow exact determination of biological 
activities or observation of subtle property difference.  
Our result clearly indicated that specific sulfate patterns are required to modulate specific 
activity of CS. In the previous study, we demonstrated that the sulfation pattern, not total negative 
charges, dictates the function of CS by showing that an artificial tetrasulfated tetrasaccharide CS-R 
have no neuritogenic activity while the equally charged CS-E tetrasaccharide promoted neurite 
outgrowth12. The current work further conformed the observation, since the CS-D and CS-E 
tetrasaccharides also have the same amount of charges.  
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Figure 4.1. Representative immunofluorescence images of hippocampal neurons cultured on a 
substratum coated with poly-D-lysine (control) and the indicated synthetic tetrasaccharides (CS-D or 
CS-E) or synthetic CS-D disaccharide. Scale bar, 50 µm. Neurons were fixed at 4 DIV and stained 
with anti-MAP-2 (red) and anti-Tau (green). 
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Figure 3.2. Quantitative analysis of neuritogenic activity of CS-D and CS-E. (a) The CS-E 
tetrasaccharide, but not the CS-D tetrasaccharide, stimulated the axonal outgrowth of embryonic 
hippocampal neurons. (b) The CS-D tetrasaccharide stimulated the dendritic outgrowth of 
hippocampal neurons, with greater potency than the CS-E tetrasaccharide. (c) The CS-D 
tetrasaccharide induced an increase in the number of dendrites, whereas the CS-E tetrasaccharide 
had no effect on dendrite number. Data represent the mean ± SEM from three experiments and are 
expressed as the percentage growth or dendrite number relative to the poly-D-lysine control. n = 
80−200 cells per experiment. Statistical analyses were performed using the one-way ANOVA test 
(*P < 0.005, **P < 0.0005.) 
 
While having the same amount of negative charges, CSs with different sulfation patterns 
favor distinct structural conformations and present unique electrostatic surface for interaction with 
proteins, which may account for how the information encoded in the sulfation pattern is translated 
in cells. Indeed, our previous microarray study showed that the CS-E tetrasaccharide binds to the 
growth factors midkine and brain-derived neurotrophic factor and further demonstrated the 
abolishment of neuritogenic activity of CS-E by addition of the function-blocking antibodies against 
these growth factors or their cell surface receptors TrkB and receptor-type protein-tyrosine 
phosphatase zeta (RPTPβ), respectively. The allyl handle on the anomeric end of the CS-D and CS-
E tetrasaccharides allow the tetrasaccharides to be coated on microarrays. We expect microarrays 
displaying the tetrasaccharides to discover novel CS-protein interactions and account for the 
observed neuritogenic activity. 
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The ability of the CS-D and CS-E tetrasaccharide to stimulate dendritic and axonal outgrowth 
of hippocampal neurons suggests that CS may play critical roles in the developing CNS. Indeed, 
both CS-D and CS-E is expressed and spatiotemporally regulated in brains of embryonic and 
newborn mice14-15. The present work also supports previous studies that CS-D and CS-E studies 
implicate the function of CS-D and CS-E motif in the growth and development of neurons.  
 
Conclusion 
With the synthetic tetrasaccharides, we demonstrated the dendrite- and axon-specific 
stimulatory effect of CS-D and CS-E. The lack of function of the CS-D disaccharide suggested that 
a minimum length of tetrasaccharide is required. The findings indicate that the CS-D and CS-E may 
potentially play important roles in developing nervous system in vivo. We envision that future protein 
binding studies might provide more insight to the molecular mechanism of the observed neuritogenic 
activities.   
 
Experimental methods 
Buffers and Reagents 
Cell culture media was purchased from Gibco BRL (Grand Island, NY). Reagents and poly-
D-lysine coated plates were purchased from Fisher (Fairlawn, NJ). Anti-Tau antibody (MAB3420) 
and anti-MAP2 antibody (AB5622) were purchased from Millipore (Darmstadt, Germany). 
Secondary antibodies were purchased from Thermo Fisher Scientific (Waltham, MA). 
Calibration of CS concentrations 
The relative concentrations of the CS oligosaccharides were calibrated by using the carbazole 
assay for uronic acid residues. Briefly, the acid borate reagent (1.5 mL of a solution of 0.80 g sodium 
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tetraborate, 16.6 mL H2O, and 83.3 mL sulfuric acid) was added to glass vials. The oligosaccharides 
were added (50 µL of a 10 mg/mL stock in H 2O) and the solution placed in a boiling H2O bath for 
10 min. Following addition of the carbazole reagent (50 µL of 0.1% w/v carbazole in 100% ethanol), 
the solution was boiled for 15 min. The absorbance was read at 530 nm and compared to a D-
glucuronolactone standard in H2O. 
Hippocampal Neuronal Cultures 
Hippocampal neuronal cultures were prepared using a modified version of the Goslin and 
Banker protocol. Embryos at the E18 stage were obtained from timed-pregnant Sprague-Dawley 
rats, and the hippocampus from each embryo was dissected. All the hippocampi from one preparation 
were transferred to a 15 mL conical tube containing 4.5 mL of ice-cold Calcium and Magnesium 
Free-Hank’s Balanced Salt Solution (CMF-HBSS).  Trypsin (2.5%, no EDTA) was added to 5 mL, 
and the tissue was digested for 15 min at 37 °C. The trypsin solution was removed without affecting 
the tissue. The tissue was then rinsed with 5 mL of CMF-HBSS three times. Next, the tissue was 
dissociated in 1 mL of CMF-HBSS by passing through a P1000 pipet tip twenty times. The cells 
were counted with a hemacytometer and plated at 20 cells/mm2 on poly-D-lysine coated plates and 
cultivated in minimal Neurobasal supplemented with the GS21 mixture. The cultures were 
maintained in 5% CO2 at 37 °C for 4 days. Poly-D-lysine coated plates were precoated with 
compounds in PBS overnight at 37 °C/ 5% CO2. The coverslips were then washed three times with 
PBS. 
 Immunocytochemistry of hippocampal neuronal cultures 
After 4 days in culture, hippocampal neurons were used for immunostaining. Cells were 
rinsed one time with PBS, fixed in 4% paraformaldehyde for 20 min at rt, washed twice with PBS, 
permeabilized in 0.2% Triton X-100 for 15 min at rt, and washed three times with PBS. Non-specific 
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binding was blocked with 2.5% NGS for 1 h at rt. The blocking solution was rinsed off one time 
with PBS. Cells were then incubated with anti-tau antibody (1:800) and anti-MAP2 antibody 
(1:1500) with 2.5% NGS in 0.02% Triton X-100 overnight at 4 °C. Excess antibody was rinsed away 
5 times with PBS. Secondary antibody anti-rabbit AlexaFluor 546 (1:1000) and anti-mouse 
AlexaFluor 488 (1:1000) was used to fluorescently label the neurons for 1 hr at rt. Excess secondary 
antibody was washed off 5 times with PBS. Cells were then subjected to confocal laser microscopy.        
Morphometric Analysis  
The neurons were imaged with Zeiss LSM 5 Pascal inverted confocal microscope (Carl Zeiss 
Microscopy). The images were then subjected to MetaMorph (Molecular Devices) software for 
quantification.  
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